MOBQW Mobiquity Technologies Inc (PK)

Table of Contents

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED September 30, 2024

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

COMMISSION FILE NUMBER: 001-41117

 

MOBIQUITY TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)

 

new york		11-3427886
(State of jurisdiction of Incorporation)		(I.R.S. Employer Identification No.)
35 TORRINGTON LANE, SHOREHAM, NY		11786
(Address of principal executive offices		(Zip Code)

 

(516) 246-9422

(Registrant's telephone number)

 

Not Applicable

(Former name, address, and fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act: Common Stock, $.0001 par value and Common Stock Purchase Warrants

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes ☒    No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one)

 

	Large accelerated filer ☐	Accelerated filer ☐
	Non-accelerated filer ☒	Smaller reporting company ☒
	Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐    No ☒

 

The number of shares issued of the registrant’s common stock, as of November 13, 2024, was 17,149,356.

 

 

 

MOBIQUITY TECHNOLOGIES, INC.

 

FORM 10-Q QUARTERLY REPORT

TABLE OF CONTENTS

 

		PAGE
PART I. FINANCIAL INFORMATION		3
Item 1. Consolidated Financial Statements		3
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		33
Item 3. Quantitative and Qualitative Disclosures		42
Item 4. Controls and Procedures		43
PART II. OTHER INFORMATION		44
Item 1. Legal Proceedings		44
Item lA. Risk Factors		44
Item 2. Changes in Securities		44
Item 3. Defaults Upon Senior Securities		46
Item 4. Mine Safety Disclosures		46
Item 5. Other Information		46
Item 6. Exhibits		47
SIGNATURES		51

 

 

 

 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Mobiquity Technology, Inc.

Consolidated Balance Sheets

 

		September 30,				December 31,
		2024 (Unaudited)				2023
Assets
Current Assets
Cash		$	189,810			$	528,272
Accounts receivable			238,730				1,192,538
Less: Allowance for credit losses			(94,066	)			(1,157,910	)
Accounts receivable, net			144,664				34,628
Prepaid and other current assets			563,034				149,635
Total Current Assets			897,508				712,535
Property and equipment, net			5,384				7,298
Goodwill			1,352,865				1,352,865
Intangible assets, net			–				76,488
Capitalized software development costs, net			3,364,679				2,049,908
Total Assets		$	5,620,436			$	4,199,094
Liabilities and Stockholders' Equity
Current Liabilities
Accounts payable and accrued expenses		$	2,308,203			$	1,626,914
Accrued interest - related party			8,532				–
Contract liabilities			77,110				195,135
Debt, current portion, net			1,102,073				168,717
Total Current Liabilities			3,495,918				1,990,766
Total Liabilities			3,495,918				1,990,766
Commitments and Contingencies (Note 8)							–
Stockholders' Equity
AAA preferred stock; $0.0001 par value, 1,250,000 shares authorized, 31,413 shares issued and outstanding			3				3
Preferred stock Series E;  $0.0001 par value, 70,000 shares authorized, 61,688 shares issued and outstanding			6				6
Preferred stock Series H; $0.0001 par value, 770,000 shares authorized, zero and 768,473 shares issued and outstanding			–				78
Common stock; $0.0001 par value, 100,000,000 shares authorized, 16,609,356 and 3,994,926 shares issued, 16,606,839 and 3,992,426 shares outstanding			1,662				400
Treasury stock, at cost, $0.0001 par value 2,517 and 2,500 shares outstanding			(1,350,006	)			(1,350,000	)
Additional paid-in capital			223,584,558				220,598,180
Accumulated deficit			(220,111,705	)			(217,040,339	)
Total Stockholders' Equity			2,124,518				2,208,328
Total Liabilities and Stockholders' Equity		$	5,620,436			$	4,199,094

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

Mobiquity Technology, Inc.

Consolidated Statements of Operations (Unaudited)

 

		Three Months Ended								Nine Months Ended
		September 30,								September 30,
		2024				2023				2024				2023
Revenues		$	566,044			$	177,271			$	1,096,218			$	441,010
Cost of revenues			230,296				114,174				625,690				281,071
Gross profit			335,748				63,097				470,528				159,939
Operating expenses
General and administrative expenses			1,270,386				1,262,988				3,312,699				3,900,693
Depreciation and amortization			44,453				195,148				208,027				521,170
Total operating expenses			1,314,839				1,458,136				3,520,726				4,421,863
Loss from operations			(979,091	)			(1,395,039	)			(3,050,198	)			(4,261,924	)
Other income (expense)
Interest expense			(152,247	)							(323,119	)			(743,396	)
Loss on extinguishment of debt - related party			–				–				–				(396,322	)
Loss on disposal of fixed assets			–								–				(695	)
Other income			–				–				237,949				–
Interest income			22				768				4,678				2,323
Total other income (expense) - net			(152,225	)			768				(80,492	)			(1,138,090	)
Net loss before income taxes			(1,131,316	)			(1,394,271	)			(3,130,690	)			(5,400,014	)
Income tax benefit			–				–				59,324				180,000
Net loss		$	(1,131,316	)		$	(1,394,271	)		$	(3,071,366	)		$	(5,220,014	)
Loss per share - basic			(0.09	)			(0.38	)			(0.39	)			(2.53	)
Loss per share - diluted			(0.09	)			(0.38	)			(0.37	)			(2.53	)
Weighted average number of shares outstanding - basic			12,762,454				3,703,314				7,832,569				2,067,264
Weighted average number of shares outstanding - diluted			12,762,454				3,703,314				7,832,569				2,067,264

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

 

Mobiquity Technology, Inc.

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

For the Nine Months Ended September 30, 2024 and 2023

 

Series E Preferred Stock

Series F Preferred Stock

Series G Preferred Stock

Series H Preferred Stock

Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Balance, at December 31, 2022

61,688

$

6

–

$

–

–

$

–

–

$

–

Common stock and pre-funded warrants issued under public offering, net of issuance costs

–

–

–

–

–

–

–

–

Common stock issued under cashless warrant exercises and exercise of pre-funded warrants

–

–

–

–

–

–

–

–

Incentive common stock and warrants issued with long-term debt

–

–

–

–

–

–

–

–

Stock based compensation

–

–

–

–

–

–

–

–

Net Loss

–

–

–

–

–

–

–

–

Balance, at March 31, 2023

61,688

6

–

–

–

–

–

–

Common stock and pre-funded warrants issued under public offering, net of issuance costs

–

–

–

–

–

–

–

–

Common stock issued under cashless warrant exercises and exercise of pre-funded warrants

–

–

–

–

–

–

–

–

Common stock issued for services rendered

–

–

–

–

–

–

–

–

Common stock issued for conversion of interest

–

–

–

–

–

–

–

–

Stock based compensation

–

–

–

–

–

–

–

–

Series F preferred stock issued for cash

–

–

1

–

–

–

–

–

Net Loss

–

–

–

–

–

–

–

–

Balance, at June 30, 2023

61,688

6

1

–

–

–

–

–

Common stock issued under exercise of pre-funded warrants

–

–

–

–

–

–

–

–

Stock based compensation

–

–

–

–

–

–

–

–

Redemption of Series F preferred stock

–

–

–

–

–

–

–

–

Net Loss

–

–

–

–

–

–

–

–

Balance, at September 30, 2023

61,688

$

6

1

$

–

–

$

–

–

$

–

 

Series E Preferred Stock

Series F Preferred Stock

Series G Preferred Stock

Series H Preferred Stock

Shares

Amount

Shares

Amount

Shares

Amount

Shares

Amount

Balance, at December 31, 2023

61,688

$

6

–

$

–

–

$

–

768,473

$

78

Common stock issued for services

–

–

–

–

–

–

–

–

Common stock issued for cash

–

–

–

–

–

–

–

–

Stock based compensation

–

–

–

–

–

–

–

–

Accrued Series H Preferred Stock cash dividends

–

–

–

–

–

–

–

–

Repurchase of common stock held in Treasury

–

–

–

–

–

–

–

–

Net loss

–

–

–

–

–

–

–

–

Balance, at March 31, 2024

61,688

6

–

–

–

–

768,473

78

Common stock issued for services

–

–

–

–

–

–

–

–

Common stock issued for cash

–

–

–

–

–

–

–

–

Common stock subscribed

–

–

–

–

–

–

–

–

Stock based compensation

–

–

–

–

–

–

–

–

Accrued Series H Preferred Stock cash dividends

–

–

–

–

–

–

–

–

Warrants issued for services

–

–

–

–

–

–

–

–

Net loss

–

–

–

–

–

–

–

–

Balance, June 30, 2024

61,688

6

–

–

–

–

768,473

78

Common stock issued for services

–

–

–

–

–

–

–

–

Common stock subscribed

–

–

–

–

–

–

–

–

Common stock issued for cash

–

–

–

–

–

–

–

–

Stock based compensation

–

–

–

–

–

–

–

–

Accrued Series H Preferred Stock cash dividends

–

–

–

–

–

–

–

–

Warrants issued for services

–

–

–

–

–

–

–

–

Series H Preferred stock converted to common shares

(768,473

)

(78

)

Series H Preferred stock dividends converted to common stock

–

–

–

–

–

–

–

–

Net loss

–

–

–

–

–

–

–

–

Balance, September 30, 2024

61,688

6

–

$

–

–

$

–

–

$

–

 

 

Mobiquity Technology, Inc.

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited)

For the Nine Months Ended September 30, 2024 and 2023 (Continued)

 

		Series AAA Preferred Stock								Common Stock								Additional Paid-in				Stock Subscription				Treasury Shares								Accumulated				Total Stockholders' Equity
		Shares				Amount				Shares				Amount				Capital				Receivable				Shares				Amount				Deficit				(Deficit)
Balance, at December 31, 2022			31,413			$	3				620,776			$	62			$	211,846,321			$	–				2,500			$	(1,350,000	)		$	(210,507,222	)		$	(10,830	)
Common stock and pre-funded warrants issued under public offering, net of issuance costs			–				–				251,843				25				3,207,475				–				–				–				–				3,207,500
Common stock issued under cashless warrant exercises and exercise of pre-funded warrants			–				–				229,327				23				(23	)			–				–				–				–				–
Incentive common stock and warrants issued with long-term debt			–				–				34,849				4				708,460				–				–				–				–				708,464
Stock based compensation			–				–				–				–				12,304				–				–				–				–				12,304
Net Loss			–				–				–				–				–				–				–				–				(1,716,804	)			(1,716,804	)
Balance, at March 31, 2023			31,413				3				1,136,795				114				215,774,537				–				2,500				(1,350,000	)			(212,224,026	)			2,200,634
Common stock and pre-funded warrants issued under public offering, net of issuance costs			–				–				375,001				38				2,527,960				–				–				–				–				2,527,998
Common stock issued under cashless warrant exercises and exercise of pre-funded warrants			–				–				459,698				45				(45	)			–				–				–				–				–
Common stock issued for services rendered			–				–				31,891				3				80,408				–				–				–				–				80,411
Common stock issued for conversion of interest			–				–				92,378				9				235,554				–				–				–				–				235,563
Stock based compensation			–				–				–				–				9,757				–				–				–				–				9,757
Series F preferred stock issued for cash			–				–				–				–				100				–				–				–				–				100
Net Loss			–				–				–				–				–				–				–				–				(2,108,939	)			(2,108,939	)
Balance, at June 30, 2023			31,413				3				2,095,763				209				218,628,271				–				2,500				(1,350,000	)			(214,332,965	)			2,945,524
Common stock issued under exercise of pre-funded warrants			–				–				478,335				48				(48	)			–				–				–				–				–
Stock based compensation			–				–				–				–				234				–				–				–				–				234
Redemption of Series F preferred stock			–				–				–				–				–				–				–				–				–				–
Net Loss			–				–				–				–				–				–				–				–				(1,394,271	)			(1,394,271	)
Balance, at September 30, 2023			31,413			$	3				2,574,098			$	257			$	218,628,457			$	–				2,500			$	(1,350,000	)		$	(215,727,236	)		$	1,551,487

 

		Series AAA Preferred Stock								Common Stock								Additional Paid-in				Stock  Subscription				Treasury Shares								Accumulated				Total Stockholders'
		Shares				Amount				Shares				Amount				Capital				Receivable				Shares				Amount				Deficit				Equity
Balance, at December 31, 2023			31,413			$	3				3,994,926			$	400			$	220,598,180			$	–				2,500			$	(1,350,000	)		$	(217,040,339	)		$	2,208,328
Common stock issued for services			–				–				118,000				12				64,988				–				–				–				–				65,000
Common stock issued for cash			–				–				1,123,334				112				399,888				–				–				–				–				400,000
Stock based compensation			–				–												234				–				–				–				–				234
Accrued Series H Preferred Stock cash dividends			–				–				–				–				(46,108	)			–				–				–				–				(46,108	)
Repurchase of common stock held in Treasury			–				–				–				–				–				–				17				(6	)			–				(6	)
Net loss			–				–				–				–				–				–				–				–				(1,042,260	)			(1,042,260	)
Balance, at March 31, 2024			31,413				3				5,236,260				524				221,017,182				–				2,517				(1,350,006	)			(218,082,599	)			1,585,188
Common stock issued for services			–				–				39,754				4				24,031				–				–				–				–				24,035
Common stock issued for cash			–				–				2,124,000				213				1,061,787				–				–				–				–				1,062,000
Common stock subscribed			–				–				200,000				20				99,980				(100,000	)			–				–				–				–
Stock based compensation			–				–				–				–				941				–				–				–				–				941
Accrued Series H Preferred Stock cash dividends			–				–				–				–				(46,108	)			–				–				–				–				(46,108	)
Warrants issued for services			–				–				–				–				171,800				–				–				–				–				171,800
Net loss			–				–				–				–				–				–				–				–				(897,790	)			(897,790	)
Balance, June 30, 2024			31,413				3				7,600,014				761				222,329,613				(100,000	)			2,517				(1,350,006	)			(218,980,389	)			1,900,066
Common stock issued for services			–				–				65,772				7				42,110				–				–				–				–				42,117
Common stock subscribed			–				–				–				–				–				100,000				–				–				–				100,000
Common stock issued for cash			–				–				1,100,000				110				674,890				–				–				–				–				675,000
Stock based compensation			–				–				–				–				235				–				–				–				–				235
Accrued Series H Preferred Stock cash dividends			–				–				–				–				(30,738	)			–				–				–				–				(30,738	)
Warrants issued for services			–				–				–				–				446,200				–				–				–				–				446,200
Series H Preferred stock converted to common shares			–				–				7,684,730				768				(690	)			–				–				–				–				–
Series H Preferred stock dividends converted to common stock			–				–				158,840				16				122,938				–				–				–				–				122,954
Net loss			–				–				–				–				–				–				–				–				(1,131,316	)			(1,131,316	)
Balance, September 30, 2024			31,413			$	3				16,609,356			$	1,662			$	223,584,558			$	–				2,517			$	(1,350,006	)		$	(220,111,705	)		$	2,124,518

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

Mobiquity Technology, Inc.

Consolidated Statements of Cash Flows (Unaudited)

 

		Nine Months Ended
		September 30,
		2024				2023
Cash flows from operating activities:
Net loss		$	(3,071,366	)		$	(5,220,014	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation			1,914				5,806
Provision for credit losses			92,779				46,458
Loss on disposal of asset			–				695
Amortization of intangible assets			76,488				450,551
Amortization of capitalized software development costs			129,625				64,813
Amortization of debt discounts			265,556				738,142
Loss on debt extinguishment			–				396,322
Common stock and warrants issued for services			131,152				–
Stock-based compensation			1,410				22,295
Income tax benefit			59,324				180,000
Changes in operating assets and liabilities
(Increase) decrease in accounts receivable			(202,815	)			165,331
(Increase) decrease prepaid expenses and other assets			204,601				47,500
Increase (decrease) in accounts payable and accrued expenses			630,497				(626,415	)
Increase (decrease) in contract liabilities			(118,025	)			(3,953	)
Net cash used in operating activities			(1,798,860	)			(3,732,469	)
Cash flows from investing activities
Increase in software development costs			(1,444,396	)			(1,507,045	)
Cash flows from financing activities
Issuance of common stock for cash			2,237,000				–
Issuance of long-term debt, net of discounts and issuance costs			1,242,546				1,011,500
Repayments on long-term debt			(574,746	)			(1,587,500	)
Repurchase of treasury stock			(6	)			–
Issuance of common stock and pre-funded warrants for cash, net of issuance costs			–				5,735,499
Issuance of Series F preferred stock			–				100
Net cash provided by financing activities			2,904,794				5,159,599
Net change in cash			(338,462	)			(79,915	)
Cash - beginning of period			528,272				220,854
Cash - end of period		$	189,810			$	140,939
Supplemental disclosure of cash flow Information
Cash paid for interest		$	49,031			$	18,848
Cash paid for taxes		$	320			$	294
Supplemental disclosure of non-cash investing and financing activities:
Accrual of Series H Preferred stock dividends		$	122,954			$	–
Conversion of Series H preferred stock and accrued dividends to common stock		$	122,954			$	–
Warrants issued in conjunction with consulting agreement		$	446,200			$	–
Issuance of incentive shares with debt recorded as debt discount		$	–			$	122,426
Warrants issued with long-term debt recorded as debt discount		$	–			$	586,038
Common stock issued under cashless warrant exercises		$	–			$	117
Common stock issued for accrued interest		$	–			$	235,563
Common stock issued for settlement of accounts payable		$	–			$	80,410

 

The accompanying notes are an integral part of these unaudited consolidated financial statements.

 

 

MOBIQUITY TECHNOLOGIES, INC.

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

September 30, 2024

(UNAUDITED)

 

 

NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS

 

Mobiquity Technologies, Inc. and its operating subsidiaries (“Mobiquity,” “we,” “our” or “the Company”), are a next generation location data intelligence company. The Company provides precise unique, at-scale location data and insights on consumer’s real-world behavior and trends for use in marketing and research. We provide one of the most accurate and scaled solutions for mobile data collection and analysis, utilizing multiple geo-location technologies. The Company is seeking to implement several new revenue streams from its data collection and analysis, including, but not limited to, Advertising, Data Licensing, Footfall Reporting, Attribution Reporting, Real Estate Planning, Financial Forecasting and Custom Research. We also are a developer of advertising and marketing technology focused on the creation, automation, and maintenance of an advertising technology operating system (or ATOS). The ATOS platform blends artificial intelligence (or AI) and machine learning (ML) based optimization technology for automatic ad serving that manages and runs digital advertising campaigns.

 

Mobiquity Technologies, Inc. was incorporated in the State of New York and has the following subsidiaries:

Schedule of subsidiaries
Company Name		State of Incorporation
Mobiquity Networks, Inc.		New York
Advangelists, LLC		Delaware

 

Mobiquity Networks, Inc.

 

Mobiquity Networks, Inc. is a wholly owned subsidiary of Mobiquity Technologies, Inc., commencing operations in May 2018. Mobiquity Networks started and developed as a mobile advertising technology company focused on driving foot-traffic throughout its indoor network and has evolved and grown into a next generation data intelligence company. Mobiquity Networks, Inc. operates our data intelligence platform business.

 

Advangelists, LLC

 

Advangelists LLC is a wholly owned subsidiary of Mobiquity Technologies, Inc., acquired through a merger transaction in December 2018, and operates our ATOS platform business.

 

Reverse Stock Split

 

On August 7, 2023, we effected a one-for-15 reverse stock split. The consolidated financial statements and notes thereto give retroactive effect to the reverse stock split as if the split had occurred prior to the dates on the consolidated financial statements included herein.

 

Liquidity, Going Concern and Management’s Plans

 

These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.

 

 

 

8

 

 

As reflected in the accompanying consolidated financial statements, for the nine months ended September 30, 2024, the Company had:

 

·	Net loss of $3,071,366 and
·	Net cash used in operations was $1,798,860

 

Additionally, at September 30, 2024, the Company had:

 

·	Accumulated deficit of $220,111,705
·	Stockholders’ equity of $2,124,518, and
·	Working capital deficit of $2,598,410.

 

We manage liquidity risk by reviewing, on an ongoing basis, our sources of liquidity and capital requirements. The Company had cash on hand of $189,810 at September 30, 2024.

 

The Company has incurred significant losses since its inception in 1998 and has not demonstrated an ability to generate sufficient revenues from the sales of its products and services to achieve profitable operations. There can be no assurance that profitable operations will ever be achieved, or if achieved, could be sustained on a continuing basis. In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flows and cash usage forecasts for the year ended December 31, 2023, and the nine months ended September 30, 2024, and our current capital structure including equity-based instruments and our obligations and debts.

 

Without sufficient revenue from operations, if the Company does not obtain additional capital, the Company will be required to reduce the scope of its business development activities or cease operations.

 

These factors create substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued, as the Company will need additional capital to meet its financial obligations. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on the basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.

 

Management’s strategic plans include the following:

 

·	Execution of business plan focused on technology development and improvement,
·	Seek out equity and/or debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders and investors will continue to advance capital to the Company or that the new business operations will be profitable.
·	Continuing to explore and execute prospective partnering, distribution and acquisition opportunities,
·	Identifying unique market opportunities that represent potential positive short-term cash flow.

 

 

 

9

 

 

NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

  

Basis of Presentation

 

The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements (U.S. GAAP) and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (SEC). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months and nine months ended September 30, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 8, 2024.

 

Management acknowledges its responsibility for the preparation of the accompanying consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented.

 

Principles of Consolidation

 

These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.

 

Business Segments and Concentrations

 

The Company uses the “management approach” to identify its reportable segments. The management approach requires companies to report segment financial information consistent with information used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. The Company manages its business as a single reporting segment. Customers in the United States accounted for 100% of our revenues. We do not have any property or equipment outside of the United States.

 

Use of Estimates

 

Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of Company assets and liabilities, including the allowance for credit losses, stock-based compensation, the deferred tax asset valuation allowance, and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.

  

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks and the potential of overall business failure.

 

 

 

10

 

 

The Company has experienced, and in the future expects to continue to experience, variability in sales and net earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s service offerings. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

 

Fair Value of Financial Instruments

 

The Company accounts for financial instruments at fair value, which is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:

 

	·	Level 1—Valuation based on quoted market prices in active markets that the Company can access for identical assets or liabilities;
	·	Level 2—Valuation based on quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability; and
	·	Level 3—Valuation based on unobservable inputs that are supported by little or no market activity, which require management’s best estimate of what market participants would use as fair value.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management.

 

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include accounts receivable, accounts payable and accrued expenses, accrued interest – related party, and contract liabilities. On September 30, 2024, and December 31, 2023, the carrying amounts of these financial instruments approximated their fair values due to the short-term nature of these instruments. The fair value of the Company’s long-term debt approximates its carrying value based on current financing rates available to the Company.

 

The Company does not have any other financial or non-financial assets or liabilities that would be characterized as Level 1, Level 2, or Level 3 instruments.

 

Cash and Cash Equivalents and Concentrations of Risk

 

For the purposes of presentation in the consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents.

 

On September 30, 2024, and December 31, 2023, the Company did not have any cash equivalents.

 

The Company is exposed to credit risk on its cash in the event of default by the financial institutions to the extent account balances exceed the amount insured by the FDIC, which is $250,000. On September 30, 2024, and December 31, 2023, the Company did not experience any losses on cash balances in excess of FDIC insured limits. Any loss incurred or a lack of access to funds could have a significant impact on the Company’s consolidated financial condition, results of operations, and cash flows.

 

 

 

11

 

 

For the quarters ended September 30, 2024, and 2023, sales of our products to four customers and three customers generated approximately 86% and 96% of our revenues, respectively. For the nine months ended September 30, 2024, and 2023, sales of our products to five customers and three customers generated approximately 86% and 76% of our revenues, respectively. Our contracts with our customers generally do not obligate them to a specified term and they can generally terminate their relationship with us at any time with a minimal amount of notice. The loss of one of these customers could have a material adverse effect on the results of operations and financial condition.

 

Accounts Receivable and Allowance for Credit Losses

 

Effective January 1, 2023, the Company adopted Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326), which significantly change how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The most significant change in this standard is a shift from the incurred loss model to the expected loss model. Under the standard, disclosures are required to provide users of the consolidated financial statements with useful information in analyzing an entity’s exposure to credit risk and the measurement of credit losses. Financial assets held by the Company that are subject to the guidance in Topic 326 were trade accounts receivable. The impact of the adoption was not considered material to the consolidated financial statements.

 

Accounts receivable represent customer obligations under normal trade terms and are stated at the amount management expects to collect from outstanding customer balances. Credit is extended to customers based on an evaluation of their financial condition and other factors. Interest is not accrued on overdue accounts receivable. The Company does not require collateral. Two of our customers combined accounted for approximately 70% of outstanding accounts receivable at September 30, 2024.

 

The Company had accounts receivable, net, of $144,664, $34,628, and $340,935 at September 30, 2024, December 31, 2023, and January 1, 2023, respectively.

 

Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for credit losses. The Company provides its allowance for credit losses based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. Accounts determined to be uncollectible losses are charged to operations when that determination is made.

 

The allowance for credit losses for accounts receivable and the related activity, for the nine months ended September 30, 2024 is as follows:

Schedule of allowance for credit losses for accounts receivable activity
Balance, December 31, 2023		$	1,157,910
Provision for credit losses			92,779
Write-off of previously reserved account balances			(1,106,025	)
Balance, September 30, 2024		$	144,664

 

Provision for credit losses expense (recovery) is recorded as a component of general and administrative expenses in the accompanying consolidated statements of operations.

 

 

 

12

 

 

Impairment of Long-lived Assets

 

Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15“Impairment or Disposal of Long-Lived Assets.” Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets and compares this to the carrying amounts of the assets.

 

If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairment was recognized by the Company for the nine months ended September 30, 2024, and 2023.

 

Property and Equipment

 

Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets.

 

Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in current results of operations.

 

Goodwill

 

The Company’s goodwill represents the excess of the consideration transferred for the acquisition of Advangelists LLC in December 2018 over the fair value of the underlying identifiable net assets acquired. Goodwill is not amortized but instead, it is tested for impairment at least annually. If management determines that the value of goodwill has become impaired, the Company will record a charge in an amount equal to the excess of the reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit during the fiscal quarter in which the determination is made.

 

The Company performs its annual impairment tests of goodwill as of December 31st of each year, or more frequently, if certain indicators are present. Goodwill is required to be tested for impairment at the reporting unit level. A reporting unit is an operating segment or one level below the operating segment level, which is referred to as a component. Management identifies its reporting units by assessing whether components (i) have discrete financial information available, (ii) engage in business activities, and (iii) whether a segment manager regularly reviews the component’s operating results. Net assets and goodwill of acquired businesses are allocated to the reporting unit associated with the acquired business based on the anticipated organizational structure of the combined entities. If two or more components are deemed economically similar, those components are aggregated into one reporting unit when performing the annual goodwill impairment review. The Company has one reporting unit as of September 30, 2024, and December 31, 2023. No impairment of goodwill was recognized by the Company during fiscal 2023 or the nine-month period ended September 30, 2024.

 

Intangible Assets

 

In December 2018, the Company acquired the majority of its intangible assets through its acquisition of Advangelists LLC, which included customer relationships and the ATOS platform technology. The Company amortizes its identifiable definite-lived intangible assets over an estimated period of 5 years.

 

 

 

13

 

 

Capitalized Software Development Costs

 

In accordance with ASC 350-40, Internal Use Software, the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i) the research and planning stage, (ii) the application and development stage, and (iii) the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. These software developments and acquired technology are amortized on a straight-line basis over the estimated useful life of five years upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess of carrying value over the fair value in its consolidated statements of operations. See Note 3 for further details.

 

Derivative Financial Instruments

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, (ASC 480), Distinguishing Liabilities from Equity and FASB ASC Topic No. 815, (ASC 815) Derivatives and Hedging.

 

Terms of financial instruments are reviewed to determine whether they contain embedded derivative instruments that are required to be accounted for separately from the host contract under ASC 815 and recorded on the balance sheet at fair value. Derivative liabilities are remeasured to reflect fair value at each reporting period, with any increase or decrease in the fair value being recorded in the results of operations. The Company generally incorporates a binomial model to determine fair value. Upon conversion of a debt instrument where an embedded conversion option has been bifurcated and accounted for separately as a derivative liability, the Company records the resulting shares issued at fair value, derecognizes all related debt principal, derivative liability, and debt discount, and recognizes a net gain or loss on debt extinguishment. Equity instruments that are initially classified as equity that become subject to reclassification under ASC 815 are reclassified to liabilities at the fair value of the instrument on the reclassification date. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. As of September 30, 2024, and December 31, 2023, the Company had no derivative instruments outstanding.

 

Debt Issuance Costs and Debt Discounts

 

Debt discounts, debt issuance costs paid to lenders or third parties, and other original issue discounts on debt, are recorded as debt discounts and amortized to interest expense in the consolidated statement of operations, over the term of the underlying debt instrument, using the effective interest method, with the unamortized portion reported net with related principal outstanding on the consolidated balance sheet. For the three months ended September 30, 2024, and 2023, the Company recognized $118,262 and no interest expense associated with the amortization of debt discounts on debt outstanding during the periods. For the nine months ended September 30, 2024, and 2023, the Company recognized $265,556 and $738,142 in interest expense associated with the amortization of debt discounts on debts outstanding during the periods. Unamortized debt discounts remaining at September 30, 2024 were approximately $229,000 and are expected to be fully amortized during the remainder of 2024. See Note 4 regarding the accounting for debt discounts and debt issuance costs during fiscal 2024 and 2023.

 

 

 

14

 

 

Revenue Recognition

 

The Company’s revenues are generated from internet advertising, the Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (ASC 606). In accordance with ASC 606, revenue is recognized when promised services are transferred to a customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:

 

Identify the contract with a customer.

 

A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

  

Identify the performance obligations in the contract.

 

Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services (performance obligations), the Company must apply a judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation. Currently, the Company does not have any contracts that contain multiple performance obligations.

 

Determine the transaction price.

 

The transaction price is determined based on the consideration of which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts outstanding at September 30, 2024 or December 31, 2023, contained a significant financing component or variable consideration terms.

 

Allocate the transaction price to performance obligations in the contract.

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation.

 

 

 

15

 

 

Recognize revenue when or as the Company satisfies a performance obligation.

 

The Company satisfies performance obligations at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised service to a customer. Under both managed services arrangements and self-service arrangements, the Company’s promised services under the contracts include identification, bidding and purchasing of advertisement opportunities. The Company also generally has discretion in establishing the pricing of the ads. Since the Company is controlling the promise to deliver the contracted services, the Company is considered the principal in all arrangements for revenue recognition purposes. The performance obligations are satisfied, and revenue recognition primarily upon publication of customer advertising content.

 

All revenues recognized were derived from internet advertising for the periods ended September 30, 2024, and 2023.

 

Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 90 days.

 

Contract Liabilities

 

Contract liabilities represent deposits made by customers before the satisfaction of performance obligation and recognition of revenue. Upon completion of the performance obligation(s) that the Company has with the customer based on the terms of the contract, the liability for the customer deposit is relieved and revenue is recognized. As of September 30, 2024, December 31, 2023, and January 1, 2023, there were $77,110, $195,135, and $193,598, respectively, in contract liabilities outstanding. Contract liabilities are expected to be recognized as revenue within the year following their respective period end.

 

Advertising

 

Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expenses in the consolidated statements of operations. Advertising costs incurred were insignificant for the periods ended September 30, 2024, and 2023.

  

Stock-Based Compensation

 

The Company accounts for our stock-based compensation, including stock options and common stock warrants, under ASC 718 Compensation – Stock Compensation, using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the requisite service period for employee awards, which is usually the vesting period, and when the goods are obtained or services are received, for nonemployee awards. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also applies to transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

In connection with certain financing, consulting and collaboration arrangements, the Company may issue warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards.

 

The fair value of stock-based compensation is generally determined by using the Black-Scholes valuation model as of the date of the grant or the date at which the performance of the services is completed (measurement date).

 

 

 

16

 

 

When determining the fair value of stock-based compensation, the Company considers the following assumptions in the Black-Scholes model:

 

·	Exercise price,
·	Expected dividends,
·	Expected volatility,
·	Risk-free interest rate; and
·	Expected life of option

 

Income Taxes

 

The Company accounts for income tax using the asset and liability method prescribed by ASC 740, Income Taxes (ASC 740). Under this method, deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more likely-than-not that all or some portion of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as gain or loss in the period that includes the date of the enactment.

 

The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740. Using that guidance, tax positions initially need to be recognized in the consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of September 30, 2024, and December 31, 2023, the Company did not identify any uncertain tax positions that qualify for either recognition or disclosure in the consolidated financial statements.

 

The Company recognizes interest and penalties, if any, related to recognized uncertain income tax positions, in other expense. No interest and penalties related to uncertain income tax positions were recorded for the periods ended September 30, 2024, and 2023. Open tax years, subject to examination by the Internal Revenue Service, generally remain open for three years from the filing date. Tax years subject to examination by the state jurisdiction generally remain open for up to four years from the filing date.

 

Related Parties

 

Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.

  

Recently Adopted Accounting Pronouncements 

 

We consider the applicability and impact of all new accounting pronouncements on our consolidated financial position, results of operations, stockholders’ equity, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the Financial Accounting Standards Board (FASB) through the date these consolidated financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective, that when adopted, will have a material impact on the consolidated financial statements of the Company.

 

 

 

17

 

 

NOTE 3: INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS

 

The Company’s definite-lived intangible assets consist of a customer relationship asset acquired through the Advangelists, LLC acquisition in 2018, and capitalized software development costs. The intangible assets are being amortized over their estimated useful lives of five years. The Company periodically evaluates the reasonableness of the useful lives of these assets. These assets are also reviewed for impairment or obsolescence when events or circumstances indicate that the carrying amount may not be recoverable. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.

Schedule of intangible assets
		Useful Lives		September 30, 2024				December 31, 2023
Customer relationship		5 years		$	3,003,676			$	3,003,676
Less accumulated amortization					(3,003,676	)			(2,927,188	)
Net carrying value				$	–			$	76,488
Software development costs		5 years		$	3,602,328			$	2,157,932
Less accumulated amortization					(237,649	)			(108,024	)
Net carrying value, software development costs				$	3,364,679			$	2,049,908

  

During the three months ended September 30, 2024, and 2023, the Company recognized zero and $150,184 in amortization expense, respectively, related to the customer relationship intangible asset, which is included in general and administrative expenses on the accompanying consolidated statements of operations. During the nine months ended September 30, 2024, and 2023, the Company recognized $76,488 and $450,551 in amortization expense, respectively, related to the customer relationship intangible asset.

  

During each of the three months ended September 30, 2024, and 2023, the Company recognized $43,209 of amortization expense related to software development costs, which is included in general and administrative expenses on the accompanying consolidated statements of operations. During the nine months ended September 30, 2024, and 2023, the Company recognized $129,625 and $64,813, respectively, of amortization expense related to software development costs.

 

As of September 30, 2024, and December 31, 2023, the Company has capitalized a total of approximately $3,600,000 and $2,200,000, respectively, of costs associated with the development of its new software enhancements, referred to as ATOS4P and AdHere. The approximately $1,440,000 in costs capitalized during the nine months ended September 30, 2024, were all related to AdHere enhancement only. The Company ceased capitalizing costs, and commenced marketing its ATOS4P enhancement to the public, during the second quarter of 2023. As of September 30, 2024, the Company has not commenced amortization of the costs associated with the AdHere technology. The product has been released to the public in October of 2024, at which time the Company began amortizing the costs.

 

Future amortization of the approximately $3,400,000 in unamortized software development costs, by fiscal year, at September 30, 2024, is as follows:

Schedule of future annual amortization
		Software Development Costs
Remainder of 2024		$	180,116
2025			720,466
2026			720,466
2027			720,466
2028			612,443
2029			410,722
Total		$	3,364,679

 

 

 

18

 

 

NOTE 4 – DEBT

 

Small Business Administration Loan

 

In June 2020, the Company received an Economic Injury Disaster Loan of $150,000 from the Small Business Administration (SBA) which carries a thirty-year term, and interest at 3.7% per annum, with a maturity date in July of 2050. The loan is to be repaid in monthly installments, including principal and interest, of $731, beginning twelve months from the date of the loan. Total accrued and unpaid interest on the debt was $13,594 at December 31, 2022 and is included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. On January 5, 2023, the Company paid $163,885 to the Small Business Administration to pay off all outstanding principal and accrued interest on the Company’s SBA loan.

 

Investor Note Payable

 

On December 30, 2022, the Company and Walleye Opportunities Master Fund Ltd, a Cayman Islands company (the Investor), entered into a Securities Purchase Agreement (the SPA) for the Investor to purchase from the Company (i) a senior secured 20% original issue discount (OID) nine-month promissory note in an aggregate gross principal amount of $1,437,500, less the 20% OID of $287,500, for a net subscription amount of $1,150,000 (the Investor Note), and (ii) a five year warrant to purchase 174,242 shares of the Company’s common stock at an exercise price of $6.60 per share, exercisable commencing July 1, 2023 and expiring December 30, 2027 (the Investor Warrant). Proceeds from the SPA were received by the Company in January 2023. Per terms of the SPA, if at any time commencing July 1, 2023, the Company issues, sells, or announces for sale, any shares of its common stock (Subsequent Equity Sale) for a per share price less than the exercise price of the Investor Warrant in effect immediately prior to such Subsequent Equity Sale, the exercise price of the Investor Warrant shall be reduced to an amount equal to the issuance price of the Subsequent Equity Sale.

 

In conjunction with the SPA, the Company issued 34,849 shares of common stock, or approximately 5.3% of the Company’s outstanding shares at the time, to the Investor as an incentive on the transaction (Incentive Shares). Total issuance fees of $138,500 associated with the closing of the SPA were paid by the Company to Spartan Capital Securities LLC and the Investor’s counsel, resulting in net proceeds of $1,011,500. Approximately $163,000 of the loan proceeds were utilized to repay the outstanding principal and accrued interest under the SBA loan (see above).

 

The Investor Note will only become convertible into common stock upon the occurrence of an Event of Default under and as defined in the Investor Note on terms set forth in the Investor Note. This Investor Note matures and was payable on or before September 30, 2023, and it provided that the Investor may demand prepayment after March 31, 2023, and before the maturity date, provided that the purchasers of securities in a future public offering by the Company, as defined in the SPA, who hold the purchased Company securities at the time the prepayment demand, unanimously consent to the prepayment. On June 30, 2023, the secured debt was paid in full through the proceeds of the Company’s June 2023 Offering. See Note 5.

 

The aforementioned Investor Warrant was assigned a relative fair value of $586,040 and the Incentive Shares were assigned a relative fair value of $122,426, at the date of closing on the SPA. The fair values of the Investor Warrant, the Incentive Shares, the OID of $287,500, and the $138,500 in debt issuance costs paid, were recorded as debt discounts and debt issuance costs totaling $1,134,466. Amortization associated with the total debt discounts is being recognized using the effective interest method over the term of the Investor Note, which matured on September 30, 2023. For the quarter ended March 31, 2023, $360,993 in amortization on the debt discounts was recognized as interest expense and is included on the accompanying consolidated statement of operations for the nine months ended September 30, 2023.

 

 

 

19

 

 

Related Party - Salkind Loans

 

On October 10, 2023, the Company received a $300,000 loan from the Marital Trust GST Subject U/W/O Leopold Salkind (Salkind October 2023 Loan), a related party through the Company’s Board chair. This unsecured loan has a maturity date of November 30, 2023, with interest at the rate of 15% per annum. The note is payable in cash on the maturity date; however, the debt holder has the right to convert the loan into restricted common stock at a conversion price of $0.70 per share or to apply the loan repayment to invest on the terms of any private financing completed by the Company prior to the maturity date. Exemption from registration for the aforesaid transactions is claimed under Section 4(2) of the Securities Act of 1933, as amended. In November 2023, the Salkind October 2023 Loan principal outstanding of $300,000 plus accrued and unpaid interest, were converted into shares of the newly designated Series G Preferred Stock. See Note 5.

 

In February 2024, Dr. Salkind, Board Chairman, loaned the Company $150,000 of short-term debt financing for working capital (Salkind February 2024 Loan). The unsecured loan was payable on demand and boar interest at 10% per annum, payable monthly.

 

On June 27, 2024, the Company entered into a new Loan Agreement with Dr. Salkind and a relative of Dr. Salkind (Salkind June 2024 Loan) for no additional consideration from the lenders, effectively cancelling the Salkind February 2024 Loan. The Salkind June 2024 Loan is a $160,000 non-interest-bearing loan, which includes an Original Issue Discount of $10,000. The $160,000 in principal is due on demand on or after December 31, 2024, and is convertible at the option of the lenders at any time into shares of the Company’s restricted common stock at a conversion rate of $0.50 per share. As of June 30, 2024, the full $150,000 in principal remains outstanding and the Company has recognized amortization of $5,080 on the debt discount.

 

On July 5, 2024, the Company entered into a Loan Agreement with Dr. Salkind for additional proceeds of $50,000. On July 23, 2024, the Company entered into a Loan Agreement with Dr. Salkind’s son for additional proceeds of $50,000. The total principal of $100,000 related to these July 2024 loans remains outstanding at September 30, 2024 and the Company has recognized amortization of $643 on the debt discount for the periods ended September 30, 2024. Both July 2024 loans were issued under the same non-interest, repayment, and conversion terms as the Salkind June 2024 Loan.

 

Related Party - Other Loans

 

During the quarter ended June 30, 2024, the Company entered into the following loan agreements with its corporate attorney in exchange for cash or the cancellation of invoices outstanding related to legal services performed by the attorney.

 

Loan 1, dated April 2024, was a non-interest-bearing demand loan issued in exchange for $70,000 cash, and included a $4,000 discount. The $74,000 in principal was paid in full prior to June 30, 2024, and the Company recognized $4,000 in interest expense associated with the debt discount during the nine months ended September 30, 2024.

 

Loan 2, dated April 2024, was a non-interest-bearing demand loan issued in exchange for $40,000 in cash. The principal was paid in full prior to June 30, 2024.

 

Loan 3, dated June 2024, is a non-interest-bearing demand loan issued in exchange for the cancellation of $20,000 in invoices outstanding related to legal services performed. Loan 3 included an Original Issue Discount (OID) of $5,000. The $25,000 in principal and Original Issue Discount is payable on demand on or after December 31, 2024, and is also convertible at the option of the lender into the Company’s restricted common stock at a conversion rate of $0.50 per share. As of September 30, 2024, the full $20,000 in principal and $5,000 in OID remains payable and the Company has recognized amortization of $2,734 on the debt discount.

 

 

 

20

 

 

Loan 4, dated June 2024, is a non-interest-bearing demand loan issued in exchange for $37,000 in cash. Loan 4 included an Original Issue Discount of $15,000. The $52,000 in principal and Original Issue Discount is payable on demand at any time on or after December 31, 2024, and is also convertible at the option of the lender into the Company’s restricted common stock at a conversion rate of $0.50 per share. As of September 30, 2024, the full $37,000 in principal and $15,000 in OID remains payable and the Company has recognized amortization of $8,100 on the debt discount.

 

During the quarter ended September 30, 2024, the Company entered into the following loan agreements with its corporate attorney in exchange for cash.

 

Loans 5 and 6, dated July 2024, consists of two verbal, non-interest-bearing loans totaling $78,000 to the Company on a short-term basis. The $78,000 in principal is payable on demand, of which $27,000 remained payable at September 30, 2024.

 

Loan 7, dated September 2024, consists of a verbal, non-interest-bearing loan issued in exchange for $75,000 in cash on a short-term basis. The $75,000 in principal is payable on demand, of which $60,000 remained payable at September 30, 2024.

 

On October 8, 2024, the corporate attorney and the Company entered into a modification to Loans 3, 4, 5, 6, and 7 above which provides the following:

 

	·	Loans 3 and 4 were amended to include a provision that, if the Company elects to prepay the loans, the Company will provide at least five days written notice to the debt holder of such intent for prepayment allowing the debt holder the opportunity to convert the debt.
	·	Loans 5, 6, and 7, totaling $87,000 in outstanding principal were amended to add a $13,000 OID and a conversion option in which the debt and OID are convertible at any time at a rate of $1.00 per share at the option of the debt holder. In addition, in the event the Company receives additional financing or revenues, the Company shall, by Friday of each week in which such event occurs, notify the debt holder and shall give the debt holder the opportunity to demand immediate payment of at least 15% of such financing and/or revenues received by the Company until Loans 5, 6, and 7 have been paid in full.
	·	The parties agree that all repayments of loans by the Company to the debt holder shall first reduce the outstanding principal and OID of Loans 5, 6, and 7.

 

Merchant Agreements

 

In November 2023, the Company entered into an agreement for the purchase and sale of future receivables (2023 Merchant Agreement) with a financial institution in exchange for $200,000 in funding (the 2023 Purchase Price). The 2023 Purchase Price is to be repaid through daily payments representing 10% of future customer payments on receivables until a total of $272,000 is paid. The Company recorded a debt discount associated with the 2023 Merchant Agreement totaling $72,000 which is being amortized through interest expense over the expected term of the agreement of 170 days. The Company recognized $33,578 in interest expense associated with the amortization of the debt discount for the six months ended June 30, 2024. In connection with the 2023 Merchant Agreement, and as additional consideration, the Company has agreed to issue 16,765 shares of its Common Stock to the financial institution in an amount equal to 5% of the Purchase Price, or $10,500, which was recorded as additional debt discount. The number of shares issued is equal to 5% of the 2023 Purchase Price divided by the average closing per share price of the common stock for the previous twenty (20) days from the signed date of the 2023 Merchant Agreement. The balance of the 2023 Merchant Agreement funding was repaid in full during the quarter ended June 30, 2024.

 

 

 

21

 

 

In February 2024, the Company entered into an agreement for the purchase and sale of future receivables (February 2024 Merchant Agreement) with the same financial institution associated with the 2023 Merchant Agreement for the sale of future receivables in exchange for $150,000 in funding (the 2024 Purchase Price), less a $7,500 origination fee. The 2024 Purchase Price is to be repaid through daily payments representing 10% of future customer payments receivables until a total of approximately $205,350 is paid. The Company recorded a debt discount associated with the February 2024 Merchant Agreement totaling $62,850 which is being amortized through interest expense over the expected term of the agreement of 170 days. In connection with the February 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 20,135 shares of its Common Stock to the financial institution in an amount equal to 5% of the Purchase Price, or $7,500, which was recorded as additional debt discount. The balance of the February 2024 Merchant Agreement funding was repaid in full in August of 2024. The Company recognized $62,850 in interest expense associated with the amortization of the debt discounts for the nine months ended September 30, 2024.

 

In April 2024, the Company entered into an agreement for the purchase and sale of future receivables (April 2024 Merchant Agreement) with a financial institution for the sale of future receivables in exchange for $250,000 in funding (the April 2024 Purchase Price) in exchange for $127,000 in cash and full settlement of the November 2023 Merchant Agreement funding discussed above. The Purchase Price is to be repaid through daily payments representing 10% of future customer payments receivables until a total of approximately $342,250 is paid. In connection with the April 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 12,854 shares of its common stock to the financial institution in an amount equal to 5% of the Purchase Price, or $12,500, which was recorded as additional debt discount. The number of shares issued is equal to 5% of the Purchase Price divided by the average closing per share price of the Company’s common stock for the previous twenty (20) days from the signed date of the Merchant Agreement. This agreement superseded the Merchant Agreement executed in November 2023. In August 2024, the total balance of principal and interest payable on the February 2024 Merchant Agreement funding of approximately $60,000, was rolled into the August 2024 Merchant Agreement funding, as discussed below. The balance of the April 2024 Merchant Agreement funding was repaid in full on September 30, 2024. The Company recognized approximately $103,000 in interest expense associated with the amortization of the debt discounts for the nine months ended September 30, 2024.

 

In August 2024, the Company entered into an agreement for the purchase and sale of future receivables (August 2024 Merchant Agreement) with a financial institution for the sale of future receivables in exchange for $200,000 in funding (the August 2024 Purchase Price), of which $121,147 represented cash proceeds, and the balance applied as full settlement of the outstanding obligations under the February 2024 Merchant Agreement funding discussed above. The Purchase Price is to be repaid through daily payments representing 16% of future customer payments received until a total of approximately $273,800 is paid. In connection with the August 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 2,779 shares of its common stock to the financial institution in an amount equal to 5% of the new principal Advance Amount, or $6,057, which was recorded as debt discount. The number of shares issued is equal to 5% of the Advance Amount divided by the average closing per share price of the Company’s common stock for the previous twenty (20) days from the date signed by the Merchant Agreement. The balance of the Merchant Agreement funding is expected to be repaid in full within the next year.

 

In September 2024, the Company entered into an agreement for the purchase and sale of future receivables (September 2024 Merchant Agreement) with a financial institution for the sale of future receivables in exchange for $250,000 funding (the September 2024 Purchase Price), of which $98,699 represented cash proceeds, and the balance applied as full settlement of the outstanding obligations under the April 2024 Merchant Agreement funding discussed above. The Purchase Price is to be repaid through daily payments representing 12% of future customer payments received until a total of approximately $342,250 is paid. In connection with the September 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 1,993 shares of its common stock to the financial institution in an amount equal to 5% of the new principal Advance Amount, or $5,560, which was recorded as debt discount. The number of shares issued is equal to 5% of the Advance Amount divided by the average closing per share price of the Company’s common stock for the previous twenty (20) days from the date signed by the Merchant Agreement. The balance of the Merchant Agreement funding is expected to be repaid in full within the next year.

 

 

 

22

 

 

For the three and nine months ended September 30, 2024, the Company recognized approximately $107,000 and $240,000 in interest expense associated with the amortization of the debt discounts on the February, April, August and September 2024 Merchant Agreements. The remaining unamortized debt discounts, totaling approximately $162,000, are expected to be expensed in full as interest expense within the next year, in conjunction with the principal payments.

 

2024 Promissory Notes

 

In March 2024, the Company issued a promissory note in the principal amount of $126,500 with an Original Issue Discount (OID) of $16,500 (March 2024 Promissory Note). Interest is charged on the principal at 14% upon issuance of the promissory note, totaling $17,710, and is payable, along with principal, in five individual payments commencing September 15, 2024, through the maturity date of January 15, 2025. In addition to the OID, the Company paid $8,150 in issuance costs associated with the 2024 March Promissory Note and recorded a debt discount totaling $24,650 which is being amortized over the repayment period of the principal through interest expense. The Company recognized $1,126 and $7,957 in interest expense for the three and nine months ended June 30, 2024, respectively, associated with amortization of the debt discount on the March 2024 Promissory Note. Solely upon an event of default, and at the option of the holder, all amounts outstanding under the March 2024 Promissory Note are convertible into shares of the Company’s common stock, at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the ten trading days prior to the conversion date. In the event of default, all outstanding obligations under the March 2024 Promissory Note shall become due and payable at 150% of the outstanding principal amount plus accrued and unpaid interest, plus any other amounts owed under the March 2024 Promissory Note. Approximately $69,000 in principal and OID remain outstanding at September 30, 2024.

 

In April 2024, the Company issued a promissory note in the principal amount of $96,000 with an Original Issue Discount of $16,000 (April 2024 Promissory Note). Interest is charged on the principal at 15% upon issuance of the April 2024 Promissory Note, totaling $14,400, and is payable, along with principal, in ten individual payments of $11,040 commencing May 30, 2024, through the maturity date of March 31, 2025. The Company recognized $4,149 in interest expense for the nine months ended June 30, 2024, associated with amortization of the debt discount on the April 2024 Promissory Note. Solely upon an event of default, and at the option of the holder of the April 2024 Promissory Note, all amounts outstanding under the April 2024 Promissory Note become convertible into shares of the Company’s common stock, at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the ten trading days prior to the conversion date. In the event of default, the April 2024 Promissory Note shall become due and payable at 150% of the outstanding principal amount of the April 2024 Promissory Note plus accrued and unpaid interest, plus any other amounts owed under the promissory note. Approximately $51,000 in principal and OID remain outstanding at September 30, 2024.

 

In September 2024, the Company issued a promissory note in the principal amount of $98,900 with an Original Issue Discount of $20,300 (September 2024 Promissory Note). Interest is charged on the principal at 14% upon issuance of the September 2024 Promissory Note, totaling $13,846, and is payable, along with principal as follows: $56,373 due March 15, 2025, $14,093 due on each of April 15, 2025 and May15, 2025 and $14,874 due on June 15, 2025 and on the maturity date of July 15,2025. The Company recognized $362 in interest expense for the nine months ended September 30, 2024, associated with amortization of the debt discount. Solely upon an event of default, and at the option of the holder of the September 2024 Promissory Note, all amounts outstanding under the September 2024 Promissory Note become convertible into shares of the Company’s common stock, at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the ten trading days prior to the conversion date. In the event of default, the September 2024 Promissory Note shall become due and payable at 150% of the outstanding principal amount of the September 2024 Promissory Note plus accrued and unpaid interest, plus any other amounts owed under the promissory note.

 

In August 2024, the Company entered into a financing arrangement with their Directors and Officers (D&O) insurance provider to fund the annual premium related to the D&O insurance policy. The total amount financed was $112,500, and incurs interest at a rate of 8.14% per annum, with nine monthly payments of principal and interest of $12,928 through May 2025.

 

 

 

23

 

 

Following is a summary of debt outstanding at December 31, 2023 and September 30, 2024:

Schedule of debt outstanding
		September 30, 2024 (Unaudited)				December 31, 2023
Merchant Agreements		$	561,290			$	216,089
Related Party – Salkind Loans			261,500				–
Related Party – Other Loans			177,000				–
2024 Promissory Notes			331,640				–
Total Debt			1,331,430				216,089
Less: Unamortized debt discounts			(229,357	)			(47,372	)
Current portion of debt		$	1,102,073			$	168,717

 

NOTE 5 – STOCKHOLDERS’ EQUITY

 

On August 7, 2023, the Company effected a 1-for-15 reverse stock split of its common stock, with all fractional common shares rounded up to the nearest whole number. The effects of this rounding resulted in the issuance of 14,162 additional shares of common stock at the time of the split.

 

The Company’s authorized capital stock consists of 105,000,000 shares, comprised of 100,000,000 shares of common stock, per share par value $0.0001, and 5,000,000 shares of preferred stock, per share par value $0.0001.

   

Of the 5,000,000 shares of preferred stock authorized, the Board of Directors has designated the following:

 

	·	1,500,000 shares as Series AA Preferred Stock, none outstanding
	·	1,250,000 shares as Series AAA Preferred Stock, 31,413 shares outstanding
	·	1,250 shares as Series AAAA Preferred Stock, none outstanding
	·	1,500 shares as Series C Preferred Stock, none outstanding
	·	2 shares as Series B Preferred Stock: none outstanding
	·	70,000 shares as Series E Preferred Stock, 61,688 shares outstanding
	·	One share of Series F Preferred Stock, none outstanding
	·	300,789 shares of Series G Preferred Stock, none outstanding
	·	770,000 shares of Series H Preferred Stock, none outstanding

 

Rights Under Preferred Stock

 

The Company’s classes of preferred stock include the following provisions:

 

Optional Conversion Rights of Preferred Stock

 

	·	Series AA – one share convertible into 3.33 shares of common stock
	·	Series AAA – one share convertible into 6.67 shares of common stock
	·	Series C – one share convertible into 6,667 shares of common stock
	·	Series E – one share at a rate of its Stated Value, as defined, divided by $0.08, convertible commencing January 31, 2020
	·	Series G – one share convertible into shares of common stock at a rate of its Stated Value divided by $0.50 (Series G Conversion Ratio)
	·	Series H – one share was convertible into shares of common stock at a rate of its Stated Value ($2.00 at August 7, 2024, date of mandatory conversion discussed below) divided by $0.20 (Series H Conversion Ratio)

 

 

 

24

 

 

Redemption Rights

 

Series E preferred stock is redeemable at any time upon 30 days’ written notice by the Company and the shareholders, at a rate of 100% of the Stated Value, as defined.

 

Mandatory Conversion Right

 

Any outstanding shares of Series G Preferred Stock shall automatically convert into common stock based on the Series G Conversion Ratio if the closing sales price of the Company’s common stock for ten (10) consecutive trading days closes over $5.00 per share.

 

Any outstanding shares of Series H Preferred Stock shall automatically convert into common stock based on the Series H Conversion Ratio at the earlier of (i) December 31, 2026, or (ii) at such time as the closing sale price of the Company’s common stock exceeds $2.00 per share for ten (10) consecutive trading days. In August 2024, the Series H Preferred Stock satisfied the mandatory conversion right, resulting in the conversion of all 768,473 shares outstanding into 7,684,730 shares of common stock, exclusive of accrued dividend liabilities totaling $122,954 also being converted into 158,840 shares of common stock.

 

Mandatory Dividend

 

Commencing after the later of (i) the first day of the calendar month after the month in which the Series G shares are issued or (ii) January 2, 2024, the holders of outstanding shares of Series G Preferred Stock shall receive a monthly dividend of 20% of the Stated Value per share. The dividend shall be paid at the election of the majority holder of the Series G Preferred Stock in cash or in common stock.

  

Commencing January 2, 2024, the holders of outstanding shares of Series H Preferred Stock shall receive a monthly dividend of 1% of the Stated Value per share. The dividend shall be paid at the election of the majority holder of the Series H Preferred Stock in cash or in common stock. If the election is for cash payment, the Company has the right to deliver a one-year secured note bearing interest at the rate of 15% per annum in lieu of paying cash. As discussed above, for the period January 1 through August 6, 2024, the mandatory conversion date, the Company accrued and paid stock dividends of 158,840 common shares totaling $122,954, to the Series H Preferred Stock shareholders.

 

Liquidation Preference

 

The Series G and Series H Preferred Stock have a liquidation preference of the Stated Value per share plus accrued and unpaid dividends.

 

Shares Issued for Services

  

On October 6, 2023, the Company entered a one-year consulting contract with Mr. Gene Salkind, its Chairman of the Board, to provide business consulting services to the Company. Mr. Salkind received 150,000 shares of restricted common stock, valued at $103,500, in consideration of his services under this agreement. The value of the shares issues is being amortized straight-line over the one-year term of the agreement. The Company recognized $25,875 and $77,625 in general and administrative expenses related to this amortization for the three and nine months ended September 30, 2024, respectively.

 

In December 2023, the Company entered a one-year consulting contract with an unrelated party. In accordance with the contract, the consultant received a signing bonus of $25,000 in cash, 100,000 shares of restricted common stock valued at $14,000, and warrants to purchase 200,000 shares of common stock, exercisable over a three-year period at $0.20 per share, valued at $25,000. In addition, the consultant is to receive monthly cash payments of $12,500 over the term of the agreement. The value of the signing bonus, shares of restricted common stock, and warrants, totaling $64,000, was recorded as a prepaid asset on the accompanying consolidated balance sheet and is being amortized through general and administrative expenses over the one-year term of the agreement. For the three and nine months ended September 30, 2024, the Company recognized approximately $16,000 and $48,000 of expense associated with amortization of the prepaid asset with approximately $12,000 remaining unamortized at September 30, 2024.

 

 

 

25

 

 

On August 15, 2024, the Company entered into a Business Development Agreement with a non-affiliated entity. The term of the agreement is three months, and the consultant has a choice of $12,500 in cash or 25,000 shares of the Company’s common stock. The consultant elected to receive 25,000 shares of restricted common stock. The $12,500 fee was recorded as a prepaid asset on the consolidated balance sheet and is being amortized through general and administrative expenses over the three month term. Approximately $4,000 in expense was recognized for the three months ended September 30, 2024.

 

Common Stock Issued in Conjunction with Debt Issuance

 

On December 30, 2022, the Company and Walleye Opportunities Master Fund Ltd, a Cayman Islands company (the Investor), entered into a Securities Purchase Agreement (the Walleye SPA) for the Investor to purchase from the Company (i) a senior secured 20% original issue discount (OID) nine-month promissory note in an aggregate gross principal amount of $1,437,500, less the 20% OID of $287,500, for a net subscription amount of $1,150,000 (the Investor Note), and (ii) a five year warrant to purchase 174,242 shares of the Company’s common stock at an exercise price of $6.60 per share, exercisable commencing July 1, 2023 and expiring December 30, 2027 (the Investor Warrant). Proceeds from the Agreement were received by the Company in January 2023.

 

In conjunction with the Walleye SPA, the Company issued 34,849 shares of common stock, or approximately 5.3% of the Company’s outstanding shares at that time, to the Investor as an incentive on the transaction (Incentive Shares). Excluding the above-mentioned Investor Warrant, the shares of Common Stock exercisable pursuant to such Investor Warrant are not being considered beneficially owned by the Investor until the Investor Warrant is exercisable within 60 days. Total issuance fees of $138,500 associated with the closing of the Walleye SPA were paid by the Company to Spartan Capital Securities LLC and the Investor’s counsel, resulting in net proceeds of $1,011,500. Approximately $163,000 of the loan proceeds were utilized to repay the outstanding principal and accrued interest under an SBA loan.

 

The Investor Note will only become convertible into common stock upon the occurrence of an Event of Default under and as defined in the Investor Note on terms set forth in the Investor Note. This Investor Note matures and is payable on or before September 30, 2023, and it provides that the Investor may demand prepayment after March 31, 2023, and before the maturity date, provided that the purchasers of securities in a future public offering by the Company, as defined in the Walleye SPA, who hold the purchased Company securities at the time the prepayment demand, unanimously consent to the prepayment. The Company granted a security interest in all of its assets to the Investor as collateral for its obligations under the Investor Note pursuant to a Security Agreement. In addition, the Company’s subsidiaries guaranteed the obligations of the Company under the Investor Note pursuant to a Subsidiary Guarantee and granted a first lien security interest in all their assets to the Investor as additional collateral pursuant to the Security Agreement. All securities sold in the above-described transaction contain certain piggy-back registration rights after the completion of our February 2023 Offering (see below). During the third quarter of 2023, the secured debt was paid in full through the proceeds of our June 2023 Offering.

 

The aforementioned Investor Warrant was deemed to be an equity-classified derivative instrument with a fair value of $1,526,363 at the date of closing on the Agreement, incorporating the use of the Black-Scholes valuation model, and the Incentive Shares were deemed to have a fair value of $318,863 based on the closing market price of the Company’s common stock on the day preceding the closing of the Walleye SPA. Per accounting guidance under ASC 815, the Company recorded the fair values of the Investor Warrant and Incentive Shares based on the relative fair value allocation method, which allocates fair values as a percentage of total fair value of the debt, Investor Warrant, and Incentive Shares, in proportion to the net proceeds received under the Investor Note of $1,150,000. As a result of applying the relative fair value allocation method, the Investor Warrant was assigned a relative fair value of $586,040 and the Incentive Shares were assigned a relative fair value of $122,426, at the date of closing on the Walleye SPA. Amortization associated with the total debt discounts is being recognized using the effective interest method over the term of the Investor Note, which matured on September 30, 2023. For the period ended June 30, 2023, $377,149 in amortization on the debt discounts was recognized as interest expense on the accompanying consolidated statement of operations, and the remaining unamortized debt discounts of $396,322 were written off as loss on debt extinguishment upon full settlement of the Investor Note in conjunction with proceeds received from the June 2023 Offering.

 

 

 

26

 

 

February 2023 Offering

 

On February 13, 2023, the Company entered into an underwriting agreement (the Underwriting Agreement) with Spartan Capital Securities LLC (the Underwriter) relating to a public offering of 251,842 shares of common stock and pre-funded warrants to purchase 285,792 shares of common stock (the Shares), for net proceeds of $3,207,500 (the February 2023 Offering). In conjunction with the February 2023 Offering, which closed on February 16, 2023, the investors also received other Warrants to purchase 806,452 shares of common stock (Series 2023 Warrants) on a cash basis or up to 403,226 shares on a cashless basis. The offered Shares were priced at $6.975 per combination of one share of common stock or one pre-funded warrant, accompanied by one Series 2023 Warrant.

 

Each pre-funded warrant is exercisable at any time, until fully exercised, to purchase one share of common stock at an exercise price of $0.0015 per share. Each Series 2023 Warrant is exercisable for five years to purchase 0.1 share of common stock at a cash exercise price of $6.975 per warrant share. The Series 2023 Warrants contain an alternative cashless exercise provision permitting the holder to acquire 0.05 share of common stock for every 0.1 warrant share any time after the earlier of (i) 30 days following the initial exercise date of February 14, 2023, and (ii) the date on which the aggregate trading volume of the Company’s common stock, beginning on the initial exercise date of the Series 2023 Warrants, exceeds 2,419,355 shares. Additionally, the exercise price of both the pre-funded warrants and the Series 2023 Warrants are subject to customary adjustments for stock splits, stock dividends, reclassifications and the like.

 

Pursuant to the terms of the Underwriter agreement, and as partial consideration to the Underwriter, the Company issued a warrant for the purchase of 26,882 shares of common stock, exercisable from February 14, 2023, through February 14, 2028, at an initial exercise price of $7.6725 per share. This warrant was cancelled by the underwriter on or about June 30, 2023, in connection with the completion of the June 2023 Offering described below. The Company also granted the Underwriter a 45-day option to purchase up to an additional 80,645 shares and/or pre-funded warrants in lieu of shares and accompanying Series 2023 Warrants to purchase 120,968 shares at the public offering price less the underwriting discounts and commissions, to cover over-allotments, if any. No additional shares or pre-funded warrants were purchased by the Underwriter. The Company paid a cash fee to the Underwriter equal to 8% of the gross proceeds raised in February 2023 Offering, plus a reimbursement of Underwriter fees totaling $242,500.

 

Between the closing of February 2023 Offering and June 30, 2023, investors holding pre-funded warrants converted all their pre-funded warrants into 285,792 shares of common stock and elected the alternative cashless exercise provision for the Series 2023 Warrants, resulting in the issuance of 403,226 shares of common stock. As of June 30, 2023, all the aforementioned pre-funded warrants and 2023 Warrants were exercised.

 

June 2023 Offering

 

On June 30, 2023, Mobiquity Technologies, Inc. closed on a public offering selling an aggregate of 375,000 shares of common stock (and 1,625,000 common stock equivalents in the form of pre-funded warrants to purchase 1,625,000 common shares) to investors pursuant to Securities Purchase Agreements at a public offering price of $1.50 per share (or $1.4985 per pre-funded warrant) (the June 2023 Offering), for total gross proceeds of $3,000,000. Placement agent fees and other offering costs totaled $472,001 and were recorded net of gross proceeds in the Company’s consolidated statement of stockholders’ equity during the quarter ended June 30, 2023. Each pre-funded warrant is exercisable at any time to purchase one share of common stock at an exercise price of $0.0015 per share. Additionally, the exercise price of pre-funded warrants is subject to customary adjustments for stock splits, stock dividends, reclassifications and the like. Spartan Capital Securities, LLC acted as the Company’s exclusive placement agent of the June 2023 Offering pursuant to a Placement Agent Agreement. The net proceeds to the Company from the sale of the shares and pre-funded warrants, after deducting the Placement Agent commissions and offering expenses payable by the Company, was approximately $2,528,000. The Company used $1,437,500 of the proceeds received from the June 2023 Offering to fully satisfy its Senior Secured 20% OID Promissory Note to Walleye Opportunities Master Fund Ltd. See Note 4. In July 2023, the Company also issued 478,334 shares of common stock upon exercise of 478,334 pre-funded warrants, increasing the number of outstanding common shares to 2,588,333.

 

 

 

27

 

 

Other 2023 Stock Transactions

 

In April 2023, the Board of Directors or the Compensation Committee of the Company’s Board of Directors approved the following transactions:

 

	·	Grant of 6,667 shares of restricted common stock to Gene Salkind, Chairman of the Board, for services previously rendered, based on a per share value of $2.505.
	·	Grant of 3,333 shares of restricted common stock each to the Company’s CEO and another member of the Board of Directors for services as directors of the Company.
	·	Grant of 2,000 shares of common stock to Gene Salkind as payment for accrued and unpaid interest of approximately $5,000 based on a per share value of $2.505.
	·	Grant of 4,791 shares of restricted common stock to the Company’s legal counsel as payment for accrued and unpaid services valued at $12,000 and $2.505 per share.
	·	Issuance of a total of 31,891 shares of restricted common stock at a per share value of $2.52 as payment and full settlement of outstanding accounts payable with a total carrying amount of $80,411.

 

Share prices used in the above transaction were based on the market price of the Company’s common stock on the consummation dates of the transactions.

 

Salkind October 2023 Loan Conversion and Series G Preferred Stock Issuance

 

Effective November 7, 2023, Mr. Gene Salkind and parties associated with him (the Series G Preferred Shareholders), invested $1,503,495 into the Company’s newly created Series G Preferred Stock, formalized through three Subscription Agreements for the sale of a combined 300,789 shares of Series G Preferred Stock for total cash proceeds of $1,200,000, plus the conversion of $300,000 in principal and $3,495 in accrued interest from the Salkind October 2023 Loan (see Note 4). Each share of the Series G Preferred Stock is convertible by the Series G Preferred Shareholders at any time after issuance into ten (10) shares of the Company’s Common Stock, or $0.50 per Common Share (Series G Conversion Ratio). The Series G Preferred Stock will automatically convert at the same Series G Conversion Ratio upon the Company’s Common Stock reporting of a closing sales price over $5.00 per share for ten (10) consecutive trading days. The Company did not pay any commissions or other compensation to any third party in connection with the transactions reported herein. Exemption from registration is claimed under section 4(2) of the Securities Act of 1933, as amended.

 

Series H Preferred Stock Issuances

 

On December 18, 2023, the Series G Preferred Shareholders agreed to exchange all 300,789 of the Series G Preferred Stock into 751,730 shares of the Company’s newly created Series H Preferred Stock. Also, our legal counsel agreed to exchange $33,000 of monies owed to the law firm for 16,500 shares of Series H Preferred Stock. Each share of the Series H Preferred Stock is convertible at any time after issuance into ten (10) shares of the Company’s Common Stock, or $0.20 per Common Share (Series H Conversion Ratio). The Series H Preferred Stock will automatically convert at the same Series H Conversion Ratio upon the Company’s Common Stock reporting of a closing sales price over $2.00 per share for ten (10) consecutive trading days or on December 31, 2026, whichever is earlier. The Company did not pay any commissions or other compensation to any third party in connection with the transactions reported herein. Exemption from registration is claimed under section 3(a)(9) of the Securities Act of 1933, as amended. During the quarter ended September 30, 2024, all outstanding shares of Series H Preferred Stock were converted into shares of the Company’s common stock, as discussed above.

 

Issuance of Common Stock for Settlement of Liabilities

 

In January 2024, the Company issued 100,000 shares of its common stock at a per share price of $0.53 in full settlement of vendor liabilities outstanding at an amount equal to $53,000. In March 2024, the Company issued 18,000 shares of its common stock in settlement of outstanding vendor liabilities at an amount equal to $12,000 stock at per share prices ranging from $0.50 to $1.00. In the third quarter of 2024, corporate counsel converted $18,000 of accrued liabilities into common stock at a conversion price of $0.50 per share.

 

 

 

28

 

 

Issuance of Common Stock for Cash

 

During the first nine months of 2024, the Company raised a total of $2,237,000 in cash from various accredited investors in conjunction with common stock subscription agreements, resulting in the issuance of a total of 4,347,334 shares at per share prices ranging from $0.30 to $0.60. In the third quarter of 2024, the Company raised a total of $675,000 in cash from various accredited investors in conjunction with common stock subscription agreements, resulting in the issuance of 1,100,000 shares at per share prices ranging from $0.50 to $1.00.

 

Issuance of Common Stock Warrant for Services

 

During June 2024, the Company entered into a consulting agreement with an unrelated party for general business consulting services. The term of the agreement is for twelve months, commencing in June 2024. Compensation under the agreement included an upfront payment of $25,000 in cash, and the issuance of 100,000 common stock warrants, exercisable through June 2027, at an exercise price of $0.50 per share. The consultant also receives a monthly fee of $5,000. The fair value of the warrants at issuance was $171,800, which is being amortized, along with the upfront payment, through general and administrative expenses, straight-line, over the twelve-month service period. In September 2024, the Company amended the consulting agreement to increase the monthly cash compensation to $10,000 and to issue additional warrants to purchase a total of 150,000 shares of common stock exercisable over a three-year period. The 150,000 warrant shares consist of 100,000 exercisable at $0.50 per share and 50,000 exercisable at $1.00 per share through September 10, 2027. The new warrants issued in September 2024 were fair valued at a total of $446,200, which was recorded as prepaid assets and is being amortized through general and administrative expense straight-line over the remaining 10 months of the agreement term. Total expense recognized related to the upfront payment and issued warrants was approximately $94,000 and $110,000 for the three and nine months ended September 30, 2024, respectively.

 

Treasury Stock

 

In the three months ended March 31, 2024, the Company repurchased 17 shares of common stock for an insignificant amount, recorded as treasury stock. There were no repurchases of the Company’s common stock for the year ended December 31, 2023, or the quarter ended September 30, 2024.

 

NOTE 6 – STOCK OPTION PLANS AND WARRANTS

 

During Fiscal 2005, the Company established, and the stockholders approved, an Employee Benefit and Consulting Services Compensation Plan (the 2005 Plan) for the granting of up to 334 non-statutory and incentive stock options and stock awards to directors, officers, consultants and key employees of the Company. On June 9, 2005, the Board of Directors amended the Plan to increase the number of stock options and awards to be granted under the Plan to 667 shares. During Fiscal 2009, the Company established a plan of long-term stock-based compensation incentives for selected Eligible Participants of the Company covering 667 shares. This plan was adopted by the Board of Directors and approved by stockholders in October 2009 (the 2009 Plan). In September 2013, the Company’s stockholders approved an increase in the number of shares covered by the 2009 Plan to 1,667 shares. In the first quarter of 2016, the Board approved, and stockholders ratified a 2016 Employee Benefit and Consulting Services Compensation Plan covering 1,667 shares (the 2016 Plan) and approved moving all options which exceeded the 2009 Plan limits to the 2016 Plan. In December 2018, the Board of Directors adopted and in February 2019 the stockholders ratified the 2018 Employee Benefit and Consulting Services Compensation Plan covering 5,000 shares (the 2018 Plan). On April 2, 2019, the Board approved the 2019 Plan identical to the 2018 Plan, except that the 2019 Plan covers 10,000 shares. The 2019 Plan required stockholder approval by April 2, 2020, to be able to grant incentive stock options under the 2019 Plan. On October 13, 2021, the Board approved the 2021 Plan identical to the 2018 Plan, except that the 2021 Plan covers 73,334 shares. The 2021 Plan required stockholder approval by October 13, 2022, to be able to grant incentive stock options under the 2021 Plan. On April 17, 2023, the Board approved an Equity Participation Plan similar to the Plans described herein, except that this Plan also provides for the grant of Restricted Unit Awards (the 2023 EP Plan). Under the 2023 EP Plan, which was approved by stockholders on May 15, 2023, a maximum of 166,667 shares may be granted under the 2023 EP Plan. On December 19, 2023, the Board approved the 2023 Plan identical to the 2018 Plan, except that the 2023 Plan covers 2,000,000 shares. The 2005 Plan, 2009 Plan, 2016 Plan, 2018 Plan, 2019 Plan, 2021 Plan, the 2023 EP Plan, and 2023 Plan are collectively referred to as the “Plans.”

 

 

 

29

 

 

In April of 2022 and April 2023, Dean Julia was granted 833 options each year from the Company’s 2021 Plan with immediate vesting, at an exercise price of $23.25 and $3.30 and expiration of April 2031 and April 2032, respectively.

 

In March and April 2023, Nate Knight and Byron Booker, respectively, were each granted 1,667 options from the Company’s 2021 Plan with immediate vesting, at an exercise price of $3.30, and expiration of March 2028 and April 2028, respectively.

 

On December 19, 2023, the board approved, under the 2023 Plan, granting five-year Non-Statutory Stock Options to purchase 1,800,000 shares of common stock, immediately exercisable at $0.20 per share to various officers, directors, employees and consultants. Exemption from registration is claimed under section 4(2) of the Securities Act of 1933, as amended.

 

In April 2024, Dean Julia was granted 833 options from the Company’s 2021 Plan with immediate vesting, at an exercise price of $0.50 and expiration of April 2033.

 

All stock options under the Plans are granted at or above the fair market value of the common stock at the grant date. Employee and non-employee stock options vest over varying periods and generally expire either 5 or 10 years from the grant date. The fair value of options at the date of grant was estimated using the Black-Scholes option pricing model. For option grants, the Company will take into consideration payments subject to the provisions of ASC 718 Stock Compensation.

 

The weighted average assumptions made by calculating the fair values of options granted during the nine months ended September 30, 2024, are as follows:

Schedule of weighted average assumptions of options granted
		Nine Months Ended September 30,
		2024				2023
Expected volatility			199.68%				166.87%
Expected dividend yield			–				–
Risk-free interest rate			3.42%				3.54%
Expected term (in years)			7.50				6.67

 

Schedule of options activity
		Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding, January 1, 2024			1,876,275			$	9.11				5.05			$	252,000
Granted			833			$	0.50				8.51			$	1,658
Cancelled or expired			(4,094	)		$	–				–			$	–
Outstanding, September 30, 2024			1,873,014			$	7.56				4.31			$	4,123,658
Options exercisable, September 30, 2024			1,873,013			$	7.56				4.31			$	4,123,658

 

 

 

30

 

 

The aggregate intrinsic value of options outstanding and options exercisable on September 30, 2024, is calculated as the difference between the exercise price of the underlying options and the market price of the Company’s common stock for the shares that had exercise prices lower than the $2.49 closing price of the Company’s common stock on September 30, 2024. Stock-based compensation expense related to stock options was $1,410 and $22,295 for the nine months ended September 30, 2024, and 2023, respectively, and is included in general and administrative expenses on the accompanying consolidated statements of operations.

 

As of September 30, 2024, there is $464 in unamortized compensation cost related to unvested stock option awards to be recognized during fiscal 2024 and 2025, respectively.

   

Warrants

 

During the fiscal year ended December 31, 2023, the Company issued a total of 2,849,551 common stock warrants. Total warrant shares issued included 174,242 shares issued in July 2023 in connection with the 20% OID Promissory note (see Note 4) which are exercisable commencing July 1, 2023, through December 30, 2027. In February 2023, 850,308 warrant shares were issued in connection with the February 2023 Public Offering, including 285,792 of pre-funded warrants (see Note 5) with a five-year contractual term, expiring February 14, 2028. On June 30, 2023, an additional 1,625,000 pre-funded warrants were issued with a five-year term in connection with the June 2023 Public Offering. During July 2023, 478,333 pre-funded warrants issued under the June 2023 Public Offering were exercised. In December 2023, the Company entered a one-year consulting contract with an unrelated party. In accordance with the said contract, the consultant received warrants to purchase 200,000 shares of common stock, exercisable over a three-year period at $0.20 per share.

 

On June 3, 2024, the Company entered into a one-year consulting agreement with a non-affiliated entity. The agreement provides for cash compensation of $85,000 (inclusive of a $25,000 signing bonus) to the consultant plus warrants to purchase 100,000 common shares at an exercise price of $0.50 per share through June 30, 2027. In September of 2024 the consultant received an additional 100,000 warrants exercisable at $0.50 and 50,000 warrants exercisable at $1.00 per share. Warrants contain the same terms as exist in the warrants issued in June of 2024. See Note 5 for further discussion.

 

The weighted average assumptions made in calculating the fair value of warrants granted during the nine months ended September 30, 2024, and 2023, are as follows:

Schedule of weighted average assumptions of warrants granted
		Nine Months Ended September 30,
		2024				2023
Expected volatility			217.65%				172.63%
Expected dividend yield			–				–
Risk-free interest rate			3.98%				3.85%
Expected term (in years)			2.88				5.00

 

Schedule of warrants activity
		Shares				Weighted Average Exercise Price				Weighted Average Remaining Contractual Term (Years)				Aggregate Intrinsic Value
Outstanding, January 1, 2024			653,357			$	58.54				4.20			$	28,000
Granted			250,000			$	0.60				4.10			$	472,500
Cancelled or expired			–			$	–				–			$	–
Outstanding, September 30, 2024			903,357			$	42.51				3.64			$	903,500
Warrants exercisable, September 30, 2024			903,357			$	42.51				3.64			$	903,500

 

 

 

31

 

 

NOTE 7 – EARNINGS (LOSS) PER SHARE

 

Pursuant to ASC 260, Earnings Per Share, basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the periods presented.

 

Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares may consist of common stock issuable for stock options and warrants (using the treasury stock method), convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. In the event of a net loss, diluted loss per share is the same as basic loss per share since the effect of the potential common stock equivalents upon conversion would be anti-dilutive.

  

The following potentially dilutive equity securities outstanding as of September 30, 2024, and December 31, 2023, are as follows:

Schedule of potentially dilutive equity securities outstanding
		September 30, 2024				December 31, 2023
Stock options			1,873,014				1,876,275
Warrants			903,357				653,358
Series AAA preferred stock			209,525				209,525
Series E preferred stock			10,281				10,281
Series H preferred stock			–				7,684,730
Total common stock equivalents			2,996,177				10,434,169

 

NOTE 8 – COMMITMENTS AND CONTINGENCIES

 

Litigation

 

Michael Trepeta, a former Co-CEO and director of the Company, filed a lawsuit against the Company and its subsidiary, Mobiquity Networks in April 2023 in the New York State Supreme Court, Nassau County. The claims stem from a Separation Agreement and Release that Mr. Trepeta and the Company entered into nine years ago in April 2017 which terminated Mr. Trepeta’ s employment agreement and discontinued his employment and directorship with the Company, among other things, by mutual agreement. Mr. Trepeta also gave the Company a release in the Separation Agreement and Release. Mr. Trepeta has claimed that the Company fraudulently induced him to enter into the Separation Agreement and Release; that the Company breached Mr. Trepeta’ s employment agreement; and that the Company breached its covenant of good faith and fair dealing and its fiduciary duty. Mr. Trepeta is claiming not less than $2.5 Million in damages. Based on the Company’s initial internal review of the situation, the Company believes the claims lack merit and it intends to vigorously defend same. In December 2023, the Company was notified that its motion to dismiss Mr. Trepeta’ s action was granted but Mr. Trepeta has filed a notice of appeal. Due to uncertainties inherent in litigation, the Company cannot predict the outcome of this matter at this time.

 

NOTE 9 – SUBSEQUENT EVENTS

 

On October 8, 2024, the Board of Directors of the Company approved the increase in the number of shares available under the 2023 Employee Benefit and Compensation Plan from 2,000,000 shares to 4,000,000 shares and granted a total of 1,725,000 non-statutory stock options with a 5-year term, immediately exercisable to several officers, directors, employees and consultants at an exercise price of $2.45 per share.

 

Between October 1, 2024 and November 12, 2024, the Company raised $540,000 from the sale of its common stock at $1.00 per share. Exemption from registration is claimed under Rule 506 and/or section 4(2) of the Securities Act of 1933, as amended. No commissions were paid in connection with these transactions.

 

 

 

 

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

References in this Management’s Discussion and Analysis of Financial Condition and Results of Operations to “us,” “we,” “our,” and similar terms refer to the Company.

 

The information contained in this Form 10-Q and documents incorporated herein by reference are intended to update the information contained in the Company's Form 10-K for its fiscal year ended December 31, 2023 which includes our audited financial statements for the years ended December 31, 2023 and 2022 and such information presumes that readers have access to, and will have read, the "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Risk Factors" and other information contained in such Form 10-K and other Company filings with the Securities and Exchange Commission ("SEC").

 

This statement contains forward-looking statements within the meaning of the Securities Act. Discussions containing such forward-looking statements may be found throughout this statement. Actual events or results may differ materially from those discussed in the forward-looking statements as a result of various factors, including the matters set forth in this statement. The accompanying consolidated financial statements as of September 30, 2024, and 2023 includes the accounts of Mobiquity Technologies, Inc. (the “Company”) and its wholly owned subsidiaries.

 

This Quarterly Report includes forward-looking statements, as that term is defined in the federal securities laws, based upon current expectations that involve risks and uncertainties, such as plans, objectives, expectations, and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. Words such as “anticipate,” “estimate,” “plan,” “continuing,” “ongoing,” “expect,” “believe,” “intend,” “may,” “will,” “should,” “could,” and similar expressions are used to identify forward-looking statements. We caution you that these statements are not guarantees of future performance or events and are subject to a number of uncertainties, risks and other influences, many of which are beyond our control, which may influence the accuracy of the statements and the projections upon which the statements are based. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of certain risk factors discussed in our Annual Report on Form 10-K (filed with the Securities and Exchange Commission (the “SEC”) on April 8, 2024.

 

Any one or more of these uncertainties, risks and other influences could materially affect our results of operations and whether forward-looking statements made by us ultimately prove to be accurate. Our actual results, performance and achievements could differ materially from those expressed or implied in these forward-looking statements. We undertake no obligation to publicly update or revise any forward-looking statements, whether from new information, future events or otherwise.

 

Our Company

 

We are a next-generation advertising technology, data compliance and intelligence company which operates through our three proprietary software platforms in the programmatic advertising industry.

 

The Programmatic Advertising Industry

 

Programmatic advertising refers to the automated buying and selling of digital ad space. In contrast to manual advertising, which relies on human interaction and negotiation between publishers and marketers, programmatic ad buying harnesses technology to purchase digital display space. This use of software and algorithms helps streamline ad buying processes, which is why programmatic has become one of the most indispensable digital marketing tools worldwide. In 2023, global programmatic ad spend reached an estimated 558 billion U.S. dollars, with spending set to surpass $700 billion by 2026. The United States remains the leading programmatic advertising market worldwide.

 

 

 

 

Our Mission

 

Our mission is to help enterprises in the programmatic industry become more efficient and effective regarding the monetization of advertising, audience segments and data compliance. We do this by offering three proprietary solutions: Our ATOS platform for brands and agencies, our data intelligence platform for audience segments and targeting, and our publisher platform for privacy compliance and publisher monetization.

 

Our Opportunity

 

Due to the recent changes to Privacy Laws, such as GDPR and CCPA, along with Apple and Google’s removal of Identifiers, we believe Publishers are facing two significant issues: increasing costs due to privacy compliance laws and decreasing revenue, due to the lack of audience targeting. We believe there is a major paradigm shift occurring in the market, where user data and the targeting intelligence to use it must shift from middlemen directly to the content publishers. Publishers must own their first party data and manage their audiences’ segments in-house. We believe that irrespective of whether a publisher chooses to work with us or not, they need to find a solution that allows advertisers to buy directly from them.

  

Our Solutions

 

Programmatic Advertising Platform

 

Our advertising technology operating system (or ATOS) platform is a single-vendor end-to-end solution that blends artificial intelligence (or AI) and machine learning (or ML)-based optimization technology that automatically serves advertising and manages digital advertising campaigns. Our ATOS platform engages with approximately 10 billion advertisement opportunities per day.

 

As an automated programmatic ecosystem, ATOS increases speed and performance, by providing dynamic technology that scales in real-time. It is this proprietary cloud-based architecture that keeps costs down and allows us to pass along savings to our customers. Also, by offering more of the features inherent in a digital advertising campaign and removing the need for third-party integration of those features, we believe that our ATOS platform can be substantially more time efficient and cost efficient than other Demand-Side Platforms (or DSPs). Our ATOS platform also decreases the effective cost basis for users by integrating all the necessary capabilities at no additional cost as compared to the costs to outsource these capabilities to one or more providers in a fragmented ecosystem. DSP and bidding technologies, AdCop™ Fraud Protection, rich media and ad serving, attribution, reporting dashboard and DMP are all included in our ATOS platform.

 

Data Intelligence Platform

 

Our data intelligence platform provides precise data and insights on consumer’s real-world behavior and trends for use in marketing and research. Our management believes, based on our experience in the industry, that we provide one of the most accurate and scaled solutions for data collection and analysis, utilizing multiple internally developed proprietary technologies.

 

We provide our data intelligence platform to our customers on a managed services basis, and offer a self-service alternative through our MobiExchange product, which is a software-as-a-service (or SaaS) fee model. MobiExchange is a data-focused technology solution that enables users to rapidly build actionable data and insights for its own use. MobiExchange’s easy-to-use, self-service tools allow anyone to reduce the complex technical and financial barriers typically associated with turning offline data, and other business data, into actionable digital products and services. MobiExchange provides out-of-the box private labeling, flexible branding, content management, user management, user communications, subscriptions, payment, invoices, reporting, gateways to third party platforms, and help desk, among other things.

 

 

 

 

Publisher Platform for Monetization and Compliance

 

Our content publisher platform is a single-vendor ad tech operating system that allows publishers to better monetize their opt-in user data and advertising inventory. The platform includes tools for: consent management, audience building, a direct advertising interface and inventory enhancement. Our publisher platform provides content publishers with the functionality to use its user identifier data to create inventories of profiled data segments and to target audiences with advertising using that data, in a data privacy compliant manner.

 

Our Revenue Sources

 

We target publishers, brands, advertising agencies and other advertising technology companies as our audience for our three platform products. Our sales and marketing strategy is focused on providing a de-fragmented operating system that facilitates a considerably more efficient and effective way for advertisers and publishers to transact with each other. Our goal is to become the programmatic display advertising industry standard for small and medium sized advertisers. We generate revenue from our platforms through two verticals:

 

	·	The first is licensing one or more of our platforms as a white-label product for use by advertising agencies, demand-side platforms (or DSP’s), brands and publishers. Under the white-label scenario, the user licenses a platform from us and is responsible for running its own business operations and is billed a percentage of amounts spent on advertising run through the platform.
	·	The third revenue stream is a managed services model, in which, the user is billed a higher percentage of revenue run through a platform, but all services are managed by us.

 

Critical Accounting Policies

 

Our discussion and analysis of our financial condition and results of operations are based upon our consolidated financial statements, which have been prepared in accordance with generally accepted accounting principles in the United States (U.S. GAAP). The preparation of financial statements requires management to make estimates and disclosures on the date of the financial statements. On an on-going basis, we evaluate our estimates including, but not limited to, those related to revenue recognition. We use authoritative pronouncements, historical experience, and other assumptions as the basis for making judgments. We believe that the following critical accounting policies affect our more significant judgments and estimates in the preparation of our financial statements.

 

Use of Estimates

 

Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported periods. Actual results could differ from those estimates, and those estimates may be material.

 

Risks and Uncertainties

 

The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risks and uncertainties including financial and operational risks including the potential risk of business failure.

 

 

 

 

The Company has experienced, and in the future expects to continue to experience, variability in sales and earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s distribution of the product. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.

 

Fair Value of Financial Instruments

 

The Company accounts for financial instruments at fair value, which as is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:

 

	·	Level 1—Valuation based on unadjusted quoted market prices for identical assets or liabilities in active markets that the Company has the ability to access;
	·	Level 2—Valuation based on observable quoted prices for similar assets and liabilities in active markets; and
	·	Level 3—Valuation based on unobservable inputs that are supported by little or no market activity, which require management’s best estimate of what market participants would use as fair value.

 

Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management.

 

The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include accounts receivable, accounts payable, accrued interest – related party, and accrued expenses, and contract liabilities. On September 30, 2024, the carrying amounts of these financial instruments approximated their fair values due to the short-term nature of these instruments, or they are receivable or payable on demand. The fair value of the Company’s debt approximates its carrying value based on the current financing rates available to the Company and its short-term nature.

 

The Company does not have any other financial or non-financial assets or liabilities that would be characterized as Level 1, Level 2, or Level 3 instruments.

 

Accounts Receivable

 

Accounts receivable represent customer obligations under normal trade terms and are stated at the amount management expects to collect from outstanding customer balances. Credit is extended to customers based on an evaluation of their financial condition and other factors. Interest is not accrued on overdue accounts receivable. The Company does not require collateral.

 

Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for credit losses. The Company provides an allowance for credit losses based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. Accounts determined to be uncollectible are charged to operations when that determination is made.

 

 

 

 

Provision for credit losses expense (recovery) is recorded as a component of general and administrative expenses in the consolidated statements of operations.

 

Impairment of Long-lived Assets

 

Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15 Impairment or Disposal of Long-Lived Assets. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets and compares this to the carrying amounts of the assets.

 

If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) Topic 606, Revenue from Contracts with Customers (ASC 606) to align revenue recognition more closely with the delivery of the Company’s services and will provide financial statement readers with enhanced disclosures. In accordance with ASC 606, revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:

 

Identify the contract with a customer.

 

A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.

 

Identify the performance obligations in the contract.

 

Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, the Company must apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation.

 

 

 

 

Determine the transaction price.

 

The transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur.

 

Allocate the transaction price to performance obligations in the contract.

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation.

 

Recognize revenue when or as the Company satisfies a performance obligation.

 

The Company satisfies performance obligations either overtime or at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring a promised service to a customer.

 

Each of the Company’s customer contracts is deemed to have a single performance obligation. Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 90 days.

 

Stock-Based Compensation

 

The Company accounts for our stock-based compensation under ASC 718 Compensation – Stock Compensation using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the fair value of the award and is recognized over the requisite service period, which is generally the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

The Company uses the Black-Scholes model for measuring the fair value of options and other equity instruments granted to both employees and non-employees.

 

When determining fair value of stock-based compensation, the Company considers the following assumptions incorporated into the Black-Scholes model:

 

	·	Exercise price,
	·	Expected dividends,
	·	Expected volatility,
	·	Risk-free interest rate; and
	·	Expected life of option

 

 

 

 

Recently Adopted Accounting Pronouncements

 

We consider the applicability and impact of all new accounting pronouncements on our consolidated financial position, results of operations, stockholders’ equity, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the Financial Accounting Standards Board (FASB) through the date their consolidated financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective, that when adopted, will have a material impact on the consolidated financial statements of the Company. 

 

Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions: On September 30, 2022, the FASB issued ASU 2022-03 (ASU 2022-03), which clarifies the guidance in Topic 820 on the fair value measurement of an equity security that is subject to contractual restrictions that prohibit the sale of an equity security. The ASU also requires specific disclosures related to such an equity security, including (1) the fair value of such equity securities reflected in the balance sheet, (2) the nature and remaining duration of the corresponding restrictions, and (3) any circumstances that could cause a lapse in the restrictions. ASU 2022-03 clarifies that a “contractual restriction prohibiting the sale of an equity security is a characteristic of the reporting entity holding the equity security” and is not included in the equity security unit of account. Accordingly, an entity should not consider the contractual sale restriction when measuring the equity security’s fair value (i.e., the entity should not apply a discount related to the contractual sale restriction, as stated in ASC 820-10-35-36B as amended by the ASU). The ASU also prohibits an entity from recognizing a contractual sale restriction as a separate unit of account. For public business entities, ASU 2022-03 is effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years, with early adoption permitted. The adoption of ASU 2022-03, effective January 1, 2024, did not have an impact on the Company’s consolidated financial statements and related disclosures.

  

Financial Instrument – Credit Losses: In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (ASU 2016-13). ASU 2016-13 replaces the incurred loss impairment methodology under current GAAP with a methodology that reflects expected credit losses and requires a consideration of a broader range of reasonable and supportable information to inform credit loss estimates. ASU 2016-13 requires the use of a forward-looking expected credit loss model for accounts receivables, loans, and other financial instruments. In May 2019, the FASB issued ASU 2019-05, which provides transition relief for entities adopting ASU 2016-13. For entities that have adopted ASU 2016-13, the amendments in ASU 2019-05 are effective for fiscal years beginning after December 15, 2019, including interim periods therein. An entity may adopt ASU No. 2019-05 in any interim period after its issuance if the entity has adopted ASU 2016-13. For all other entities, the effective date will be the same as the effective date of ASU 2016-13. ASU 2016-13 is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted ASU 2016-13 on January 1, 2023, and the adoption of the guidance did not have a significant impact on its consolidated financial statements and disclosures.

 

Accounting for Contract Assets and Contract Liabilities from Contracts with Customers: In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (ASU 2021-08). Under ASU 2021-08, an acquirer in a business combination must apply ASC 606 principles when recognizing and measuring acquired contract assets and contract liabilities. The provisions of ASU 2021-08 are applicable for the Company for fiscal years and interim periods beginning after December 15, 2022. The Company adopted ASU 2021-08 on January 1, 2023, and the adoption of the guidance did not have a significant impact on its consolidated financial statements and disclosures.

 

 

 

 

Plan of Operation

 

Mobiquity intends to hire several new sales and sales support individuals to help generate additional revenue using the Advangelists platform, our new Publisher Platform, and the Mobiquity Networks MobiExchange. Mobiquity’s sales team will focus on Advertising Agencies, Brands, and publishers to help increase both supply and demand across the Advangelists platform while providing unique data segments utilizing MobiExchange. Together the Advangelists platform and MobiExchange platform create multiple revenue streams for Mobiquity. The first is licensing the Advangelists platform as a white-label product for use by Advertising Agencies, DSP’s, Publishers, and Brands. Under the White-Label scenario, the user licenses the technology and is responsible for running its own business operations and is billed a percentage of volume run through the platform. The third revenue stream is a managed services model in which the user is billed a higher percentage of revenue run through the platform, but all services are managed by the Mobiquity/Advangelists team. The third revenue model is a seat model, where the user is billed a percentage of revenue run through the platform and business operations are shared between the user and the Mobiquity/Advangelists team. Additional revenue can be generated by offering data segments and digital audiences through MobiExchange for use in omnichannel marketing programs that include but not limited to programmatic advertising email marketing and SMS. The goal of the sales team is to inform potential users of the benefits in efficiency and effectiveness of utilizing the end-to-end, fully integrated ATOS created by Advangelists and Mobiquity Networks. New sales and support individuals are also needed to generate revenue for our new Publisher Platform. The target audiences for this platform will be website publishers, application publishers, Connected TV (CTV) publishers and Supply-Side Platform (SSP) operators.

 

Results of Operations

 

Quarter ended September 30, 2024, versus quarter ended September 30, 2023

 

The following table sets forth certain selected statements of operations data for the periods indicated in dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance.

 

		Three Months Ended
		September 30, 2024				September 30, 2023
Revenues		$	566,044			$	177,271
Cost of revenues			230,296				114,174
Gross profit			335,748				63,097
Total operating expenses			1,314,839				1,458,136
Loss from operations		$	(979,091	)		$	(1,395,039	)

 

We generated revenues of $566,044 in the third quarter of 2024 compared to $177,271 for the same period of 2023, an increase of $388,773, or 219%. The increase can be directly attributed to the uptick of political revenue in 2024. The Company has developed several new features which we believe will help grow revenue throughout the remainder of 2024 and beyond.

 

Cost of revenues was $230,296 or 41% of revenues in the third quarter of 2024 as compared to $114,174 or 64% of revenues in the same fiscal period of 2023. Costs of revenues include audience building, targeting features and web services for storage of our data and web engineers who are building and maintaining our platforms. Our ability to capture and store data for sales does not translate to increased cost of revenues.

 

Gross profit was $335,748 or 59% of revenues for the third quarter of 2024 as compared to $63,097 in the same period of 2023 or 36% of revenues.

 

 

 

 

Operating expenses were $1,314,839 in the third quarter of 2024 compared to $1,458,136 in the comparable period of the prior year, a decrease of $143,297, or 10%. The decrease in operating costs was primarily related to a decrease in professional fees of approximately $130,000 and a decrease in licenses and permits of approximately $12,000.

 

The loss from operations for the third quarter of 2024 was $979,091 as compared to $1,395,039 for the comparable period of the prior year. Our losses from operations decreased by approximately $416,000, or 30%, driven in part by professional fees and licenses and permits as stated above, $150,000 in amortization costs and $173,000 decrease in operating expenses is related to the Company’s capitalization of net software development costs during the third quarter of 2024 related to the development of new products. These costs were primarily internal salaries for technological engineers, and external consultant costs. Similar projects were under development during the third half of 2023. The continuing operating loss is attributable to the focused effort in creating the products and services required to move forward with our business.

 

Nine Months ended September 30, 2024, versus nine months ended September 30, 2023

 

The following table sets forth certain selected statements of operations data for the periods indicated in dollars. In addition, we note that the period-to-period comparison may not be indicative of future performance.

 

		Nine Months Ended
		September 30, 2024				September 30, 2023
Revenues		$	1,096,218			$	441,010
Cost of revenues			625,690				281,071
Gross profit			470,528				159,939
Total operating expenses			3,520,726				4,421,863
Loss from operations		$	(3,050,198	)		$	(4,261,924	)

 

We generated revenues of $1,096,218 in the first nine months of 2024 compared to $441,010 for the same period of 2023, an increase of $655,208, or 149%. The increase can be directly attributed to the uptick of political revenue in 2024. The Company has developed several new features which we believe will help grow revenue throughout the remainder of 2024 and beyond.

 

Cost of revenues was $625,690 or 57% of revenues in the first nine months of 2024 as compared to $281,071 or 64% of revenues in the same fiscal period of 2023. Costs of revenues include audience building, targeting features and web services for storage of our data and web engineers who are building and maintaining our platforms. Our ability to capture and store data for sales does not translate to increased cost of revenues.

 

Gross profit was $470,528 or 43% of revenues for the first nine months of 2024 as compared to $159,939 in the same period of 2023 or 36% of revenues.

 

Operating expenses were $3,520,726 in the first nine months of 2024 compared to $4,421,863 in the comparable period of the prior year, a decrease of $901,137, or 20%. The decrease in operating costs was primarily related to a decrease in professional fees of approximately $663,000, license and permits of approximately $150,000.

 

The loss from operations for the first nine months of 2024 was $3,050,198 as compared to $4,261,924 for the comparable period of the prior year. Our loss from operations decreased by approximately $1,200,000, or 28%, driven in part by amortization costs of $309,000, professional fees and licenses and permits as stated above. The decrease in operating expenses is related to the Company’s capitalization of net software development costs during the first nine months of 2024 related to the development of new products. These costs were primarily internal salaries for technological engineers, and external consultant costs. Similar projects were under development during the first nine months of 2024. The continuing operating loss is attributable to the focused effort in creating the products and services required to move forward with our business.

 

On November 12, 2024, we announced the expansion of our strategic partnership with Context Networks and the rollout of their advanced ad tech solution for casinos, seamlessly integrating digital ads into slot machines to enhance player engagement. This innovative approach not only transforms the in-casino experience but also extends advertising across mobile and CTV platforms, reconnecting with players after they leave. With plans for a broader rollout, we believe this technology is poised to set a new standard in multi-platform advertising within the gaming industry. Furthermore, management believes that the aforementioned strategic partnership will have a material impact on our results of operations in fiscal 2025 and beyond.

 

 

 

 

Liquidity and Capital Resources

 

We have a history of operating losses, and our management has concluded that factors raise substantial doubt about our ability to continue as a going concern and our auditor has included an explanatory paragraph relating to our ability to continue as a going concern in its audit report for the fiscal year ended December 31, 2023.

 

The Company had cash of $189,810 at September 30, 2024. Cash used in operating activities for the nine months ended September 30, 2024, was $1,798,860. This resulted primarily from a net loss of $2,918,723 offset by stock-based compensation of $1,410, amortization of intangible assets and capitalized software development costs of $206,113, increase in accounts receivable of $202,815, an increase in accounts payable and accrued expenses of $630,497, issuance of common stock and warrants for services rendered of $749,152, provision for credit losses of $92,779, amortization of debt discounts of $265,556, decrease in contract liabilities of $118,025, and an income tax benefit of $59,324. Cash used in investing activities was related to the development of new software of $1,444,396. Cash flows provided by financing activities of $2,904,794 were related to repayment of debt of $574,746 offset by net proceeds received from the sale of common stock of $2,237,000 and proceeds from the issuance of debt of $1,242,546 and the repayments on notes payable, net of issuance costs.

 

The Company had cash of $140,939 at September 30, 2023. Cash used in operating activities for the nine months ended September 30, 2023, was $3,732,469. This resulted primarily from a net loss of $5,220,014 offset by stock-based compensation of $22,295, amortization of intangible assets and capitalized software development costs of $515,364, decrease in accounts receivable of $165,331, a decrease in accounts payable and accrued expenses of $626,415, loss on debt extinguishment of $396,322, amortization of debt discounts of $738,142, and an income tax benefit of $180,000. Cash used in investing activities was related to the development of new software of $1,507,045. Cash flows provided by financing activities of $5,159,599 were related to repayment of debt of $1,587,500 offset by net proceeds received from the sale of common stock and pre-funded warrants of $5,735,499 and proceeds from the issuance of debt of $1,011,500, net of issuance costs.

 

Our company commenced operations in 1998 and was initially funded by our three founders, each of whom has made demand loans to our company that have been repaid. Since 1999, we have relied on equity financing and borrowings from outside investors to supplement our cash flow from operations and expect this to continue in 2024 and beyond until cash flow from our proximity marketing operations becomes substantial.

 

Debt and Equity Transactions

 

See Notes 4, 5, and 9 to the consolidated financial statements herein for a complete description of various debt and equity transactions in the periods covered by this report.

 

Off-Balance Sheet Arrangements

 

As of September 30, 2024, we did not have any off-balance-sheet arrangements, as defined in Item 303(a)(4)(ii) of Regulation S-K.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not applicable

 

 

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer evaluated the effectiveness of the disclosure controls and procedures as of each fiscal year and quarter. Based upon this evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were not effective as of September 30, 2024, due primarily to the Company’s lack of segregation of duties in the finance and accounting department similar to other companies our size.

   

We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure.

 

There were changes in the Company’s internal control over financial reporting during the most recently completed fiscal year, which includes the integration of the new staff, that have materially affected or are reasonably likely to materially affect the Company’s internal control over financial reporting.

 

We performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. generally accepted accounting principles. Accordingly, the management believes that the financial statements included in this Form 10-Q present fairly in all material respects our financial position, results of operations and cash flows for the period presented.

 

Continuing Internal Controls Remediation Efforts

 

During fiscal 2022 the Company identified control gaps and deficiencies. The Company continues to mitigate and remediate the gaps, deficiencies, and material weaknesses in its internal controls. The Board of Directors and The Audit Committee, as a priority, initiated these remediation activities to ensure the Company has proper internal controls over financial reporting and corporate governance. The Company has instituted independent monitoring and testing of these aforementioned controls. These procedures were applied during fiscal 2023 and will continue in fiscal 2024, with mitigation and revision of controls continuing to be an ongoing process. Management has decided to defer the allocation of the additional talent necessary for the full implementation of the planned remediations until late fiscal 2024. The Company has instituted detective controls as well as independent monitoring and testing of these aforementioned controls, which gives management comfort that reporting represents the financial results of the Company in all material respects.

 

 

 

 

 

 

 

 

 

PART II. OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS.

 

Michael Trepeta, a former Co-CEO and director of the Company, filed a lawsuit against the Company and its subsidiary, Mobiquity Networks in April 2023 in the New York State Supreme Court, Nassau County. The claims stem from a Separation Agreement and Release that Mr. Trepeta and the Company entered into nine years ago in April 2017 which terminated Mr. Trepeta’ s employment agreement and discontinued his employment and directorship with the Company, among other things, by mutual agreement. Mr. Trepeta also gave the Company a release in the Separation Agreement and Release. Mr. Trepeta has claimed that the Company fraudulently induced him to enter into the Separation Agreement and Release; that the Company breached Mr. Trepeta’ s employment agreement; and that the Company breached its covenant of good faith and fair dealing and its fiduciary duty. Mr. Trepeta is claiming not less than $2.5 million in damages. Based on the Company’s initial internal review of the situation, the Company believes the claims lack merit and it intends to vigorously defend the same. In December 2023, the Company was notified that its motion to dismiss Mr. Trepeta’s action was granted but Mr. Trepeta has filed a notice of appeal. Due to uncertainties inherent in litigation, the Company cannot predict the outcome of this matter at this time.

 

ITEM 1A. RISK FACTORS

 

Incorporated by reference are the risk factors contained in our Form 10-K for the fiscal year ended December 31, 2023.

 

ITEM 2. CHANGES IN SECURITIES.

 

RECENT SALES OF UNREGISTERED SECURITIES

 

(a) For fiscal 2023 and 2024, we had no sales or issuances of unregistered capital stock, except as described below:

 

Date of Sale		Title of Security		Number Sold		Consideration Received and Description of Underwriting or Other Discounts to Market Price or Convertible Security, Afforded to Purchasers		Exemption from Registration Claimed		If Option, Warrant or Convertible Security, terms of exercise or conversion
2023		Common Stock		291,891 shares		Services rendered		Rule 506, Section 4(2)		Not applicable
2023		Common Stock		626, 844 shares 2,448,427 warrants		Shares sold for cash		Rule 506, Section 4(2)		Warrant exercise price ranging from $1.50 to 6.975 per share
2023		Common Stock		34, 849 shares		Original issue discount		Section 3 (a)(9)		Not applicable
2023		Common Stock		2,314,026 shares		Warrant conversion		Section 3 (a)(9)		Each warrant exercise price $6.975
2023		Common Stock		92,378 shares		Interest conversion		Rule 506, Section 4(2)		Not applicable
Jan-September 2024		Common Stock		4,347,334 shares		Shares sold for cash		Rule 506, Section 4(2)		Not applicable
Jan-September 2024		Common Stock		223,526 shares		Services rendered		Rule 506, Section 4(2)		Not applicable
Jan-September 2024		Common Stock		7,684,730 shares		Conversion of Series H Preferred stock		Section 3 (a)(9)		Not applicable
Jan-September 2024		Common Stock		158,840		Conversion of Series H Preferred dividends		Section 3 (a)(9)		Not applicable

 

 

 

 

In April 2023, the Board of Directors or the Compensation Committee of the Company’s Board of Directors approved the following transactions:

 

	·	Grant of 6,667 shares of restricted common stock to Gene Salkind, Chairman of the Board, for services previously rendered, based on a per share value of $2.505.
	·	Grant of 3,333 shares of restricted common stock each to the Company’s CEO and another member of the Board of Directors for services as directors of the Company.
	·	Grant of 2,000 shares of common stock to Gene Salkind as payment for accrued and unpaid interest of approximately $5,000 based on a per share value of $2.505.
	·	Grant of 4,791 shares of restricted common stock to the Company’s legal counsel as payment for accrued and unpaid services valued at $12,000 and $2.505 per share.
	·	Issuance of a total of 31,891 shares of restricted common stock at a per share value of $2.52 as payment and full settlement of outstanding accounts payable with a total carrying amount of $80,411.

  

Share prices used in the above transaction were based on the market price of the Company’s common stock on the consummation dates of the transactions.

 

Salkind October 2023 Loan Conversion and Series G Preferred Stock Issuance

 

Effective November 7, 2023, Mr. Gene Salkind and parties associated with him (the Series G Preferred Shareholders), invested $1,503,495 into the Company’s newly created Series G Preferred Stock, formalized through three Subscription Agreements for the sale of a combined 300,789 shares of Series G Preferred Stock for total cash proceeds of $1,200,000, plus the conversion of $300,000 in principal and $3,495 in accrued interest from the Salkind October 2023 Loan (see Note 4). Each share of the Series G Preferred Stock is convertible by the Series G Preferred Shareholders at any time after issuance into ten (10) shares of the Company’s Common Stock, or $0.50 per Common Share (Series G Conversion Ratio). The Series G Preferred Stock will automatically convert at the same Series G Conversion Ratio upon the Company’s Common Stock reporting of a closing sales price over $5.00 per share for ten (10) consecutive trading days. The Company did not pay any commissions or other compensation to any third party in connection with the transactions reported herein. Exemption from registration is claimed under section 4(2) of the Securities Act of 1933, as amended.

 

Series H Preferred Stock Issuances

 

On December 18, 2023, the Series G Preferred Shareholders agreed to exchange all 300,789 of the Series G Preferred Stock into 751,730 shares of the Company’s newly created Series H Preferred Stock. Also, our legal counsel agreed to exchange $33,000 of monies owed to the law firm for 16,500 shares of Series H Preferred Stock. Each share of the Series H Preferred Stock is convertible at any time after issuance into ten (10) shares of the Company’s Common Stock, or $0.20 per Common Share (Series H Conversion Ratio). The Series H Preferred Stock will automatically convert at the same Series H Conversion Ratio upon the Company’s Common Stock reporting of a closing sales price over $2.00 per share for ten (10) consecutive trading days or on December 31, 2026, whichever is earlier. The Company did not pay any commissions or other compensation to any third party in connection with the transactions reported herein. Exemption from registration is claimed under section 3(a)(9) of the Securities Act of 1933, as amended. During the quarter ended September 30, 2024, all outstanding shares of Series H Preferred Stock were converted into shares of the Company’s common stock, as discussed above.

 

Issuance of Common Stock for Settlement of Liabilities

 

In January 2024, the Company issued 100,000 shares of its common stock at a per share price of $0.53 in full settlement of vendor liabilities outstanding at an amount equal to $53,000. In March 2024, the Company issued 18,000 shares of its common stock in settlement of outstanding vendor liabilities at an amount equal to $12,000 stock at per share prices ranging from $0.50 to $1.00. In the third quarter of 2024, corporate counsel converted $18,000 of accrued liabilities into common stock at a conversion price of $0.50 per share.

 

 

 

 

Issuance of Common Stock for Cash

 

During the first nine months of 2024, the Company raised a total of $2,237,000 in cash from various accredited investors in conjunction with common stock subscription agreements, resulting in the issuance of a total of 4,347,334 shares at per share prices ranging from $0.30 to $0.60. In the third quarter of 2024, the Company raised a total of $675,000 in cash from various accredited investors in conjunction with common stock subscription agreements, resulting in the issuance of 1,100,000 shares at per share prices ranging from $0.50 to $1.00.

 

Issuance of Common Stock Warrant for Services

 

During June 2024, the Company entered into a consulting agreement with an unrelated party for general business consulting services. The term of the agreement is for twelve months, commencing in June 2024. Compensation under the agreement included an upfront payment of $25,000 in cash, and the issuance of 100,000 common stock warrants, exercisable through June 2027, at an exercise price of $0.50 per share. The consultant also receives a monthly fee of $5,000. The fair value of the warrants at issuance was $171,800, which is being amortized, along with the upfront payment, through general and administrative expenses, straight-line, over the twelve-month service period. In September 2024, the Company amended the consulting agreement to increase the monthly cash compensation to $10,000 and to issue additional warrants to purchase a total of 150,000 shares of common stock exercisable over a three-year period. The 150,000 warrant shares consist of 100,000 exercisable at $0.50 per share and 50,000 exercisable at $1.00 per share through September 10, 2027. The new warrants issued in September 2024 were fair valued at a total of $446,200, which was recorded as prepaid assets and is being amortized through general and administrative expense straight-line over the remaining 10 months of the agreement term. Total expense recognized related to the upfront payment and issued warrants was approximately $94,000 and $110,000 for the three and nine months ended September 30, 2024, respectively.

 

Treasury Stock

 

In the three months ended March 31, 2024, the Company repurchased 17 shares of common stock in the first quarter of March 31,2024 for an insignificant amount of money, recorded as treasury stock. There were no repurchases of the Company’s common stock for the year ended December 31, 2023, or the quarter ended September 30, 2024.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES.

 

Not applicable.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

ITEM 5. OTHER INFORMATION.

 

During the quarter ended September 30, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

 

 

 

 

ITEM 6. EXHIBITS

 

Exhibit
Number		Exhibit Title
2.1		Agreement and Plan of Merger dated November 20, 2018 between Mobiquity Technologies, Inc., Glen Eagles Acquisition LP, Avng Acquisition Sub, LLC, Advangelists, LLC, and Deepankar Katyal as Member Representative (the “Advangelists Merger Agreement”) (Incorporated by reference to Form 8-K dated December 11, 2018.)
2.2		First Amendment to the Advangelists Merger Agreement dated December 6, 2018 (Incorporated by reference to Form 8-K dated December 11, 2018.)
2.3		Membership Interest Purchase Agreement dated as of April 30, 2019 between Mobiquity Technologies, Inc. and Glen Eagles Acquisition LP (Incorporated by reference to Form 8-K dated April 30, 2019.)
2.4		Membership Interest Purchase Agreement, effective as of May 8, 2019 between Mobiquity Technologies, Inc. and Gopher Protocol, Inc. (Incorporated by reference to Form 8-K dated May 10, 2019.)
2.5		Assignment and Assumption Agreement effective as of May 8, 2019 between Mobiquity Technologies, Inc. and Gopher Protocol, Inc. (Incorporated by reference to Form 8-K dated May 10, 2019.)
2.6		Stock Purchase Agreement, effective as of September 13, 2019, by and between Mobiquity Technologies, Inc. and GBT Technologies, Inc. (Incorporated by reference to Form 8-K dated September 13, 2019.)
2.7		Subscription Agreement, dated as of September 13, 2019, by and between Mobiquity Technologies, Inc. and Dr. Gene Salkind (Incorporated by reference to Form 8-K/A dated September 13, 2019.)
2.8		Subscription Agreement, dated as of September 13, 2019, by and between Mobiquity Technologies, Inc. and Marital Trust GST Subject U/W/O Leopold Salkind (Incorporated by reference to Form 8-K/A dated September 13, 2019.)
2.9		Securities Purchase Agreement dated September 20, 2021, by and between Mobiquity Technologies, Inc. and Talos Victory Fund, LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)
2.10		Securities Purchase Agreement dated September 20, 2021, by and between Mobiquity Technologies, Inc. and Blue Lake Partners LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)
2.11		Securities Purchase Agreement dated December 30, 2022, with Walleye (Incorporated by reference to Form 8-K filed with the SEC on January 4, 2023)
3.1		Certificate of Incorporation filed March 26, 1998 (Incorporated by reference to Registrant’s Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)
3.2		Amendment to Certificate of Incorporation filed June 10, 1999 (Incorporated by reference to Registrant’s Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)
3.3		Amendment to Certificate of Incorporation approved by stockholders in 2005(Incorporated by reference to Registrant’s Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)
3.4		Amendment to Certificate of Incorporation dated September 11, 2008 (Incorporated by reference to the Registrant’s Form 10-K for its fiscal year ended December 31, 2012.)
3.5		Amendment to Certificate of Incorporation dated October 7, 2009 (Incorporated by reference to the Registrant’s Form 10-K for its fiscal year ended December 31, 2012.)
3.6		Amendment to Certificate of Incorporation dated May 18, 2012 (Incorporated by reference to the Registrant’s Form 10-K for its fiscal year ended December 31, 2012.)
3.7		Amendment to Certificate of Incorporation dated September 10, 2013 (Incorporated by reference to Registrant’s Form 8-K filed on September 11, 2013.)

 

 

 

 

Exhibit
Number		Exhibit Title
3.8		Amendment to Certificate of Incorporation filed December 22, 2015 (Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2015.)
3.9		Amendment to Certificate of Incorporation dated March 23, 2016 (Incorporated by reference to Form 8-K dated March 24, 2016.)
3.10		Amendment to Certificate of Incorporation dated February 28, 2017 (Incorporated by reference to Form 8-K dated March 1, 2017.)
3.11		Amendment to Certificate of Incorporation dated September 2018 (Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.)
3.12		Amendment to Certificate of Incorporation dated February 2019 (Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.)
3.13		Amendment to Certificate of Incorporation dated December 17, 2018 (Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.)
3.14		Amendment to Certificate of Incorporation dated December 4, 2018 (Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.)
3.15		Restated Certificate of Incorporation dated July 16, 2019 (Incorporated by reference to Form 8-K dated July 15, 2019.)
3.16		Amendment to Certificate of Incorporation-Series dated September 23, 2019 ***
3.17		Amendment to Certificate of Incorporation dated August 24, 2020***
3.18		Amendment to Restated Certificate of Incorporation dated June 15, 2023*****
3.19		Amended By-Laws (Incorporated by reference to Registrant’s Registration Statement on Form 10-SB as filed with the Commission on February 10, 2005)
3.20		2014 Amendment to By-Laws (Incorporated by reference to Form 8-K filed with the SEC on December 24, 2014.)
3.21		November 2021 Amendment to By-Laws****
3.22		Amendment No. 3 to Bylaws (Incorporated by reference to Form 8-K filed with the SEC on May 16, 2023.)
3.23		Amendment to Certificate of Incorporation dated November 2023**
3.24		Amendment to Certificate of Incorporation dated December 2023**
4.1		Amended and Restated $7,512,500 Promissory Note dated as of May 10, 2019, from Mobiquity Technologies, Inc. to Deepanker Katyal, as representative of the former members of Advangelists, LLC (Incorporated by reference to Form 8-K dated May 10, 2019.)
4.2		Second Amended and Restated Promissory Note, dated as of September 13, 2019, by and between Mobiquity Technologies, Inc. and Deepankar Katyal, as representative of the former owners of Advangelists, LLC (Incorporated by reference to Form 8-K dated September 13, 2019.)
4.3		Form of Common Stock Purchase Warrant (Incorporated by reference to Form 8-K dated September 13, 2019.)
4.4		Convertible Promissory Note in favor of Dr. Gene Salkind, dated as of September 13, 2019 (Incorporated by reference to Form 8-K/A dated September 13, 2019.)
4.5		Amended and Restated Convertible Promissory Note in favor of Dr. Gene Salkind, dated as of December 31, 2019 ***
4.6		Second Amended and Restated Convertible Promissory Note in favor of Dr. Gene Salkind, dated as of April 1, 2019 ***
4.7		Convertible Promissory Note in favor of Marital Trust GST Subject U/W/O Leopold Salkind, dated as of September 13, 2019 (Incorporated by reference to Form 8-K/A dated September 13, 2019.)
4.8		Amended and Restated Convertible Promissory Note in favor of Marital Trust GST Subject U/W/O Leopold Salkind, dated as of December 31, 2019***
4.9		Second Amended and Restated Convertible Promissory Note in favor of Marital Trust GST Subject U/W/O Leopold Salkind, dated as of April 1, 2019***

 

 

 

 

Exhibit
Number		Exhibit Title
4.10		Form of Lender Warrant (Incorporated by reference to Form 8-K/A dated September 13, 2019.)
4.11		Promissory Note in favor of Talos Victory Fund, LLC dated September 20, 2021 (Incorporated by reference to Form 8-K dated September 20, 2021.)
4.12		Promissory Note in favor of Blue Lake Partners LLC dated September 20, 2021 (Incorporated by reference to Form 8-K dated September 20, 2021.)
4.13		Common Stock Purchase Warrant dated September 20, 2021, issued to Talos Victory Fund, LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)
4.14		Common Stock Purchase Warrant dated September 20, 2021, issued to Blue Lake Partners LLC (Incorporated by reference to Form 8-K dated September 20, 2021.)
4.15		Form of 2021 Representative’s warrant***
4.16		Form of 2021Warrant Agent Agreement by and between the Company and Continental Stock Transfer & Trust Company***
4.17		Form of 2021 Warrant (Annex C to the Form of Warrant Agent Agreement attached as Exhibit 4.16)***
4.18		Form of Representative’s Warrant***
4.19		Form of Series 2023 Warrant***
4.20		Form of Pre-funded Warrant (Form 2023)***
4.21		Form of Investor Convertible Debt Subscription Agreement (5% Original Issue Discount)***
4.22		Form of Investor Convertible Debt Subscription Agreement (10% Original Issue Discount)***
4.23		Form of Investor Convertible Debt Subscription Agreement (10% Annual Interest)***
4.24		Promissory Note dated December 30, 2022, issued to Walleye (Incorporated by reference to Form 8-K filed with the SEC on January 4, 2023)
4.25		Amendment dated February 7, 2023 to Promissory Note dated December 30, 2022 issued to Walleye****
4.26		Warrant dated December 30, 2022, issued to Walleye (Incorporated by reference to Form 8-K filed with the SEC on January 4, 2023)
4.27		Form of Pre-funded Warrant for the Offering*****
4.28		Amendment dated February 13, 2023, to Promissory Note dated December 30, 2022 issued to Walleye*****
10.1		Employment Agreement dated April 2, 2019 – Dean L. Julia (Incorporated by reference to Form 10-K/A filed with the SEC on April 26, 2019.)
10.2		Employment Agreement dated April 2, 2019 – Sean Trepeta (Incorporated by reference to Form 10-K/A filed with the SEC on April 26, 2019.)
10.3		Employment Agreement dated April 2, 2019 – Paul Bauersfeld (Incorporated by reference to Form 10-K/A filed with the SEC on April 26, 2019.)
10.4		Employment Agreement dated January 4, 2022 – Deepanker Katyal (Incorporated by reference to Form 10-K filed with the SEC on March 30, 2022)
10.5		Security Agreement and Subsidiary Guarantee with Walleye (Incorporated by reference to Form 8-K filed with the SEC on January 4, 2023)
21.1		Subsidiaries of the Issuer (Incorporated by reference to Form 10-K for the fiscal year ended December 31, 2018.)
31.1		Rule 13a-14(a) Certification in accordance with section 302of the Sarbanes-Oxley Act of 2002*
31.2		Rule 13a-14(a) Certification in accordance with section 302of the Sarbanes-Oxley Act of 2002*
32.1		Certification Pursuant to 18.U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
32.2		Certification Pursuant to 18.U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002*
99.1		2005 Employee Benefit and Consulting Services Compensation Plan (Incorporated by reference to Registrant’s Registration Statement on Form 10-SB/A filed with the Commission March 21, 2005.)

 

 

 

 

 

Exhibit
Number		Exhibit Title
99.2		Amendment to 2005 Plan (Incorporated by reference to the Registrant’s Form 10-QSB/A filed with the Commission on August 15, 2005.)
99.3		2009 Employee Benefit and Consulting Services Compensation Plan (Incorporated by reference to Form 10-K filed for the fiscal year ended December 31, 2009.)
99.4		2018 Employee Benefit and Consulting Services Compensation Plan. (Incorporated by reference to Definitive Proxy Statement filed with the SEC on January 11, 2019.)
99.5		2021 Employee Benefit and Consulting Compensation Plan***
99.6		2023 Equity Participation Plan (Incorporated by reference to Definitive Proxy Statement filed with the SEC on April 18, 2023.)
99.7		2023 Employee Benefit and Consulting Compensation Plan**
101.INS		Inline XBRL Instance Document *
101.SCH		Inline Document, XBRL Taxonomy Extension *
101.CAL		Inline Calculation Linkbase, XBRL Taxonomy Extension Definition *
101.DEF		Inline Linkbase, XBRL Taxonomy Extension Labels *
101.LAB		Inline Linkbase, XBRL Taxonomy Extension *
101.PRE		Inline Presentation Linkbase *

 

__________________

*	Filed herewith.
**	Filed with form 10-K for fiscal year ended December 31, 2023
***	Previously filed under Form S-1 Registration Statement, File No. 333-260364.
****	Previously filed under Form S-1 Registration Statement File No. 333-269293.
*****	Previously filed under Form S-1 Registration Statement File No. 333-272572

 

 

 

 

 

 

 

 

 

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

	MOBIQUITY TECHNOLOGIES, INC.
Date: November 14, 2024	By:	/s/ Dean L. Julia
		Dean L. Julia,
		Principal Executive Officer
Date: November 14, 2024	By:	/s/ Sean McDonnell
		Sean McDonnell,
		Principal Financial Officer

 

 

 

 

 

 

 

 

 

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

 

I, Dean L. Julia, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Mobiquity Technologies, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report.

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared.

 

b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 14, 2024	/s/ DEAN L. JULIA
	DEAN L. JULIA,
	PRINCIPAL EXECUTIVE OFFICER

 

EXHIBIT 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

 

I, Sean McDonnell, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of Mobiquity Technologies, Inc.

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared.

 

b) Designed such internal control over financial reporting or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles.

 

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: November 14, 2024	/s/ SEAN MCDONNELL
	SEAN MCDONNELL, PRINCIPAL FINANCIAL OFFICER

 

EXHIBIT 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report of Mobiquity Technologies, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Dean L. Julia, Principal Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

	/s/ DEAN L. JULIA
	DEAN L. JULIA
	PRINCIPAL EXECUTIVE OFFICER
Date: November 14, 2024

 

 

EXHIBIT 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report of Mobiquity Technologies, Inc. (the “Company”) on Form 10-Q for the period ended September 30, 2024, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Sean McDonnell, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

	/s/ SEAN MCDONNELL
	SEAN MCDONNELL
	PRINCIPAL FINANCIAL OFFICER
Date: November 14, 2024

 

v3.24.3

Cover - shares	9 Months Ended
	Sep. 30, 2024	Nov. 13, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2024
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2024
Current Fiscal Year End Date	--12-31
Entity File Number	001-41117
Entity Registrant Name	MOBIQUITY TECHNOLOGIES, INC.
Entity Central Index Key	0001084267
Entity Tax Identification Number	11-3427886
Entity Incorporation, State or Country Code	NY
Entity Address, Address Line One	35 TORRINGTON LANE
Entity Address, City or Town	SHOREHAM
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	11786
City Area Code	516
Local Phone Number	246-9422
Title of 12(g) Security	Common Stock, $.0001 par value and Common Stock Purchase Warrants
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		17,149,356

v3.24.3

Consolidated Balance Sheets - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Current Assets
Cash	$ 189,810	$ 528,272
Accounts receivable	238,730	1,192,538
Less: Allowance for credit losses	(94,066)	(1,157,910)
Accounts receivable, net	144,664	34,628
Prepaid and other current assets	563,034	149,635
Total Current Assets	897,508	712,535
Property and equipment, net	5,384	7,298
Goodwill	1,352,865	1,352,865
Intangible assets, net	0	76,488
Capitalized software development costs, net	3,364,679	2,049,908
Total Assets	5,620,436	4,199,094
Current Liabilities
Accounts payable and accrued expenses	2,308,203	1,626,914
Accrued interest - related party	8,532	0
Contract liabilities	77,110	195,135
Debt, current portion, net	1,102,073	168,717
Total Current Liabilities	3,495,918	1,990,766
Total Liabilities	3,495,918	1,990,766
Commitments and Contingencies (Note 8)
Stockholders' Equity
Common stock; $0.0001 par value, 100,000,000 shares authorized, 16,609,356 and 3,994,926 shares issued, 16,606,839 and 3,992,426 shares outstanding	1,662	400
Treasury stock, at cost, $0.0001 par value 2,517 and 2,500 shares outstanding	(1,350,006)	(1,350,000)
Additional paid-in capital	223,584,558	220,598,180
Accumulated deficit	(220,111,705)	(217,040,339)
Total Stockholders' Equity	2,124,518	2,208,328
Total Liabilities and Stockholders' Equity	5,620,436	4,199,094
AAA Preferred Stock [Member]
Stockholders' Equity
Preferred stock, value	3	3
Series E Preferred Stock [Member]
Stockholders' Equity
Preferred stock, value	6	6
Series H Preferred Stock [Member]
Stockholders' Equity
Preferred stock, value	$ 0	$ 78

v3.24.3

Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2024	Dec. 31, 2023
Common stock, par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	16,609,356	3,994,926
Common stock, shares outstanding	16,606,839	3,992,426
Treasury stock, shares	2,517	2,500
AAA Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	1,250,000	1,250,000
Preferred stock, shares issued	31,413	31,413
Preferred stock, shares outstanding	31,413	31,413
Series E Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	70,000	70,000
Preferred stock, shares issued	61,688	61,688
Preferred stock, shares outstanding	61,688	61,688
Series H Preferred Stock [Member]
Preferred stock, par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	770,000	770,000
Preferred stock, shares issued	0	768,473
Preferred stock, shares outstanding	0	768,473

v3.24.3

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Income Statement [Abstract]
Revenues	$ 566,044	$ 177,271	$ 1,096,218	$ 441,010
Cost of revenues	230,296	114,174	625,690	281,071
Gross profit	335,748	63,097	470,528	159,939
Operating expenses
General and administrative expenses	1,270,386	1,262,988	3,312,699	3,900,693
Depreciation and amortization	44,453	195,148	208,027	521,170
Total operating expenses	1,314,839	1,458,136	3,520,726	4,421,863
Loss from operations	(979,091)	(1,395,039)	(3,050,198)	(4,261,924)
Other income (expense)
Interest expense	(152,247)		(323,119)	(743,396)
Loss on extinguishment of debt - related party	0	0	0	(396,322)
Loss on disposal of fixed assets	0		0	(695)
Other income	0	0	237,949	0
Interest income	22	768	4,678	2,323
Total other income (expense) - net	(152,225)	768	(80,492)	(1,138,090)
Net loss before income taxes	(1,131,316)	(1,394,271)	(3,130,690)	(5,400,014)
Income tax benefit	0	0	59,324	180,000
Net loss	$ (1,131,316)	$ (1,394,271)	$ (3,071,366)	$ (5,220,014)
Loss per share - basic	$ (0.09)	$ (0.38)	$ (0.39)	$ (2.53)
Loss per share - diluted	$ (0.09)	$ (0.38)	$ (0.37)	$ (2.53)
Weighted average number of shares outstanding - basic	12,762,454	3,703,314	7,832,569	2,067,264
Weighted average number of shares outstanding - diluted	12,762,454	3,703,314	7,832,569	2,067,264

v3.24.3

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Series E Preferred Stock [Member]	Series F Preferred Stock [Member]	Series G Preferred Stock [Member]	Series H Preferred Stocks [Member]	Series AAA Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Stock Subscription Receivable [Member]	Treasury Stock, Common [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2022	$ 6	$ 0	$ 0	$ 0	$ 3	$ 62	$ 211,846,321	$ 0	$ (1,350,000)	$ (210,507,222)	$ (10,830)
Beginning balance, shares at Dec. 31, 2022	61,688	0	0	0	31,413	620,776			2,500
Common stock and pre-funded warrants issued under public offering, net of issuance costs						$ 25	3,207,475				3,207,500
Common stock and pre-funded warrants issued under public offering, net of issuance costs, shares						251,843
Common stock issued under cashless warrant exercises and exercise of pre-funded warrants						$ 23	(23)
Common stock issued under cashless warrant exercises and exercise of pre-funded warrants, shares						229,327
Incentive common stock and warrants issued with long-term debt						$ 4	708,460				708,464
Incentive common stock and warrants issued with long-term debt, shares						34,849
Stock based compensation							12,304				12,304
Ending balance, value at Mar. 31, 2023	6	0	0	0	3	114	215,774,537	0	(1,350,000)	(212,224,026)	2,200,634
Net loss										(1,716,804)	(1,716,804)
Ending balance, shares at Mar. 31, 2023	61,688	0	0	0	31,413	1,136,795			2,500
Beginning balance, value at Dec. 31, 2022	$ 6	$ 0	$ 0	$ 0	$ 3	$ 62	211,846,321	0	$ (1,350,000)	(210,507,222)	(10,830)
Beginning balance, shares at Dec. 31, 2022	61,688	0	0	0	31,413	620,776			2,500
Ending balance, value at Sep. 30, 2023	$ 6	$ 0	$ 0	$ 0	$ 3	$ 257	218,628,457	0	$ (1,350,000)	(215,727,236)	1,551,487
Net loss											(5,220,014)
Ending balance, shares at Sep. 30, 2023	61,688	1	0	0	31,413	2,574,098			2,500
Beginning balance, value at Mar. 31, 2023	$ 6	$ 0	$ 0	$ 0	$ 3	$ 114	215,774,537	0	$ (1,350,000)	(212,224,026)	2,200,634
Beginning balance, shares at Mar. 31, 2023	61,688	0	0	0	31,413	1,136,795			2,500
Common stock and pre-funded warrants issued under public offering, net of issuance costs						$ 38	2,527,960				2,527,998
Common stock and pre-funded warrants issued under public offering, net of issuance costs, shares						375,001
Common stock issued under cashless warrant exercises and exercise of pre-funded warrants						$ 45	(45)
Common stock issued under cashless warrant exercises and exercise of pre-funded warrants, shares						459,698
Common stock issued for services						$ 3	80,408				80,411
Stock based compensation							9,757				9,757
Ending balance, value at Jun. 30, 2023	6	0	0	0	3	209	218,628,271	0	(1,350,000)	(214,332,965)	2,945,524
Series F preferred stock issued for cash							100				100
Series F preferred stock issued for cash, shares		1
Net loss										(2,108,939)	(2,108,939)
Common stock issued for services, shares						31,891
Common stock issued for conversion of interest						$ 9	235,554				235,563
Common stock issued for conversion of interest, shares						92,378
Ending balance, shares at Jun. 30, 2023	61,688	1	0	0	31,413	2,095,763			2,500
Common stock issued under exercise of pre-funded warrants						$ 48	(48)
Common stock issued under exercise of pre-funded warrants, shares						478,335
Stock based compensation							234				234
Ending balance, value at Sep. 30, 2023	6	0	0	0	3	257	218,628,457	0	(1,350,000)	(215,727,236)	1,551,487
Redemption of Series F preferred stock
Net loss										(1,394,271)	(1,394,271)
Ending balance, shares at Sep. 30, 2023	61,688	1	0	0	31,413	2,574,098			2,500
Beginning balance, value at Dec. 31, 2023	$ 6	$ 0	$ 0	$ 78	$ 3	$ 400	220,598,180	0	$ (1,350,000)	(217,040,339)	2,208,328
Beginning balance, shares at Dec. 31, 2023	61,688	0	0	768,473	31,413	3,994,926			2,500
Common stock issued for cash						$ 112	399,888				400,000
Common stock issued for services						$ 12	64,988				65,000
Common stock issued for cash, shares						1,123,334
Accrued Series H Preferred Stock cash dividends							(46,108)				(46,108)
Repurchase of common stock held in Treasury									$ (6)		(6)
Repurchase of common stock held in Treasury, shares									17
Stock based compensation							234				234
Ending balance, value at Mar. 31, 2024	6	0	0	78	3	524	221,017,182	0	(1,350,006)	(218,082,599)	1,585,188
Net loss										(1,042,260)	(1,042,260)
Common stock issued for services, shares						118,000
Ending balance, shares at Mar. 31, 2024	61,688	0	0	768,473	31,413	5,236,260			2,517
Beginning balance, value at Dec. 31, 2023	$ 6	$ 0	$ 0	$ 78	$ 3	$ 400	220,598,180	0	$ (1,350,000)	(217,040,339)	2,208,328
Beginning balance, shares at Dec. 31, 2023	61,688	0	0	768,473	31,413	3,994,926			2,500
Ending balance, value at Sep. 30, 2024	$ 6	$ 0	$ 0	$ 0	$ 3	$ 1,662	223,584,558	0	$ (1,350,006)	(220,111,705)	2,124,518
Net loss											(3,071,366)
Ending balance, shares at Sep. 30, 2024	61,688	0	0	0	31,413	16,609,356			2,517
Beginning balance, value at Mar. 31, 2024	$ 6	$ 0	$ 0	$ 78	$ 3	$ 524	221,017,182	0	$ (1,350,006)	(218,082,599)	1,585,188
Beginning balance, shares at Mar. 31, 2024	61,688	0	0	768,473	31,413	5,236,260			2,517
Common stock issued for cash						$ 213	1,061,787				1,062,000
Common stock issued for services						$ 4	24,031				24,035
Common stock issued for cash, shares						2,124,000
Accrued Series H Preferred Stock cash dividends							(46,108)				(46,108)
Warrants issued for services							171,800				171,800
Stock based compensation							941				941
Common stock subscribed, shares						200,000
Common stock subscribed						$ 20	99,980	(100,000)
Ending balance, value at Jun. 30, 2024	6	0	0	78	3	761	222,329,613	(100,000)	(1,350,006)	(218,980,389)	1,900,066
Net loss										(897,790)	(897,790)
Common stock issued for services, shares						39,754
Ending balance, shares at Jun. 30, 2024	61,688	0	0	768,473	31,413	7,600,014			2,517
Common stock issued for cash						$ 110	674,890				675,000
Common stock issued for services						$ 7	42,110				42,117
Common stock issued for cash, shares						1,100,000
Accrued Series H Preferred Stock cash dividends							(30,738)				(30,738)
Warrants issued for services							446,200				446,200
Series H Preferred stock converted to common shares				$ (78)		$ 768	(690)
Series H Preferred stock converted to common shares, shares				(768,473)		7,684,730
Series H Preferred stock dividends converted to common stock						$ 16	122,938				122,954
Series H Preferred stock dividends converted to common stock, shares						158,840
Stock based compensation							235				235
Common stock subscribed								100,000			100,000
Ending balance, value at Sep. 30, 2024	6	0	0	0	3	1,662	223,584,558	0	(1,350,006)	(220,111,705)	2,124,518
Net loss										$ (1,131,316)	$ (1,131,316)
Common stock issued for services, shares						65,772
Ending balance, shares at Sep. 30, 2024	61,688	0	0	0	31,413	16,609,356			2,517

v3.24.3

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash flows from operating activities:
Net loss	$ (3,071,366)	$ (5,220,014)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	1,914	5,806
Provision for credit losses	92,779	46,458
Loss on disposal of asset	0	695
Amortization of intangible assets	76,488	450,551
Amortization of capitalized software development costs	129,625	64,813
Amortization of debt discounts	265,556	738,142
Loss on debt extinguishment	0	396,322
Common stock and warrants issued for services	131,152	0
Stock-based compensation	1,410	22,295
Income tax benefit	59,324	180,000
Changes in operating assets and liabilities
(Increase) decrease in accounts receivable	(202,815)	165,331
(Increase) decrease prepaid expenses and other assets	204,601	47,500
Increase (decrease) in accounts payable and accrued expenses	630,497	(626,415)
Increase (decrease) in contract liabilities	(118,025)	(3,953)
Net cash used in operating activities	(1,798,860)	(3,732,469)
Cash flows from investing activities
Increase in software development costs	(1,444,396)	(1,507,045)
Cash flows from financing activities
Issuance of common stock for cash	2,237,000	0
Issuance of long-term debt, net of discounts and issuance costs	1,242,546	1,011,500
Repayments on long-term debt	(574,746)	(1,587,500)
Repurchase of treasury stock	(6)	0
Issuance of common stock and pre-funded warrants for cash, net of issuance costs	0	5,735,499
Issuance of Series F preferred stock	0	100
Net cash provided by financing activities	2,904,794	5,159,599
Net change in cash	(338,462)	(79,915)
Cash - beginning of period	528,272	220,854
Cash - end of period	189,810	140,939
Supplemental disclosure of cash flow Information
Cash paid for interest	49,031	18,848
Cash paid for taxes	320	294
Supplemental disclosure of non-cash investing and financing activities:
Accrual of Series H Preferred stock dividends	122,954	0
Conversion of Series H preferred stock and accrued dividends to common stock	122,954	0
Warrants issued in conjunction with consulting agreement	446,200	0
Issuance of incentive shares with debt recorded as debt discount	0	122,426
Warrants issued with long-term debt recorded as debt discount	0	586,038
Common stock issued under cashless warrant exercises	0	117
Common stock issued for accrued interest	0	235,563
Common stock issued for settlement of accounts payable	$ 0	$ 80,410

v3.24.3

Pay vs Performance Disclosure - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023
Pay vs Performance Disclosure [Table]
Net Income (Loss)	$ (1,131,316)	$ (897,790)	$ (1,042,260)	$ (1,394,271)	$ (2,108,939)	$ (1,716,804)	$ (3,071,366)	$ (5,220,014)

v3.24.3

Insider Trading Arrangements	3 Months Ended
	Sep. 30, 2024
Insider Trading Arrangements [Line Items]
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

v3.24.3

ORGANIZATION AND NATURE OF OPERATIONS	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND NATURE OF OPERATIONS	NOTE 1 – ORGANIZATION AND NATURE OF OPERATIONS   Mobiquity Technologies, Inc. and its operating subsidiaries (“Mobiquity,” “we,” “our” or “the Company”), are a next generation location data intelligence company. The Company provides precise unique, at-scale location data and insights on consumer’s real-world behavior and trends for use in marketing and research. We provide one of the most accurate and scaled solutions for mobile data collection and analysis, utilizing multiple geo-location technologies. The Company is seeking to implement several new revenue streams from its data collection and analysis, including, but not limited to, Advertising, Data Licensing, Footfall Reporting, Attribution Reporting, Real Estate Planning, Financial Forecasting and Custom Research. We also are a developer of advertising and marketing technology focused on the creation, automation, and maintenance of an advertising technology operating system (or ATOS). The ATOS platform blends artificial intelligence (or AI) and machine learning (ML) based optimization technology for automatic ad serving that manages and runs digital advertising campaigns.   Mobiquity Technologies, Inc. was incorporated in the State of New York and has the following subsidiaries:  Schedule of subsidiaries     Company Name   State of Incorporation Mobiquity Networks, Inc.   New York Advangelists, LLC   Delaware   Mobiquity Networks, Inc.   Mobiquity Networks, Inc. is a wholly owned subsidiary of Mobiquity Technologies, Inc., commencing operations in May 2018. Mobiquity Networks started and developed as a mobile advertising technology company focused on driving foot-traffic throughout its indoor network and has evolved and grown into a next generation data intelligence company. Mobiquity Networks, Inc. operates our data intelligence platform business.   Advangelists, LLC   Advangelists LLC is a wholly owned subsidiary of Mobiquity Technologies, Inc., acquired through a merger transaction in December 2018, and operates our ATOS platform business.   Reverse Stock Split   On August 7, 2023, we effected a one-for-15 reverse stock split. The consolidated financial statements and notes thereto give retroactive effect to the reverse stock split as if the split had occurred prior to the dates on the consolidated financial statements included herein.   Liquidity, Going Concern and Management’s Plans   These consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business.   As reflected in the accompanying consolidated financial statements, for the nine months ended September 30, 2024, the Company had:   · Net loss of $3,071,366 and · Net cash used in operations was $1,798,860   Additionally, at September 30, 2024, the Company had:   · Accumulated deficit of $220,111,705 · Stockholders’ equity of $2,124,518, and · Working capital deficit of $2,598,410.   We manage liquidity risk by reviewing, on an ongoing basis, our sources of liquidity and capital requirements. The Company had cash on hand of $189,810 at September 30, 2024.   The Company has incurred significant losses since its inception in 1998 and has not demonstrated an ability to generate sufficient revenues from the sales of its products and services to achieve profitable operations. There can be no assurance that profitable operations will ever be achieved, or if achieved, could be sustained on a continuing basis. In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flows and cash usage forecasts for the year ended December 31, 2023, and the nine months ended September 30, 2024, and our current capital structure including equity-based instruments and our obligations and debts.   Without sufficient revenue from operations, if the Company does not obtain additional capital, the Company will be required to reduce the scope of its business development activities or cease operations.   These factors create substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these consolidated financial statements are issued, as the Company will need additional capital to meet its financial obligations. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on the basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.   Management’s strategic plans include the following:   · Execution of business plan focused on technology development and improvement, · Seek out equity and/or debt financing to obtain the capital required to meet the Company’s financial obligations. There is no assurance, however, that lenders and investors will continue to advance capital to the Company or that the new business operations will be profitable. · Continuing to explore and execute prospective partnering, distribution and acquisition opportunities, · Identifying unique market opportunities that represent potential positive short-term cash flow.

v3.24.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES    Basis of Presentation   The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements (U.S. GAAP) and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (SEC). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months and nine months ended September 30, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 8, 2024.   Management acknowledges its responsibility for the preparation of the accompanying consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented.   Principles of Consolidation   These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.   Business Segments and Concentrations   The Company uses the “management approach” to identify its reportable segments. The management approach requires companies to report segment financial information consistent with information used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. The Company manages its business as a single reporting segment. Customers in the United States accounted for 100% of our revenues. We do not have any property or equipment outside of the United States.   Use of Estimates   Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of Company assets and liabilities, including the allowance for credit losses, stock-based compensation, the deferred tax asset valuation allowance, and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.    Risks and Uncertainties   The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks and the potential of overall business failure.   The Company has experienced, and in the future expects to continue to experience, variability in sales and net earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s service offerings. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.   Fair Value of Financial Instruments   The Company accounts for financial instruments at fair value, which is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:     · Level 1—Valuation based on quoted market prices in active markets that the Company can access for identical assets or liabilities;         · Level 2—Valuation based on quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability; and         · Level 3—Valuation based on unobservable inputs that are supported by little or no market activity, which require management’s best estimate of what market participants would use as fair value.   Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management.   The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include accounts receivable, accounts payable and accrued expenses, accrued interest – related party, and contract liabilities. On September 30, 2024, and December 31, 2023, the carrying amounts of these financial instruments approximated their fair values due to the short-term nature of these instruments. The fair value of the Company’s long-term debt approximates its carrying value based on current financing rates available to the Company.   The Company does not have any other financial or non-financial assets or liabilities that would be characterized as Level 1, Level 2, or Level 3 instruments.   Cash and Cash Equivalents and Concentrations of Risk   For the purposes of presentation in the consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents.   On September 30, 2024, and December 31, 2023, the Company did not have any cash equivalents.   The Company is exposed to credit risk on its cash in the event of default by the financial institutions to the extent account balances exceed the amount insured by the FDIC, which is $250,000. On September 30, 2024, and December 31, 2023, the Company did not experience any losses on cash balances in excess of FDIC insured limits. Any loss incurred or a lack of access to funds could have a significant impact on the Company’s consolidated financial condition, results of operations, and cash flows.   For the quarters ended September 30, 2024, and 2023, sales of our products to four customers and three customers generated approximately 86% and 96% of our revenues, respectively. For the nine months ended September 30, 2024, and 2023, sales of our products to five customers and three customers generated approximately 86% and 76% of our revenues, respectively. Our contracts with our customers generally do not obligate them to a specified term and they can generally terminate their relationship with us at any time with a minimal amount of notice. The loss of one of these customers could have a material adverse effect on the results of operations and financial condition.   Accounts Receivable and Allowance for Credit Losses   Effective January 1, 2023, the Company adopted Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326), which significantly change how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The most significant change in this standard is a shift from the incurred loss model to the expected loss model. Under the standard, disclosures are required to provide users of the consolidated financial statements with useful information in analyzing an entity’s exposure to credit risk and the measurement of credit losses. Financial assets held by the Company that are subject to the guidance in Topic 326 were trade accounts receivable. The impact of the adoption was not considered material to the consolidated financial statements.   Accounts receivable represent customer obligations under normal trade terms and are stated at the amount management expects to collect from outstanding customer balances. Credit is extended to customers based on an evaluation of their financial condition and other factors. Interest is not accrued on overdue accounts receivable. The Company does not require collateral. Two of our customers combined accounted for approximately 70% of outstanding accounts receivable at September 30, 2024.   The Company had accounts receivable, net, of $144,664, $34,628, and $340,935 at September 30, 2024, December 31, 2023, and January 1, 2023, respectively.   Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for credit losses. The Company provides its allowance for credit losses based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. Accounts determined to be uncollectible losses are charged to operations when that determination is made.   The allowance for credit losses for accounts receivable and the related activity, for the nine months ended September 30, 2024 is as follows:  Schedule of allowance for credit losses for accounts receivable activity       Balance, December 31, 2023   $ 1,157,910   Provision for credit losses     92,779   Write-off of previously reserved account balances     (1,106,025 ) Balance, September 30, 2024   $ 144,664     Provision for credit losses expense (recovery) is recorded as a component of general and administrative expenses in the accompanying consolidated statements of operations.   Impairment of Long-lived Assets   Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15“Impairment or Disposal of Long-Lived Assets.” Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets and compares this to the carrying amounts of the assets.   If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairment was recognized by the Company for the nine months ended September 30, 2024, and 2023.   Property and Equipment   Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets.   Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in current results of operations.   Goodwill   The Company’s goodwill represents the excess of the consideration transferred for the acquisition of Advangelists LLC in December 2018 over the fair value of the underlying identifiable net assets acquired. Goodwill is not amortized but instead, it is tested for impairment at least annually. If management determines that the value of goodwill has become impaired, the Company will record a charge in an amount equal to the excess of the reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit during the fiscal quarter in which the determination is made.   The Company performs its annual impairment tests of goodwill as of December 31st of each year, or more frequently, if certain indicators are present. Goodwill is required to be tested for impairment at the reporting unit level. A reporting unit is an operating segment or one level below the operating segment level, which is referred to as a component. Management identifies its reporting units by assessing whether components (i) have discrete financial information available, (ii) engage in business activities, and (iii) whether a segment manager regularly reviews the component’s operating results. Net assets and goodwill of acquired businesses are allocated to the reporting unit associated with the acquired business based on the anticipated organizational structure of the combined entities. If two or more components are deemed economically similar, those components are aggregated into one reporting unit when performing the annual goodwill impairment review. The Company has one reporting unit as of September 30, 2024, and December 31, 2023. No impairment of goodwill was recognized by the Company during fiscal 2023 or the nine-month period ended September 30, 2024.   Intangible Assets   In December 2018, the Company acquired the majority of its intangible assets through its acquisition of Advangelists LLC, which included customer relationships and the ATOS platform technology. The Company amortizes its identifiable definite-lived intangible assets over an estimated period of 5 years.   Capitalized Software Development Costs   In accordance with ASC 350-40, Internal Use Software, the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i) the research and planning stage, (ii) the application and development stage, and (iii) the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. These software developments and acquired technology are amortized on a straight-line basis over the estimated useful life of five years upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess of carrying value over the fair value in its consolidated statements of operations. See Note 3 for further details.   Derivative Financial Instruments   The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, (ASC 480), Distinguishing Liabilities from Equity and FASB ASC Topic No. 815, (ASC 815) Derivatives and Hedging.   Terms of financial instruments are reviewed to determine whether they contain embedded derivative instruments that are required to be accounted for separately from the host contract under ASC 815 and recorded on the balance sheet at fair value. Derivative liabilities are remeasured to reflect fair value at each reporting period, with any increase or decrease in the fair value being recorded in the results of operations. The Company generally incorporates a binomial model to determine fair value. Upon conversion of a debt instrument where an embedded conversion option has been bifurcated and accounted for separately as a derivative liability, the Company records the resulting shares issued at fair value, derecognizes all related debt principal, derivative liability, and debt discount, and recognizes a net gain or loss on debt extinguishment. Equity instruments that are initially classified as equity that become subject to reclassification under ASC 815 are reclassified to liabilities at the fair value of the instrument on the reclassification date. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. As of September 30, 2024, and December 31, 2023, the Company had no derivative instruments outstanding.   Debt Issuance Costs and Debt Discounts   Debt discounts, debt issuance costs paid to lenders or third parties, and other original issue discounts on debt, are recorded as debt discounts and amortized to interest expense in the consolidated statement of operations, over the term of the underlying debt instrument, using the effective interest method, with the unamortized portion reported net with related principal outstanding on the consolidated balance sheet. For the three months ended September 30, 2024, and 2023, the Company recognized $118,262 and no interest expense associated with the amortization of debt discounts on debt outstanding during the periods. For the nine months ended September 30, 2024, and 2023, the Company recognized $265,556 and $738,142 in interest expense associated with the amortization of debt discounts on debts outstanding during the periods. Unamortized debt discounts remaining at September 30, 2024 were approximately $229,000 and are expected to be fully amortized during the remainder of 2024. See Note 4 regarding the accounting for debt discounts and debt issuance costs during fiscal 2024 and 2023.   Revenue Recognition   The Company’s revenues are generated from internet advertising, the Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (ASC 606). In accordance with ASC 606, revenue is recognized when promised services are transferred to a customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:   Identify the contract with a customer.   A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.    Identify the performance obligations in the contract.   Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services (performance obligations), the Company must apply a judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation. Currently, the Company does not have any contracts that contain multiple performance obligations.   Determine the transaction price.   The transaction price is determined based on the consideration of which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts outstanding at September 30, 2024 or December 31, 2023, contained a significant financing component or variable consideration terms.   Allocate the transaction price to performance obligations in the contract.   If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation.   Recognize revenue when or as the Company satisfies a performance obligation.   The Company satisfies performance obligations at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised service to a customer. Under both managed services arrangements and self-service arrangements, the Company’s promised services under the contracts include identification, bidding and purchasing of advertisement opportunities. The Company also generally has discretion in establishing the pricing of the ads. Since the Company is controlling the promise to deliver the contracted services, the Company is considered the principal in all arrangements for revenue recognition purposes. The performance obligations are satisfied, and revenue recognition primarily upon publication of customer advertising content.   All revenues recognized were derived from internet advertising for the periods ended September 30, 2024, and 2023.   Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 90 days.   Contract Liabilities   Contract liabilities represent deposits made by customers before the satisfaction of performance obligation and recognition of revenue. Upon completion of the performance obligation(s) that the Company has with the customer based on the terms of the contract, the liability for the customer deposit is relieved and revenue is recognized. As of September 30, 2024, December 31, 2023, and January 1, 2023, there were $77,110, $195,135, and $193,598, respectively, in contract liabilities outstanding. Contract liabilities are expected to be recognized as revenue within the year following their respective period end.   Advertising   Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expenses in the consolidated statements of operations. Advertising costs incurred were insignificant for the periods ended September 30, 2024, and 2023.    Stock-Based Compensation   The Company accounts for our stock-based compensation, including stock options and common stock warrants, under ASC 718 Compensation – Stock Compensation, using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the requisite service period for employee awards, which is usually the vesting period, and when the goods are obtained or services are received, for nonemployee awards. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also applies to transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.   In connection with certain financing, consulting and collaboration arrangements, the Company may issue warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards.   The fair value of stock-based compensation is generally determined by using the Black-Scholes valuation model as of the date of the grant or the date at which the performance of the services is completed (measurement date).   When determining the fair value of stock-based compensation, the Company considers the following assumptions in the Black-Scholes model:   · Exercise price, · Expected dividends, · Expected volatility, · Risk-free interest rate; and · Expected life of option   Income Taxes   The Company accounts for income tax using the asset and liability method prescribed by ASC 740, Income Taxes (ASC 740). Under this method, deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more likely-than-not that all or some portion of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as gain or loss in the period that includes the date of the enactment.   The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740. Using that guidance, tax positions initially need to be recognized in the consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of September 30, 2024, and December 31, 2023, the Company did not identify any uncertain tax positions that qualify for either recognition or disclosure in the consolidated financial statements.   The Company recognizes interest and penalties, if any, related to recognized uncertain income tax positions, in other expense. No interest and penalties related to uncertain income tax positions were recorded for the periods ended September 30, 2024, and 2023. Open tax years, subject to examination by the Internal Revenue Service, generally remain open for three years from the filing date. Tax years subject to examination by the state jurisdiction generally remain open for up to four years from the filing date.   Related Parties   Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.    Recently Adopted Accounting Pronouncements    We consider the applicability and impact of all new accounting pronouncements on our consolidated financial position, results of operations, stockholders’ equity, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the Financial Accounting Standards Board (FASB) through the date these consolidated financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective, that when adopted, will have a material impact on the consolidated financial statements of the Company.

v3.24.3

INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS	NOTE 3: INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS   The Company’s definite-lived intangible assets consist of a customer relationship asset acquired through the Advangelists, LLC acquisition in 2018, and capitalized software development costs. The intangible assets are being amortized over their estimated useful lives of five years. The Company periodically evaluates the reasonableness of the useful lives of these assets. These assets are also reviewed for impairment or obsolescence when events or circumstances indicate that the carrying amount may not be recoverable. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized in the amount by which the carrying amount of the asset exceeds the fair value of the asset.  Schedule of intangible assets                     Useful Lives   September 30, 2024     December 31, 2023                     Customer relationship   5 years   $ 3,003,676     $ 3,003,676   Less accumulated amortization         (3,003,676 )     (2,927,188 ) Net carrying value       $ –     $ 76,488                         Software development costs   5 years   $ 3,602,328     $ 2,157,932   Less accumulated amortization         (237,649 )     (108,024 ) Net carrying value, software development costs       $ 3,364,679     $ 2,049,908      During the three months ended September 30, 2024, and 2023, the Company recognized zero and $150,184 in amortization expense, respectively, related to the customer relationship intangible asset, which is included in general and administrative expenses on the accompanying consolidated statements of operations. During the nine months ended September 30, 2024, and 2023, the Company recognized $76,488 and $450,551 in amortization expense, respectively, related to the customer relationship intangible asset.    During each of the three months ended September 30, 2024, and 2023, the Company recognized $43,209 of amortization expense related to software development costs, which is included in general and administrative expenses on the accompanying consolidated statements of operations. During the nine months ended September 30, 2024, and 2023, the Company recognized $129,625 and $64,813, respectively, of amortization expense related to software development costs.   As of September 30, 2024, and December 31, 2023, the Company has capitalized a total of approximately $3,600,000 and $2,200,000, respectively, of costs associated with the development of its new software enhancements, referred to as ATOS4P and AdHere. The approximately $1,440,000 in costs capitalized during the nine months ended September 30, 2024, were all related to AdHere enhancement only. The Company ceased capitalizing costs, and commenced marketing its ATOS4P enhancement to the public, during the second quarter of 2023. As of September 30, 2024, the Company has not commenced amortization of the costs associated with the AdHere technology. The product has been released to the public in October of 2024, at which time the Company began amortizing the costs.   Future amortization of the approximately $3,400,000 in unamortized software development costs, by fiscal year, at September 30, 2024, is as follows:  Schedule of future annual amortization           Software Development Costs   Remainder of 2024   $ 180,116   2025     720,466   2026     720,466   2027     720,466   2028     612,443   2029     410,722   Total   $ 3,364,679

v3.24.3

DEBT	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
DEBT	NOTE 4 – DEBT   Small Business Administration Loan   In June 2020, the Company received an Economic Injury Disaster Loan of $150,000 from the Small Business Administration (SBA) which carries a thirty-year term, and interest at 3.7% per annum, with a maturity date in July of 2050. The loan is to be repaid in monthly installments, including principal and interest, of $731, beginning twelve months from the date of the loan. Total accrued and unpaid interest on the debt was $13,594 at December 31, 2022 and is included in accounts payable and accrued expenses on the accompanying consolidated balance sheet. On January 5, 2023, the Company paid $163,885 to the Small Business Administration to pay off all outstanding principal and accrued interest on the Company’s SBA loan.   Investor Note Payable   On December 30, 2022, the Company and Walleye Opportunities Master Fund Ltd, a Cayman Islands company (the Investor), entered into a Securities Purchase Agreement (the SPA) for the Investor to purchase from the Company (i) a senior secured 20% original issue discount (OID) nine-month promissory note in an aggregate gross principal amount of $1,437,500, less the 20% OID of $287,500, for a net subscription amount of $1,150,000 (the Investor Note), and (ii) a five year warrant to purchase 174,242 shares of the Company’s common stock at an exercise price of $6.60 per share, exercisable commencing July 1, 2023 and expiring December 30, 2027 (the Investor Warrant). Proceeds from the SPA were received by the Company in January 2023. Per terms of the SPA, if at any time commencing July 1, 2023, the Company issues, sells, or announces for sale, any shares of its common stock (Subsequent Equity Sale) for a per share price less than the exercise price of the Investor Warrant in effect immediately prior to such Subsequent Equity Sale, the exercise price of the Investor Warrant shall be reduced to an amount equal to the issuance price of the Subsequent Equity Sale.   In conjunction with the SPA, the Company issued 34,849 shares of common stock, or approximately 5.3% of the Company’s outstanding shares at the time, to the Investor as an incentive on the transaction (Incentive Shares). Total issuance fees of $138,500 associated with the closing of the SPA were paid by the Company to Spartan Capital Securities LLC and the Investor’s counsel, resulting in net proceeds of $1,011,500. Approximately $163,000 of the loan proceeds were utilized to repay the outstanding principal and accrued interest under the SBA loan (see above).   The Investor Note will only become convertible into common stock upon the occurrence of an Event of Default under and as defined in the Investor Note on terms set forth in the Investor Note. This Investor Note matures and was payable on or before September 30, 2023, and it provided that the Investor may demand prepayment after March 31, 2023, and before the maturity date, provided that the purchasers of securities in a future public offering by the Company, as defined in the SPA, who hold the purchased Company securities at the time the prepayment demand, unanimously consent to the prepayment. On June 30, 2023, the secured debt was paid in full through the proceeds of the Company’s June 2023 Offering. See Note 5.   The aforementioned Investor Warrant was assigned a relative fair value of $586,040 and the Incentive Shares were assigned a relative fair value of $122,426, at the date of closing on the SPA. The fair values of the Investor Warrant, the Incentive Shares, the OID of $287,500, and the $138,500 in debt issuance costs paid, were recorded as debt discounts and debt issuance costs totaling $1,134,466. Amortization associated with the total debt discounts is being recognized using the effective interest method over the term of the Investor Note, which matured on September 30, 2023. For the quarter ended March 31, 2023, $360,993 in amortization on the debt discounts was recognized as interest expense and is included on the accompanying consolidated statement of operations for the nine months ended September 30, 2023.   Related Party - Salkind Loans   On October 10, 2023, the Company received a $300,000 loan from the Marital Trust GST Subject U/W/O Leopold Salkind (Salkind October 2023 Loan), a related party through the Company’s Board chair. This unsecured loan has a maturity date of November 30, 2023, with interest at the rate of 15% per annum. The note is payable in cash on the maturity date; however, the debt holder has the right to convert the loan into restricted common stock at a conversion price of $0.70 per share or to apply the loan repayment to invest on the terms of any private financing completed by the Company prior to the maturity date. Exemption from registration for the aforesaid transactions is claimed under Section 4(2) of the Securities Act of 1933, as amended. In November 2023, the Salkind October 2023 Loan principal outstanding of $300,000 plus accrued and unpaid interest, were converted into shares of the newly designated Series G Preferred Stock. See Note 5.   In February 2024, Dr. Salkind, Board Chairman, loaned the Company $150,000 of short-term debt financing for working capital (Salkind February 2024 Loan). The unsecured loan was payable on demand and boar interest at 10% per annum, payable monthly.   On June 27, 2024, the Company entered into a new Loan Agreement with Dr. Salkind and a relative of Dr. Salkind (Salkind June 2024 Loan) for no additional consideration from the lenders, effectively cancelling the Salkind February 2024 Loan. The Salkind June 2024 Loan is a $160,000 non-interest-bearing loan, which includes an Original Issue Discount of $10,000. The $160,000 in principal is due on demand on or after December 31, 2024, and is convertible at the option of the lenders at any time into shares of the Company’s restricted common stock at a conversion rate of $0.50 per share. As of June 30, 2024, the full $150,000 in principal remains outstanding and the Company has recognized amortization of $5,080 on the debt discount.   On July 5, 2024, the Company entered into a Loan Agreement with Dr. Salkind for additional proceeds of $50,000. On July 23, 2024, the Company entered into a Loan Agreement with Dr. Salkind’s son for additional proceeds of $50,000. The total principal of $100,000 related to these July 2024 loans remains outstanding at September 30, 2024 and the Company has recognized amortization of $643 on the debt discount for the periods ended September 30, 2024. Both July 2024 loans were issued under the same non-interest, repayment, and conversion terms as the Salkind June 2024 Loan.   Related Party - Other Loans   During the quarter ended June 30, 2024, the Company entered into the following loan agreements with its corporate attorney in exchange for cash or the cancellation of invoices outstanding related to legal services performed by the attorney.   Loan 1, dated April 2024, was a non-interest-bearing demand loan issued in exchange for $70,000 cash, and included a $4,000 discount. The $74,000 in principal was paid in full prior to June 30, 2024, and the Company recognized $4,000 in interest expense associated with the debt discount during the nine months ended September 30, 2024.   Loan 2, dated April 2024, was a non-interest-bearing demand loan issued in exchange for $40,000 in cash. The principal was paid in full prior to June 30, 2024.   Loan 3, dated June 2024, is a non-interest-bearing demand loan issued in exchange for the cancellation of $20,000 in invoices outstanding related to legal services performed. Loan 3 included an Original Issue Discount (OID) of $5,000. The $25,000 in principal and Original Issue Discount is payable on demand on or after December 31, 2024, and is also convertible at the option of the lender into the Company’s restricted common stock at a conversion rate of $0.50 per share. As of September 30, 2024, the full $20,000 in principal and $5,000 in OID remains payable and the Company has recognized amortization of $2,734 on the debt discount.   Loan 4, dated June 2024, is a non-interest-bearing demand loan issued in exchange for $37,000 in cash. Loan 4 included an Original Issue Discount of $15,000. The $52,000 in principal and Original Issue Discount is payable on demand at any time on or after December 31, 2024, and is also convertible at the option of the lender into the Company’s restricted common stock at a conversion rate of $0.50 per share. As of September 30, 2024, the full $37,000 in principal and $15,000 in OID remains payable and the Company has recognized amortization of $8,100 on the debt discount.   During the quarter ended September 30, 2024, the Company entered into the following loan agreements with its corporate attorney in exchange for cash.   Loans 5 and 6, dated July 2024, consists of two verbal, non-interest-bearing loans totaling $78,000 to the Company on a short-term basis. The $78,000 in principal is payable on demand, of which $27,000 remained payable at September 30, 2024.   Loan 7, dated September 2024, consists of a verbal, non-interest-bearing loan issued in exchange for $75,000 in cash on a short-term basis. The $75,000 in principal is payable on demand, of which $60,000 remained payable at September 30, 2024.   On October 8, 2024, the corporate attorney and the Company entered into a modification to Loans 3, 4, 5, 6, and 7 above which provides the following:   · Loans 3 and 4 were amended to include a provision that, if the Company elects to prepay the loans, the Company will provide at least five days written notice to the debt holder of such intent for prepayment allowing the debt holder the opportunity to convert the debt.       · Loans 5, 6, and 7, totaling $87,000 in outstanding principal were amended to add a $13,000 OID and a conversion option in which the debt and OID are convertible at any time at a rate of $1.00 per share at the option of the debt holder. In addition, in the event the Company receives additional financing or revenues, the Company shall, by Friday of each week in which such event occurs, notify the debt holder and shall give the debt holder the opportunity to demand immediate payment of at least 15% of such financing and/or revenues received by the Company until Loans 5, 6, and 7 have been paid in full.       · The parties agree that all repayments of loans by the Company to the debt holder shall first reduce the outstanding principal and OID of Loans 5, 6, and 7.   Merchant Agreements   In November 2023, the Company entered into an agreement for the purchase and sale of future receivables (2023 Merchant Agreement) with a financial institution in exchange for $200,000 in funding (the 2023 Purchase Price). The 2023 Purchase Price is to be repaid through daily payments representing 10% of future customer payments on receivables until a total of $272,000 is paid. The Company recorded a debt discount associated with the 2023 Merchant Agreement totaling $72,000 which is being amortized through interest expense over the expected term of the agreement of 170 days. The Company recognized $33,578 in interest expense associated with the amortization of the debt discount for the six months ended June 30, 2024. In connection with the 2023 Merchant Agreement, and as additional consideration, the Company has agreed to issue 16,765 shares of its Common Stock to the financial institution in an amount equal to 5% of the Purchase Price, or $10,500, which was recorded as additional debt discount. The number of shares issued is equal to 5% of the 2023 Purchase Price divided by the average closing per share price of the common stock for the previous twenty (20) days from the signed date of the 2023 Merchant Agreement. The balance of the 2023 Merchant Agreement funding was repaid in full during the quarter ended June 30, 2024.   In February 2024, the Company entered into an agreement for the purchase and sale of future receivables (February 2024 Merchant Agreement) with the same financial institution associated with the 2023 Merchant Agreement for the sale of future receivables in exchange for $150,000 in funding (the 2024 Purchase Price), less a $7,500 origination fee. The 2024 Purchase Price is to be repaid through daily payments representing 10% of future customer payments receivables until a total of approximately $205,350 is paid. The Company recorded a debt discount associated with the February 2024 Merchant Agreement totaling $62,850 which is being amortized through interest expense over the expected term of the agreement of 170 days. In connection with the February 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 20,135 shares of its Common Stock to the financial institution in an amount equal to 5% of the Purchase Price, or $7,500, which was recorded as additional debt discount. The balance of the February 2024 Merchant Agreement funding was repaid in full in August of 2024. The Company recognized $62,850 in interest expense associated with the amortization of the debt discounts for the nine months ended September 30, 2024.   In April 2024, the Company entered into an agreement for the purchase and sale of future receivables (April 2024 Merchant Agreement) with a financial institution for the sale of future receivables in exchange for $250,000 in funding (the April 2024 Purchase Price) in exchange for $127,000 in cash and full settlement of the November 2023 Merchant Agreement funding discussed above. The Purchase Price is to be repaid through daily payments representing 10% of future customer payments receivables until a total of approximately $342,250 is paid. In connection with the April 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 12,854 shares of its common stock to the financial institution in an amount equal to 5% of the Purchase Price, or $12,500, which was recorded as additional debt discount. The number of shares issued is equal to 5% of the Purchase Price divided by the average closing per share price of the Company’s common stock for the previous twenty (20) days from the signed date of the Merchant Agreement. This agreement superseded the Merchant Agreement executed in November 2023. In August 2024, the total balance of principal and interest payable on the February 2024 Merchant Agreement funding of approximately $60,000, was rolled into the August 2024 Merchant Agreement funding, as discussed below. The balance of the April 2024 Merchant Agreement funding was repaid in full on September 30, 2024. The Company recognized approximately $103,000 in interest expense associated with the amortization of the debt discounts for the nine months ended September 30, 2024.   In August 2024, the Company entered into an agreement for the purchase and sale of future receivables (August 2024 Merchant Agreement) with a financial institution for the sale of future receivables in exchange for $200,000 in funding (the August 2024 Purchase Price), of which $121,147 represented cash proceeds, and the balance applied as full settlement of the outstanding obligations under the February 2024 Merchant Agreement funding discussed above. The Purchase Price is to be repaid through daily payments representing 16% of future customer payments received until a total of approximately $273,800 is paid. In connection with the August 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 2,779 shares of its common stock to the financial institution in an amount equal to 5% of the new principal Advance Amount, or $6,057, which was recorded as debt discount. The number of shares issued is equal to 5% of the Advance Amount divided by the average closing per share price of the Company’s common stock for the previous twenty (20) days from the date signed by the Merchant Agreement. The balance of the Merchant Agreement funding is expected to be repaid in full within the next year.   In September 2024, the Company entered into an agreement for the purchase and sale of future receivables (September 2024 Merchant Agreement) with a financial institution for the sale of future receivables in exchange for $250,000 funding (the September 2024 Purchase Price), of which $98,699 represented cash proceeds, and the balance applied as full settlement of the outstanding obligations under the April 2024 Merchant Agreement funding discussed above. The Purchase Price is to be repaid through daily payments representing 12% of future customer payments received until a total of approximately $342,250 is paid. In connection with the September 2024 Merchant Agreement, and as additional consideration, the Company has agreed to issue 1,993 shares of its common stock to the financial institution in an amount equal to 5% of the new principal Advance Amount, or $5,560, which was recorded as debt discount. The number of shares issued is equal to 5% of the Advance Amount divided by the average closing per share price of the Company’s common stock for the previous twenty (20) days from the date signed by the Merchant Agreement. The balance of the Merchant Agreement funding is expected to be repaid in full within the next year.   For the three and nine months ended September 30, 2024, the Company recognized approximately $107,000 and $240,000 in interest expense associated with the amortization of the debt discounts on the February, April, August and September 2024 Merchant Agreements. The remaining unamortized debt discounts, totaling approximately $162,000, are expected to be expensed in full as interest expense within the next year, in conjunction with the principal payments.   2024 Promissory Notes   In March 2024, the Company issued a promissory note in the principal amount of $126,500 with an Original Issue Discount (OID) of $16,500 (March 2024 Promissory Note). Interest is charged on the principal at 14% upon issuance of the promissory note, totaling $17,710, and is payable, along with principal, in five individual payments commencing September 15, 2024, through the maturity date of January 15, 2025. In addition to the OID, the Company paid $8,150 in issuance costs associated with the 2024 March Promissory Note and recorded a debt discount totaling $24,650 which is being amortized over the repayment period of the principal through interest expense. The Company recognized $1,126 and $7,957 in interest expense for the three and nine months ended June 30, 2024, respectively, associated with amortization of the debt discount on the March 2024 Promissory Note. Solely upon an event of default, and at the option of the holder, all amounts outstanding under the March 2024 Promissory Note are convertible into shares of the Company’s common stock, at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the ten trading days prior to the conversion date. In the event of default, all outstanding obligations under the March 2024 Promissory Note shall become due and payable at 150% of the outstanding principal amount plus accrued and unpaid interest, plus any other amounts owed under the March 2024 Promissory Note. Approximately $69,000 in principal and OID remain outstanding at September 30, 2024.   In April 2024, the Company issued a promissory note in the principal amount of $96,000 with an Original Issue Discount of $16,000 (April 2024 Promissory Note). Interest is charged on the principal at 15% upon issuance of the April 2024 Promissory Note, totaling $14,400, and is payable, along with principal, in ten individual payments of $11,040 commencing May 30, 2024, through the maturity date of March 31, 2025. The Company recognized $4,149 in interest expense for the nine months ended June 30, 2024, associated with amortization of the debt discount on the April 2024 Promissory Note. Solely upon an event of default, and at the option of the holder of the April 2024 Promissory Note, all amounts outstanding under the April 2024 Promissory Note become convertible into shares of the Company’s common stock, at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the ten trading days prior to the conversion date. In the event of default, the April 2024 Promissory Note shall become due and payable at 150% of the outstanding principal amount of the April 2024 Promissory Note plus accrued and unpaid interest, plus any other amounts owed under the promissory note. Approximately $51,000 in principal and OID remain outstanding at September 30, 2024.   In September 2024, the Company issued a promissory note in the principal amount of $98,900 with an Original Issue Discount of $20,300 (September 2024 Promissory Note). Interest is charged on the principal at 14% upon issuance of the September 2024 Promissory Note, totaling $13,846, and is payable, along with principal as follows: $56,373 due March 15, 2025, $14,093 due on each of April 15, 2025 and May15, 2025 and $14,874 due on June 15, 2025 and on the maturity date of July 15,2025. The Company recognized $362 in interest expense for the nine months ended September 30, 2024, associated with amortization of the debt discount. Solely upon an event of default, and at the option of the holder of the September 2024 Promissory Note, all amounts outstanding under the September 2024 Promissory Note become convertible into shares of the Company’s common stock, at a conversion price equal to 65% of the lowest trading price of the Company’s common stock during the ten trading days prior to the conversion date. In the event of default, the September 2024 Promissory Note shall become due and payable at 150% of the outstanding principal amount of the September 2024 Promissory Note plus accrued and unpaid interest, plus any other amounts owed under the promissory note.   In August 2024, the Company entered into a financing arrangement with their Directors and Officers (D&O) insurance provider to fund the annual premium related to the D&O insurance policy. The total amount financed was $112,500, and incurs interest at a rate of 8.14% per annum, with nine monthly payments of principal and interest of $12,928 through May 2025.   Following is a summary of debt outstanding at December 31, 2023 and September 30, 2024:  Schedule of debt outstanding                 September 30, 2024 (Unaudited)     December 31, 2023   Merchant Agreements   $ 561,290     $ 216,089   Related Party – Salkind Loans     261,500       –   Related Party – Other Loans     177,000       –   2024 Promissory Notes     331,640       –   Total Debt     1,331,430       216,089   Less: Unamortized debt discounts     (229,357 )     (47,372 ) Current portion of debt   $ 1,102,073     $ 168,717

v3.24.3

STOCKHOLDERS’ EQUITY	9 Months Ended
	Sep. 30, 2024
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 5 – STOCKHOLDERS’ EQUITY   On August 7, 2023, the Company effected a 1-for-15 reverse stock split of its common stock, with all fractional common shares rounded up to the nearest whole number. The effects of this rounding resulted in the issuance of 14,162 additional shares of common stock at the time of the split.   The Company’s authorized capital stock consists of 105,000,000 shares, comprised of 100,000,000 shares of common stock, per share par value $0.0001, and 5,000,000 shares of preferred stock, per share par value $0.0001.     Of the 5,000,000 shares of preferred stock authorized, the Board of Directors has designated the following:     · 1,500,000 shares as Series AA Preferred Stock, none outstanding   · 1,250,000 shares as Series AAA Preferred Stock, 31,413 shares outstanding   · 1,250 shares as Series AAAA Preferred Stock, none outstanding   · 1,500 shares as Series C Preferred Stock, none outstanding   · 2 shares as Series B Preferred Stock: none outstanding   · 70,000 shares as Series E Preferred Stock, 61,688 shares outstanding   · One share of Series F Preferred Stock, none outstanding   · 300,789 shares of Series G Preferred Stock, none outstanding   · 770,000 shares of Series H Preferred Stock, none outstanding   Rights Under Preferred Stock   The Company’s classes of preferred stock include the following provisions:   Optional Conversion Rights of Preferred Stock     · Series AA – one share convertible into 3.33 shares of common stock   · Series AAA – one share convertible into 6.67 shares of common stock   · Series C – one share convertible into 6,667 shares of common stock   · Series E – one share at a rate of its Stated Value, as defined, divided by $0.08, convertible commencing January 31, 2020   · Series G – one share convertible into shares of common stock at a rate of its Stated Value divided by $0.50 (Series G Conversion Ratio)   · Series H – one share was convertible into shares of common stock at a rate of its Stated Value ($2.00 at August 7, 2024, date of mandatory conversion discussed below) divided by $0.20 (Series H Conversion Ratio)   Redemption Rights   Series E preferred stock is redeemable at any time upon 30 days’ written notice by the Company and the shareholders, at a rate of 100% of the Stated Value, as defined.   Mandatory Conversion Right   Any outstanding shares of Series G Preferred Stock shall automatically convert into common stock based on the Series G Conversion Ratio if the closing sales price of the Company’s common stock for ten (10) consecutive trading days closes over $5.00 per share.   Any outstanding shares of Series H Preferred Stock shall automatically convert into common stock based on the Series H Conversion Ratio at the earlier of (i) December 31, 2026, or (ii) at such time as the closing sale price of the Company’s common stock exceeds $2.00 per share for ten (10) consecutive trading days. In August 2024, the Series H Preferred Stock satisfied the mandatory conversion right, resulting in the conversion of all 768,473 shares outstanding into 7,684,730 shares of common stock, exclusive of accrued dividend liabilities totaling $122,954 also being converted into 158,840 shares of common stock.   Mandatory Dividend   Commencing after the later of (i) the first day of the calendar month after the month in which the Series G shares are issued or (ii) January 2, 2024, the holders of outstanding shares of Series G Preferred Stock shall receive a monthly dividend of 20% of the Stated Value per share. The dividend shall be paid at the election of the majority holder of the Series G Preferred Stock in cash or in common stock.    Commencing January 2, 2024, the holders of outstanding shares of Series H Preferred Stock shall receive a monthly dividend of 1% of the Stated Value per share. The dividend shall be paid at the election of the majority holder of the Series H Preferred Stock in cash or in common stock. If the election is for cash payment, the Company has the right to deliver a one-year secured note bearing interest at the rate of 15% per annum in lieu of paying cash. As discussed above, for the period January 1 through August 6, 2024, the mandatory conversion date, the Company accrued and paid stock dividends of 158,840 common shares totaling $122,954, to the Series H Preferred Stock shareholders.   Liquidation Preference   The Series G and Series H Preferred Stock have a liquidation preference of the Stated Value per share plus accrued and unpaid dividends.   Shares Issued for Services    On October 6, 2023, the Company entered a one-year consulting contract with Mr. Gene Salkind, its Chairman of the Board, to provide business consulting services to the Company. Mr. Salkind received 150,000 shares of restricted common stock, valued at $103,500, in consideration of his services under this agreement. The value of the shares issues is being amortized straight-line over the one-year term of the agreement. The Company recognized $25,875 and $77,625 in general and administrative expenses related to this amortization for the three and nine months ended September 30, 2024, respectively.   In December 2023, the Company entered a one-year consulting contract with an unrelated party. In accordance with the contract, the consultant received a signing bonus of $25,000 in cash, 100,000 shares of restricted common stock valued at $14,000, and warrants to purchase 200,000 shares of common stock, exercisable over a three-year period at $0.20 per share, valued at $25,000. In addition, the consultant is to receive monthly cash payments of $12,500 over the term of the agreement. The value of the signing bonus, shares of restricted common stock, and warrants, totaling $64,000, was recorded as a prepaid asset on the accompanying consolidated balance sheet and is being amortized through general and administrative expenses over the one-year term of the agreement. For the three and nine months ended September 30, 2024, the Company recognized approximately $16,000 and $48,000 of expense associated with amortization of the prepaid asset with approximately $12,000 remaining unamortized at September 30, 2024.   On August 15, 2024, the Company entered into a Business Development Agreement with a non-affiliated entity. The term of the agreement is three months, and the consultant has a choice of $12,500 in cash or 25,000 shares of the Company’s common stock. The consultant elected to receive 25,000 shares of restricted common stock. The $12,500 fee was recorded as a prepaid asset on the consolidated balance sheet and is being amortized through general and administrative expenses over the three month term. Approximately $4,000 in expense was recognized for the three months ended September 30, 2024.   Common Stock Issued in Conjunction with Debt Issuance   On December 30, 2022, the Company and Walleye Opportunities Master Fund Ltd, a Cayman Islands company (the Investor), entered into a Securities Purchase Agreement (the Walleye SPA) for the Investor to purchase from the Company (i) a senior secured 20% original issue discount (OID) nine-month promissory note in an aggregate gross principal amount of $1,437,500, less the 20% OID of $287,500, for a net subscription amount of $1,150,000 (the Investor Note), and (ii) a five year warrant to purchase 174,242 shares of the Company’s common stock at an exercise price of $6.60 per share, exercisable commencing July 1, 2023 and expiring December 30, 2027 (the Investor Warrant). Proceeds from the Agreement were received by the Company in January 2023.   In conjunction with the Walleye SPA, the Company issued 34,849 shares of common stock, or approximately 5.3% of the Company’s outstanding shares at that time, to the Investor as an incentive on the transaction (Incentive Shares). Excluding the above-mentioned Investor Warrant, the shares of Common Stock exercisable pursuant to such Investor Warrant are not being considered beneficially owned by the Investor until the Investor Warrant is exercisable within 60 days. Total issuance fees of $138,500 associated with the closing of the Walleye SPA were paid by the Company to Spartan Capital Securities LLC and the Investor’s counsel, resulting in net proceeds of $1,011,500. Approximately $163,000 of the loan proceeds were utilized to repay the outstanding principal and accrued interest under an SBA loan.   The Investor Note will only become convertible into common stock upon the occurrence of an Event of Default under and as defined in the Investor Note on terms set forth in the Investor Note. This Investor Note matures and is payable on or before September 30, 2023, and it provides that the Investor may demand prepayment after March 31, 2023, and before the maturity date, provided that the purchasers of securities in a future public offering by the Company, as defined in the Walleye SPA, who hold the purchased Company securities at the time the prepayment demand, unanimously consent to the prepayment. The Company granted a security interest in all of its assets to the Investor as collateral for its obligations under the Investor Note pursuant to a Security Agreement. In addition, the Company’s subsidiaries guaranteed the obligations of the Company under the Investor Note pursuant to a Subsidiary Guarantee and granted a first lien security interest in all their assets to the Investor as additional collateral pursuant to the Security Agreement. All securities sold in the above-described transaction contain certain piggy-back registration rights after the completion of our February 2023 Offering (see below). During the third quarter of 2023, the secured debt was paid in full through the proceeds of our June 2023 Offering.   The aforementioned Investor Warrant was deemed to be an equity-classified derivative instrument with a fair value of $1,526,363 at the date of closing on the Agreement, incorporating the use of the Black-Scholes valuation model, and the Incentive Shares were deemed to have a fair value of $318,863 based on the closing market price of the Company’s common stock on the day preceding the closing of the Walleye SPA. Per accounting guidance under ASC 815, the Company recorded the fair values of the Investor Warrant and Incentive Shares based on the relative fair value allocation method, which allocates fair values as a percentage of total fair value of the debt, Investor Warrant, and Incentive Shares, in proportion to the net proceeds received under the Investor Note of $1,150,000. As a result of applying the relative fair value allocation method, the Investor Warrant was assigned a relative fair value of $586,040 and the Incentive Shares were assigned a relative fair value of $122,426, at the date of closing on the Walleye SPA. Amortization associated with the total debt discounts is being recognized using the effective interest method over the term of the Investor Note, which matured on September 30, 2023. For the period ended June 30, 2023, $377,149 in amortization on the debt discounts was recognized as interest expense on the accompanying consolidated statement of operations, and the remaining unamortized debt discounts of $396,322 were written off as loss on debt extinguishment upon full settlement of the Investor Note in conjunction with proceeds received from the June 2023 Offering.   February 2023 Offering   On February 13, 2023, the Company entered into an underwriting agreement (the Underwriting Agreement) with Spartan Capital Securities LLC (the Underwriter) relating to a public offering of 251,842 shares of common stock and pre-funded warrants to purchase 285,792 shares of common stock (the Shares), for net proceeds of $3,207,500 (the February 2023 Offering). In conjunction with the February 2023 Offering, which closed on February 16, 2023, the investors also received other Warrants to purchase 806,452 shares of common stock (Series 2023 Warrants) on a cash basis or up to 403,226 shares on a cashless basis. The offered Shares were priced at $6.975 per combination of one share of common stock or one pre-funded warrant, accompanied by one Series 2023 Warrant.   Each pre-funded warrant is exercisable at any time, until fully exercised, to purchase one share of common stock at an exercise price of $0.0015 per share. Each Series 2023 Warrant is exercisable for five years to purchase 0.1 share of common stock at a cash exercise price of $6.975 per warrant share. The Series 2023 Warrants contain an alternative cashless exercise provision permitting the holder to acquire 0.05 share of common stock for every 0.1 warrant share any time after the earlier of (i) 30 days following the initial exercise date of February 14, 2023, and (ii) the date on which the aggregate trading volume of the Company’s common stock, beginning on the initial exercise date of the Series 2023 Warrants, exceeds 2,419,355 shares. Additionally, the exercise price of both the pre-funded warrants and the Series 2023 Warrants are subject to customary adjustments for stock splits, stock dividends, reclassifications and the like.   Pursuant to the terms of the Underwriter agreement, and as partial consideration to the Underwriter, the Company issued a warrant for the purchase of 26,882 shares of common stock, exercisable from February 14, 2023, through February 14, 2028, at an initial exercise price of $7.6725 per share. This warrant was cancelled by the underwriter on or about June 30, 2023, in connection with the completion of the June 2023 Offering described below. The Company also granted the Underwriter a 45-day option to purchase up to an additional 80,645 shares and/or pre-funded warrants in lieu of shares and accompanying Series 2023 Warrants to purchase 120,968 shares at the public offering price less the underwriting discounts and commissions, to cover over-allotments, if any. No additional shares or pre-funded warrants were purchased by the Underwriter. The Company paid a cash fee to the Underwriter equal to 8% of the gross proceeds raised in February 2023 Offering, plus a reimbursement of Underwriter fees totaling $242,500.   Between the closing of February 2023 Offering and June 30, 2023, investors holding pre-funded warrants converted all their pre-funded warrants into 285,792 shares of common stock and elected the alternative cashless exercise provision for the Series 2023 Warrants, resulting in the issuance of 403,226 shares of common stock. As of June 30, 2023, all the aforementioned pre-funded warrants and 2023 Warrants were exercised.   June 2023 Offering   On June 30, 2023, Mobiquity Technologies, Inc. closed on a public offering selling an aggregate of 375,000 shares of common stock (and 1,625,000 common stock equivalents in the form of pre-funded warrants to purchase 1,625,000 common shares) to investors pursuant to Securities Purchase Agreements at a public offering price of $1.50 per share (or $1.4985 per pre-funded warrant) (the June 2023 Offering), for total gross proceeds of $3,000,000. Placement agent fees and other offering costs totaled $472,001 and were recorded net of gross proceeds in the Company’s consolidated statement of stockholders’ equity during the quarter ended June 30, 2023. Each pre-funded warrant is exercisable at any time to purchase one share of common stock at an exercise price of $0.0015 per share. Additionally, the exercise price of pre-funded warrants is subject to customary adjustments for stock splits, stock dividends, reclassifications and the like. Spartan Capital Securities, LLC acted as the Company’s exclusive placement agent of the June 2023 Offering pursuant to a Placement Agent Agreement. The net proceeds to the Company from the sale of the shares and pre-funded warrants, after deducting the Placement Agent commissions and offering expenses payable by the Company, was approximately $2,528,000. The Company used $1,437,500 of the proceeds received from the June 2023 Offering to fully satisfy its Senior Secured 20% OID Promissory Note to Walleye Opportunities Master Fund Ltd. See Note 4. In July 2023, the Company also issued 478,334 shares of common stock upon exercise of 478,334 pre-funded warrants, increasing the number of outstanding common shares to 2,588,333.   Other 2023 Stock Transactions   In April 2023, the Board of Directors or the Compensation Committee of the Company’s Board of Directors approved the following transactions:     · Grant of 6,667 shares of restricted common stock to Gene Salkind, Chairman of the Board, for services previously rendered, based on a per share value of $2.505.   · Grant of 3,333 shares of restricted common stock each to the Company’s CEO and another member of the Board of Directors for services as directors of the Company.   · Grant of 2,000 shares of common stock to Gene Salkind as payment for accrued and unpaid interest of approximately $5,000 based on a per share value of $2.505.   · Grant of 4,791 shares of restricted common stock to the Company’s legal counsel as payment for accrued and unpaid services valued at $12,000 and $2.505 per share.   · Issuance of a total of 31,891 shares of restricted common stock at a per share value of $2.52 as payment and full settlement of outstanding accounts payable with a total carrying amount of $80,411.   Share prices used in the above transaction were based on the market price of the Company’s common stock on the consummation dates of the transactions.   Salkind October 2023 Loan Conversion and Series G Preferred Stock Issuance   Effective November 7, 2023, Mr. Gene Salkind and parties associated with him (the Series G Preferred Shareholders), invested $1,503,495 into the Company’s newly created Series G Preferred Stock, formalized through three Subscription Agreements for the sale of a combined 300,789 shares of Series G Preferred Stock for total cash proceeds of $1,200,000, plus the conversion of $300,000 in principal and $3,495 in accrued interest from the Salkind October 2023 Loan (see Note 4). Each share of the Series G Preferred Stock is convertible by the Series G Preferred Shareholders at any time after issuance into ten (10) shares of the Company’s Common Stock, or $0.50 per Common Share (Series G Conversion Ratio). The Series G Preferred Stock will automatically convert at the same Series G Conversion Ratio upon the Company’s Common Stock reporting of a closing sales price over $5.00 per share for ten (10) consecutive trading days. The Company did not pay any commissions or other compensation to any third party in connection with the transactions reported herein. Exemption from registration is claimed under section 4(2) of the Securities Act of 1933, as amended.   Series H Preferred Stock Issuances   On December 18, 2023, the Series G Preferred Shareholders agreed to exchange all 300,789 of the Series G Preferred Stock into 751,730 shares of the Company’s newly created Series H Preferred Stock. Also, our legal counsel agreed to exchange $33,000 of monies owed to the law firm for 16,500 shares of Series H Preferred Stock. Each share of the Series H Preferred Stock is convertible at any time after issuance into ten (10) shares of the Company’s Common Stock, or $0.20 per Common Share (Series H Conversion Ratio). The Series H Preferred Stock will automatically convert at the same Series H Conversion Ratio upon the Company’s Common Stock reporting of a closing sales price over $2.00 per share for ten (10) consecutive trading days or on December 31, 2026, whichever is earlier. The Company did not pay any commissions or other compensation to any third party in connection with the transactions reported herein. Exemption from registration is claimed under section 3(a)(9) of the Securities Act of 1933, as amended. During the quarter ended September 30, 2024, all outstanding shares of Series H Preferred Stock were converted into shares of the Company’s common stock, as discussed above.   Issuance of Common Stock for Settlement of Liabilities   In January 2024, the Company issued 100,000 shares of its common stock at a per share price of $0.53 in full settlement of vendor liabilities outstanding at an amount equal to $53,000. In March 2024, the Company issued 18,000 shares of its common stock in settlement of outstanding vendor liabilities at an amount equal to $12,000 stock at per share prices ranging from $0.50 to $1.00. In the third quarter of 2024, corporate counsel converted $18,000 of accrued liabilities into common stock at a conversion price of $0.50 per share.   Issuance of Common Stock for Cash   During the first nine months of 2024, the Company raised a total of $2,237,000 in cash from various accredited investors in conjunction with common stock subscription agreements, resulting in the issuance of a total of 4,347,334 shares at per share prices ranging from $0.30 to $0.60. In the third quarter of 2024, the Company raised a total of $675,000 in cash from various accredited investors in conjunction with common stock subscription agreements, resulting in the issuance of 1,100,000 shares at per share prices ranging from $0.50 to $1.00.   Issuance of Common Stock Warrant for Services   During June 2024, the Company entered into a consulting agreement with an unrelated party for general business consulting services. The term of the agreement is for twelve months, commencing in June 2024. Compensation under the agreement included an upfront payment of $25,000 in cash, and the issuance of 100,000 common stock warrants, exercisable through June 2027, at an exercise price of $0.50 per share. The consultant also receives a monthly fee of $5,000. The fair value of the warrants at issuance was $171,800, which is being amortized, along with the upfront payment, through general and administrative expenses, straight-line, over the twelve-month service period. In September 2024, the Company amended the consulting agreement to increase the monthly cash compensation to $10,000 and to issue additional warrants to purchase a total of 150,000 shares of common stock exercisable over a three-year period. The 150,000 warrant shares consist of 100,000 exercisable at $0.50 per share and 50,000 exercisable at $1.00 per share through September 10, 2027. The new warrants issued in September 2024 were fair valued at a total of $446,200, which was recorded as prepaid assets and is being amortized through general and administrative expense straight-line over the remaining 10 months of the agreement term. Total expense recognized related to the upfront payment and issued warrants was approximately $94,000 and $110,000 for the three and nine months ended September 30, 2024, respectively.   Treasury Stock   In the three months ended March 31, 2024, the Company repurchased 17 shares of common stock for an insignificant amount, recorded as treasury stock. There were no repurchases of the Company’s common stock for the year ended December 31, 2023, or the quarter ended September 30, 2024.

v3.24.3

STOCK OPTION PLANS AND WARRANTS	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
STOCK OPTION PLANS AND WARRANTS	NOTE 6 – STOCK OPTION PLANS AND WARRANTS   During Fiscal 2005, the Company established, and the stockholders approved, an Employee Benefit and Consulting Services Compensation Plan (the 2005 Plan) for the granting of up to 334 non-statutory and incentive stock options and stock awards to directors, officers, consultants and key employees of the Company. On June 9, 2005, the Board of Directors amended the Plan to increase the number of stock options and awards to be granted under the Plan to 667 shares. During Fiscal 2009, the Company established a plan of long-term stock-based compensation incentives for selected Eligible Participants of the Company covering 667 shares. This plan was adopted by the Board of Directors and approved by stockholders in October 2009 (the 2009 Plan). In September 2013, the Company’s stockholders approved an increase in the number of shares covered by the 2009 Plan to 1,667 shares. In the first quarter of 2016, the Board approved, and stockholders ratified a 2016 Employee Benefit and Consulting Services Compensation Plan covering 1,667 shares (the 2016 Plan) and approved moving all options which exceeded the 2009 Plan limits to the 2016 Plan. In December 2018, the Board of Directors adopted and in February 2019 the stockholders ratified the 2018 Employee Benefit and Consulting Services Compensation Plan covering 5,000 shares (the 2018 Plan). On April 2, 2019, the Board approved the 2019 Plan identical to the 2018 Plan, except that the 2019 Plan covers 10,000 shares. The 2019 Plan required stockholder approval by April 2, 2020, to be able to grant incentive stock options under the 2019 Plan. On October 13, 2021, the Board approved the 2021 Plan identical to the 2018 Plan, except that the 2021 Plan covers 73,334 shares. The 2021 Plan required stockholder approval by October 13, 2022, to be able to grant incentive stock options under the 2021 Plan. On April 17, 2023, the Board approved an Equity Participation Plan similar to the Plans described herein, except that this Plan also provides for the grant of Restricted Unit Awards (the 2023 EP Plan). Under the 2023 EP Plan, which was approved by stockholders on May 15, 2023, a maximum of 166,667 shares may be granted under the 2023 EP Plan. On December 19, 2023, the Board approved the 2023 Plan identical to the 2018 Plan, except that the 2023 Plan covers 2,000,000 shares. The 2005 Plan, 2009 Plan, 2016 Plan, 2018 Plan, 2019 Plan, 2021 Plan, the 2023 EP Plan, and 2023 Plan are collectively referred to as the “Plans.”   In April of 2022 and April 2023, Dean Julia was granted 833 options each year from the Company’s 2021 Plan with immediate vesting, at an exercise price of $23.25 and $3.30 and expiration of April 2031 and April 2032, respectively.   In March and April 2023, Nate Knight and Byron Booker, respectively, were each granted 1,667 options from the Company’s 2021 Plan with immediate vesting, at an exercise price of $3.30, and expiration of March 2028 and April 2028, respectively.   On December 19, 2023, the board approved, under the 2023 Plan, granting five-year Non-Statutory Stock Options to purchase 1,800,000 shares of common stock, immediately exercisable at $0.20 per share to various officers, directors, employees and consultants. Exemption from registration is claimed under section 4(2) of the Securities Act of 1933, as amended.   In April 2024, Dean Julia was granted 833 options from the Company’s 2021 Plan with immediate vesting, at an exercise price of $0.50 and expiration of April 2033.   All stock options under the Plans are granted at or above the fair market value of the common stock at the grant date. Employee and non-employee stock options vest over varying periods and generally expire either 5 or 10 years from the grant date. The fair value of options at the date of grant was estimated using the Black-Scholes option pricing model. For option grants, the Company will take into consideration payments subject to the provisions of ASC 718 Stock Compensation.   The weighted average assumptions made by calculating the fair values of options granted during the nine months ended September 30, 2024, are as follows: Schedule of weighted average assumptions of options granted                 Nine Months Ended September 30,       2024     2023   Expected volatility     199.68%       166.87%   Expected dividend yield     –       –   Risk-free interest rate     3.42%       3.54%   Expected term (in years)     7.50       6.67     Schedule of options activity                                     Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic Value   Outstanding, January 1, 2024     1,876,275     $ 9.11       5.05     $ 252,000   Granted     833     $ 0.50       8.51     $ 1,658   Cancelled or expired     (4,094 )   $ –       –     $ –   Outstanding, September 30, 2024     1,873,014     $ 7.56       4.31     $ 4,123,658   Options exercisable, September 30, 2024     1,873,013     $ 7.56       4.31     $ 4,123,658     The aggregate intrinsic value of options outstanding and options exercisable on September 30, 2024, is calculated as the difference between the exercise price of the underlying options and the market price of the Company’s common stock for the shares that had exercise prices lower than the $2.49 closing price of the Company’s common stock on September 30, 2024. Stock-based compensation expense related to stock options was $1,410 and $22,295 for the nine months ended September 30, 2024, and 2023, respectively, and is included in general and administrative expenses on the accompanying consolidated statements of operations.   As of September 30, 2024, there is $464 in unamortized compensation cost related to unvested stock option awards to be recognized during fiscal 2024 and 2025, respectively.     Warrants   During the fiscal year ended December 31, 2023, the Company issued a total of 2,849,551 common stock warrants. Total warrant shares issued included 174,242 shares issued in July 2023 in connection with the 20% OID Promissory note (see Note 4) which are exercisable commencing July 1, 2023, through December 30, 2027. In February 2023, 850,308 warrant shares were issued in connection with the February 2023 Public Offering, including 285,792 of pre-funded warrants (see Note 5) with a five-year contractual term, expiring February 14, 2028. On June 30, 2023, an additional 1,625,000 pre-funded warrants were issued with a five-year term in connection with the June 2023 Public Offering. During July 2023, 478,333 pre-funded warrants issued under the June 2023 Public Offering were exercised. In December 2023, the Company entered a one-year consulting contract with an unrelated party. In accordance with the said contract, the consultant received warrants to purchase 200,000 shares of common stock, exercisable over a three-year period at $0.20 per share.   On June 3, 2024, the Company entered into a one-year consulting agreement with a non-affiliated entity. The agreement provides for cash compensation of $85,000 (inclusive of a $25,000 signing bonus) to the consultant plus warrants to purchase 100,000 common shares at an exercise price of $0.50 per share through June 30, 2027. In September of 2024 the consultant received an additional 100,000 warrants exercisable at $0.50 and 50,000 warrants exercisable at $1.00 per share. Warrants contain the same terms as exist in the warrants issued in June of 2024. See Note 5 for further discussion.   The weighted average assumptions made in calculating the fair value of warrants granted during the nine months ended September 30, 2024, and 2023, are as follows: Schedule of weighted average assumptions of warrants granted                 Nine Months Ended September 30,       2024     2023   Expected volatility     217.65%       172.63%   Expected dividend yield     –       –   Risk-free interest rate     3.98%       3.85%   Expected term (in years)     2.88       5.00     Schedule of warrants activity                                     Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic Value   Outstanding, January 1, 2024     653,357     $ 58.54       4.20     $ 28,000   Granted     250,000     $ 0.60       4.10     $ 472,500   Cancelled or expired     –     $ –       –     $ –   Outstanding, September 30, 2024     903,357     $ 42.51       3.64     $ 903,500   Warrants exercisable, September 30, 2024     903,357     $ 42.51       3.64     $ 903,500

v3.24.3

EARNINGS (LOSS) PER SHARE	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
EARNINGS (LOSS) PER SHARE	NOTE 7 – EARNINGS (LOSS) PER SHARE   Pursuant to ASC 260, Earnings Per Share, basic earnings (loss) per common share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding for the periods presented.   Diluted earnings (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock, common stock equivalents and potentially dilutive securities outstanding during the period. Potentially dilutive common shares may consist of common stock issuable for stock options and warrants (using the treasury stock method), convertible notes and common stock issuable. These common stock equivalents may be dilutive in the future. In the event of a net loss, diluted loss per share is the same as basic loss per share since the effect of the potential common stock equivalents upon conversion would be anti-dilutive.    The following potentially dilutive equity securities outstanding as of September 30, 2024, and December 31, 2023, are as follows: Schedule of potentially dilutive equity securities outstanding                 September 30, 2024     December 31, 2023   Stock options     1,873,014       1,876,275   Warrants     903,357       653,358   Series AAA preferred stock     209,525       209,525   Series E preferred stock     10,281       10,281   Series H preferred stock     –       7,684,730   Total common stock equivalents     2,996,177       10,434,169

v3.24.3

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2024
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 – COMMITMENTS AND CONTINGENCIES   Litigation   Michael Trepeta, a former Co-CEO and director of the Company, filed a lawsuit against the Company and its subsidiary, Mobiquity Networks in April 2023 in the New York State Supreme Court, Nassau County. The claims stem from a Separation Agreement and Release that Mr. Trepeta and the Company entered into nine years ago in April 2017 which terminated Mr. Trepeta’ s employment agreement and discontinued his employment and directorship with the Company, among other things, by mutual agreement. Mr. Trepeta also gave the Company a release in the Separation Agreement and Release. Mr. Trepeta has claimed that the Company fraudulently induced him to enter into the Separation Agreement and Release; that the Company breached Mr. Trepeta’ s employment agreement; and that the Company breached its covenant of good faith and fair dealing and its fiduciary duty. Mr. Trepeta is claiming not less than $2.5 Million in damages. Based on the Company’s initial internal review of the situation, the Company believes the claims lack merit and it intends to vigorously defend same. In December 2023, the Company was notified that its motion to dismiss Mr. Trepeta’ s action was granted but Mr. Trepeta has filed a notice of appeal. Due to uncertainties inherent in litigation, the Company cannot predict the outcome of this matter at this time.

v3.24.3

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2024
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 – SUBSEQUENT EVENTS   On October 8, 2024, the Board of Directors of the Company approved the increase in the number of shares available under the 2023 Employee Benefit and Compensation Plan from 2,000,000 shares to 4,000,000 shares and granted a total of 1,725,000 non-statutory stock options with a 5-year term, immediately exercisable to several officers, directors, employees and consultants at an exercise price of $2.45 per share.   Between October 1, 2024 and November 12, 2024, the Company raised $540,000 from the sale of its common stock at $1.00 per share. Exemption from registration is claimed under Rule 506 and/or section 4(2) of the Securities Act of 1933, as amended. No commissions were paid in connection with these transactions.

v3.24.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation   The accompanying consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial statements (U.S. GAAP) and with the instructions to Form 10-Q and Article 8 of Regulation S-X of the United States Securities and Exchange Commission (SEC). Accordingly, they do not contain all information and footnotes required by accounting principles generally accepted in the United States of America for annual financial statements. In the opinion of the Company’s management, the accompanying consolidated financial statements contain all the adjustments necessary (consisting only of normal recurring accruals) to present the financial position of the Company as of September 30, 2024, and the results of operations and cash flows for the periods presented. The results of operations for the three months and nine months ended September 30, 2024, are not necessarily indicative of the operating results for the full fiscal year or any future period. These consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the SEC on April 8, 2024.   Management acknowledges its responsibility for the preparation of the accompanying consolidated financial statements which reflect all adjustments, consisting of normal recurring adjustments, considered necessary in its opinion for a fair statement of its consolidated financial position and the consolidated results of its operations for the periods presented.
Principles of Consolidation	Principles of Consolidation   These consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (U.S. GAAP) and include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated.
Business Segments and Concentrations	Business Segments and Concentrations   The Company uses the “management approach” to identify its reportable segments. The management approach requires companies to report segment financial information consistent with information used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. The Company manages its business as a single reporting segment. Customers in the United States accounted for 100% of our revenues. We do not have any property or equipment outside of the United States.
Use of Estimates	Use of Estimates   Preparing financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of Company assets and liabilities, including the allowance for credit losses, stock-based compensation, the deferred tax asset valuation allowance, and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ from those estimates.
Risks and Uncertainties	Risks and Uncertainties   The Company operates in an industry that is subject to intense competition and changes in consumer demand. The Company’s operations are subject to significant risk and uncertainties including financial and operational risks and the potential of overall business failure.   The Company has experienced, and in the future expects to continue to experience, variability in sales and net earnings. The factors expected to contribute to this variability include, among others, (i) the cyclical nature of the industry, (ii) general economic conditions in the various local markets in which the Company competes, including a potential general downturn in the economy, and (iii) the volatility of prices in connection with the Company’s service offerings. These factors, among others, make it difficult to project the Company’s operating results on a consistent basis.
Fair Value of Financial Instruments	Fair Value of Financial Instruments   The Company accounts for financial instruments at fair value, which is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (exit price) in an orderly transaction between market participants at the measurement date. The valuation techniques are based on observable and unobservable inputs. Observable inputs reflect readily obtainable data from independent sources, while unobservable inputs reflect certain market assumptions. There are three levels of inputs that may be used to measure fair value:     · Level 1—Valuation based on quoted market prices in active markets that the Company can access for identical assets or liabilities;         · Level 2—Valuation based on quoted prices in active markets for similar assets and liabilities and inputs that are observable for the asset or liability; and         · Level 3—Valuation based on unobservable inputs that are supported by little or no market activity, which require management’s best estimate of what market participants would use as fair value.   Fair value estimates discussed herein are based upon certain market assumptions and pertinent information available to management.   The respective carrying value of certain on-balance-sheet financial instruments approximated their fair value. These financial instruments include accounts receivable, accounts payable and accrued expenses, accrued interest – related party, and contract liabilities. On September 30, 2024, and December 31, 2023, the carrying amounts of these financial instruments approximated their fair values due to the short-term nature of these instruments. The fair value of the Company’s long-term debt approximates its carrying value based on current financing rates available to the Company.   The Company does not have any other financial or non-financial assets or liabilities that would be characterized as Level 1, Level 2, or Level 3 instruments.
Cash and Cash Equivalents and Concentrations of Risk	Cash and Cash Equivalents and Concentrations of Risk   For the purposes of presentation in the consolidated statements of cash flows, the Company considers all highly liquid instruments with a maturity of three months or less at the purchase date and money market accounts to be cash equivalents.   On September 30, 2024, and December 31, 2023, the Company did not have any cash equivalents.   The Company is exposed to credit risk on its cash in the event of default by the financial institutions to the extent account balances exceed the amount insured by the FDIC, which is $250,000. On September 30, 2024, and December 31, 2023, the Company did not experience any losses on cash balances in excess of FDIC insured limits. Any loss incurred or a lack of access to funds could have a significant impact on the Company’s consolidated financial condition, results of operations, and cash flows.   For the quarters ended September 30, 2024, and 2023, sales of our products to four customers and three customers generated approximately 86% and 96% of our revenues, respectively. For the nine months ended September 30, 2024, and 2023, sales of our products to five customers and three customers generated approximately 86% and 76% of our revenues, respectively. Our contracts with our customers generally do not obligate them to a specified term and they can generally terminate their relationship with us at any time with a minimal amount of notice. The loss of one of these customers could have a material adverse effect on the results of operations and financial condition.
Accounts Receivable and Allowance for Credit Losses	Accounts Receivable and Allowance for Credit Losses   Effective January 1, 2023, the Company adopted Accounting Standards Update (ASU) 2016-13, Financial Instruments – Credit Losses: Measurement of Credit Losses on Financial Instruments (Topic 326), which significantly change how entities measure credit losses for most financial assets and certain other instruments that are not measured at fair value through net income. The most significant change in this standard is a shift from the incurred loss model to the expected loss model. Under the standard, disclosures are required to provide users of the consolidated financial statements with useful information in analyzing an entity’s exposure to credit risk and the measurement of credit losses. Financial assets held by the Company that are subject to the guidance in Topic 326 were trade accounts receivable. The impact of the adoption was not considered material to the consolidated financial statements.   Accounts receivable represent customer obligations under normal trade terms and are stated at the amount management expects to collect from outstanding customer balances. Credit is extended to customers based on an evaluation of their financial condition and other factors. Interest is not accrued on overdue accounts receivable. The Company does not require collateral. Two of our customers combined accounted for approximately 70% of outstanding accounts receivable at September 30, 2024.   The Company had accounts receivable, net, of $144,664, $34,628, and $340,935 at September 30, 2024, December 31, 2023, and January 1, 2023, respectively.   Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for credit losses. The Company provides its allowance for credit losses based upon a review of the outstanding accounts receivable, historical collection information and existing economic conditions. Accounts determined to be uncollectible losses are charged to operations when that determination is made.   The allowance for credit losses for accounts receivable and the related activity, for the nine months ended September 30, 2024 is as follows:  Schedule of allowance for credit losses for accounts receivable activity       Balance, December 31, 2023   $ 1,157,910   Provision for credit losses     92,779   Write-off of previously reserved account balances     (1,106,025 ) Balance, September 30, 2024   $ 144,664     Provision for credit losses expense (recovery) is recorded as a component of general and administrative expenses in the accompanying consolidated statements of operations.
Impairment of Long-lived Assets	Impairment of Long-lived Assets   Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists, in accordance with the provisions of ASC 360-10-35-15“Impairment or Disposal of Long-Lived Assets.” Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include but are not limited to significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets and compares this to the carrying amounts of the assets.   If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment to be recognized is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairment was recognized by the Company for the nine months ended September 30, 2024, and 2023.
Property and Equipment	Property and Equipment   Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets.   Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in current results of operations.
Goodwill	Goodwill   The Company’s goodwill represents the excess of the consideration transferred for the acquisition of Advangelists LLC in December 2018 over the fair value of the underlying identifiable net assets acquired. Goodwill is not amortized but instead, it is tested for impairment at least annually. If management determines that the value of goodwill has become impaired, the Company will record a charge in an amount equal to the excess of the reporting unit’s carrying amount over its fair value, not to exceed the total amount of goodwill allocated to the reporting unit during the fiscal quarter in which the determination is made.   The Company performs its annual impairment tests of goodwill as of December 31st of each year, or more frequently, if certain indicators are present. Goodwill is required to be tested for impairment at the reporting unit level. A reporting unit is an operating segment or one level below the operating segment level, which is referred to as a component. Management identifies its reporting units by assessing whether components (i) have discrete financial information available, (ii) engage in business activities, and (iii) whether a segment manager regularly reviews the component’s operating results. Net assets and goodwill of acquired businesses are allocated to the reporting unit associated with the acquired business based on the anticipated organizational structure of the combined entities. If two or more components are deemed economically similar, those components are aggregated into one reporting unit when performing the annual goodwill impairment review. The Company has one reporting unit as of September 30, 2024, and December 31, 2023. No impairment of goodwill was recognized by the Company during fiscal 2023 or the nine-month period ended September 30, 2024.
Intangible Assets	Intangible Assets   In December 2018, the Company acquired the majority of its intangible assets through its acquisition of Advangelists LLC, which included customer relationships and the ATOS platform technology. The Company amortizes its identifiable definite-lived intangible assets over an estimated period of 5 years.
Capitalized Software Development Costs	Capitalized Software Development Costs   In accordance with ASC 350-40, Internal Use Software, the Company capitalizes certain internal-use software development costs associated with creating and enhancing internally developed software related to its platforms. Software development activities generally consist of three stages (i) the research and planning stage, (ii) the application and development stage, and (iii) the post-implementation stage. Costs incurred in the research and planning stage and in the post-implementation stage of software development, or other maintenance and development expenses that do not meet the qualification for capitalization, are expensed as incurred. Costs incurred in the application and development stage, including significant enhancements and upgrades, are capitalized. These costs include personnel and related employee benefits expenses for employees or consultants directly associated with and who devote time to software projects and external direct costs of materials obtained in developing the software. These software developments and acquired technology are amortized on a straight-line basis over the estimated useful life of five years upon the initial release of the software or additional features. The Company reviews the software development costs for impairment when circumstances indicate their carrying amounts may not be recoverable. If the carrying value of an asset group is not recoverable, the Company recognizes an impairment loss for the excess of carrying value over the fair value in its consolidated statements of operations. See Note 3 for further details.
Derivative Financial Instruments	Derivative Financial Instruments   The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, (ASC 480), Distinguishing Liabilities from Equity and FASB ASC Topic No. 815, (ASC 815) Derivatives and Hedging.   Terms of financial instruments are reviewed to determine whether they contain embedded derivative instruments that are required to be accounted for separately from the host contract under ASC 815 and recorded on the balance sheet at fair value. Derivative liabilities are remeasured to reflect fair value at each reporting period, with any increase or decrease in the fair value being recorded in the results of operations. The Company generally incorporates a binomial model to determine fair value. Upon conversion of a debt instrument where an embedded conversion option has been bifurcated and accounted for separately as a derivative liability, the Company records the resulting shares issued at fair value, derecognizes all related debt principal, derivative liability, and debt discount, and recognizes a net gain or loss on debt extinguishment. Equity instruments that are initially classified as equity that become subject to reclassification under ASC 815 are reclassified to liabilities at the fair value of the instrument on the reclassification date. The Company does not use derivative instruments to hedge exposures to cash flow, market or foreign currency risk. As of September 30, 2024, and December 31, 2023, the Company had no derivative instruments outstanding.
Debt Issuance Costs and Debt Discounts	Debt Issuance Costs and Debt Discounts   Debt discounts, debt issuance costs paid to lenders or third parties, and other original issue discounts on debt, are recorded as debt discounts and amortized to interest expense in the consolidated statement of operations, over the term of the underlying debt instrument, using the effective interest method, with the unamortized portion reported net with related principal outstanding on the consolidated balance sheet. For the three months ended September 30, 2024, and 2023, the Company recognized $118,262 and no interest expense associated with the amortization of debt discounts on debt outstanding during the periods. For the nine months ended September 30, 2024, and 2023, the Company recognized $265,556 and $738,142 in interest expense associated with the amortization of debt discounts on debts outstanding during the periods. Unamortized debt discounts remaining at September 30, 2024 were approximately $229,000 and are expected to be fully amortized during the remainder of 2024. See Note 4 regarding the accounting for debt discounts and debt issuance costs during fiscal 2024 and 2023.
Revenue Recognition	Revenue Recognition   The Company’s revenues are generated from internet advertising, the Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (ASC 606). In accordance with ASC 606, revenue is recognized when promised services are transferred to a customer. The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these services. To achieve this core principle, the Company applies the following five steps:   Identify the contract with a customer.   A contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s rights regarding the services to be transferred and identifies the payment terms related to these services, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration for services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration. The Company applies judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit and financial information pertaining to the customer.    Identify the performance obligations in the contract.   Performance obligations promised in a contract are identified based on the services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the service either on its own or together with other resources that are readily available from third parties or from the Company, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services (performance obligations), the Company must apply a judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met the promised services are accounted for as a combined performance obligation. Currently, the Company does not have any contracts that contain multiple performance obligations.   Determine the transaction price.   The transaction price is determined based on the consideration of which the Company will be entitled in exchange for transferring services to the customer. To the extent the transaction price includes variable consideration, the Company estimates the amount of variable consideration that should be included in the transaction price utilizing either the expected value method or the most likely amount method depending on the nature of the variable consideration. Variable consideration is included in the transaction price if, in the Company’s judgment, it is probable that a significant future reversal of cumulative revenue under the contract will not occur. None of the Company’s contracts outstanding at September 30, 2024 or December 31, 2023, contained a significant financing component or variable consideration terms.   Allocate the transaction price to performance obligations in the contract.   If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. However, if a series of distinct services that are substantially the same qualifies as a single performance obligation in a contract with variable consideration, the Company must determine if the variable consideration is attributable to the entire contract or to a specific part of the contract. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative standalone selling price basis unless the transaction price is variable and meets the criteria to be allocated entirely to a performance obligation or to a distinct service that forms part of a single performance obligation.   Recognize revenue when or as the Company satisfies a performance obligation.   The Company satisfies performance obligations at a point in time. Revenue is recognized at the time the related performance obligation is satisfied by transferring the promised service to a customer. Under both managed services arrangements and self-service arrangements, the Company’s promised services under the contracts include identification, bidding and purchasing of advertisement opportunities. The Company also generally has discretion in establishing the pricing of the ads. Since the Company is controlling the promise to deliver the contracted services, the Company is considered the principal in all arrangements for revenue recognition purposes. The performance obligations are satisfied, and revenue recognition primarily upon publication of customer advertising content.   All revenues recognized were derived from internet advertising for the periods ended September 30, 2024, and 2023.   Payment terms and conditions vary by contract, although terms generally include a requirement of payment within 30 to 90 days.   Contract Liabilities   Contract liabilities represent deposits made by customers before the satisfaction of performance obligation and recognition of revenue. Upon completion of the performance obligation(s) that the Company has with the customer based on the terms of the contract, the liability for the customer deposit is relieved and revenue is recognized. As of September 30, 2024, December 31, 2023, and January 1, 2023, there were $77,110, $195,135, and $193,598, respectively, in contract liabilities outstanding. Contract liabilities are expected to be recognized as revenue within the year following their respective period end.
Advertising	Advertising   Advertising costs are expensed as incurred. Advertising costs are included as a component of general and administrative expenses in the consolidated statements of operations. Advertising costs incurred were insignificant for the periods ended September 30, 2024, and 2023.
Stock-Based Compensation	Stock-Based Compensation   The Company accounts for our stock-based compensation, including stock options and common stock warrants, under ASC 718 Compensation – Stock Compensation, using the fair value-based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the requisite service period for employee awards, which is usually the vesting period, and when the goods are obtained or services are received, for nonemployee awards. This guidance establishes standards for the accounting for transactions in which an entity exchanges its equity instruments for goods or services. It also applies to transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.   In connection with certain financing, consulting and collaboration arrangements, the Company may issue warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards.   The fair value of stock-based compensation is generally determined by using the Black-Scholes valuation model as of the date of the grant or the date at which the performance of the services is completed (measurement date).   When determining the fair value of stock-based compensation, the Company considers the following assumptions in the Black-Scholes model:   · Exercise price, · Expected dividends, · Expected volatility, · Risk-free interest rate; and · Expected life of option
Income Taxes	Income Taxes   The Company accounts for income tax using the asset and liability method prescribed by ASC 740, Income Taxes (ASC 740). Under this method, deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if based on the weight of available evidence, it is more likely-than-not that all or some portion of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as gain or loss in the period that includes the date of the enactment.   The Company follows the accounting guidance for uncertainty in income taxes using the provisions of ASC 740. Using that guidance, tax positions initially need to be recognized in the consolidated financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities. As of September 30, 2024, and December 31, 2023, the Company did not identify any uncertain tax positions that qualify for either recognition or disclosure in the consolidated financial statements.   The Company recognizes interest and penalties, if any, related to recognized uncertain income tax positions, in other expense. No interest and penalties related to uncertain income tax positions were recorded for the periods ended September 30, 2024, and 2023. Open tax years, subject to examination by the Internal Revenue Service, generally remain open for three years from the filing date. Tax years subject to examination by the state jurisdiction generally remain open for up to four years from the filing date.
Related Parties	Related Parties   Parties are considered to be related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements    We consider the applicability and impact of all new accounting pronouncements on our consolidated financial position, results of operations, stockholders’ equity, cash flows, or presentation thereof. Management has evaluated all recent accounting pronouncements as issued by the Financial Accounting Standards Board (FASB) through the date these consolidated financial statements were available to be issued and found no recent accounting pronouncements issued, but not yet effective, that when adopted, will have a material impact on the consolidated financial statements of the Company.

v3.24.3

ORGANIZATION AND NATURE OF OPERATIONS (Tables)	9 Months Ended
	Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Schedule of subsidiaries	Schedule of subsidiaries     Company Name   State of Incorporation Mobiquity Networks, Inc.   New York Advangelists, LLC   Delaware

v3.24.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2024
Accounting Policies [Abstract]
Schedule of allowance for credit losses for accounts receivable activity	Schedule of allowance for credit losses for accounts receivable activity       Balance, December 31, 2023   $ 1,157,910   Provision for credit losses     92,779   Write-off of previously reserved account balances     (1,106,025 ) Balance, September 30, 2024   $ 144,664

v3.24.3

INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS (Tables)	9 Months Ended
	Sep. 30, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of intangible assets	Schedule of intangible assets                     Useful Lives   September 30, 2024     December 31, 2023                     Customer relationship   5 years   $ 3,003,676     $ 3,003,676   Less accumulated amortization         (3,003,676 )     (2,927,188 ) Net carrying value       $ –     $ 76,488                         Software development costs   5 years   $ 3,602,328     $ 2,157,932   Less accumulated amortization         (237,649 )     (108,024 ) Net carrying value, software development costs       $ 3,364,679     $ 2,049,908
Schedule of future annual amortization	Schedule of future annual amortization           Software Development Costs   Remainder of 2024   $ 180,116   2025     720,466   2026     720,466   2027     720,466   2028     612,443   2029     410,722   Total   $ 3,364,679

v3.24.3

DEBT (Tables)	9 Months Ended
	Sep. 30, 2024
Debt Disclosure [Abstract]
Schedule of debt outstanding	Schedule of debt outstanding                 September 30, 2024 (Unaudited)     December 31, 2023   Merchant Agreements   $ 561,290     $ 216,089   Related Party – Salkind Loans     261,500       –   Related Party – Other Loans     177,000       –   2024 Promissory Notes     331,640       –   Total Debt     1,331,430       216,089   Less: Unamortized debt discounts     (229,357 )     (47,372 ) Current portion of debt   $ 1,102,073     $ 168,717

v3.24.3

STOCK OPTION PLANS AND WARRANTS (Tables)	9 Months Ended
	Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]
Schedule of weighted average assumptions of options granted	Schedule of weighted average assumptions of options granted                 Nine Months Ended September 30,       2024     2023   Expected volatility     199.68%       166.87%   Expected dividend yield     –       –   Risk-free interest rate     3.42%       3.54%   Expected term (in years)     7.50       6.67
Schedule of options activity	Schedule of options activity                                     Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic Value   Outstanding, January 1, 2024     1,876,275     $ 9.11       5.05     $ 252,000   Granted     833     $ 0.50       8.51     $ 1,658   Cancelled or expired     (4,094 )   $ –       –     $ –   Outstanding, September 30, 2024     1,873,014     $ 7.56       4.31     $ 4,123,658   Options exercisable, September 30, 2024     1,873,013     $ 7.56       4.31     $ 4,123,658
Schedule of weighted average assumptions of warrants granted	Schedule of weighted average assumptions of warrants granted                 Nine Months Ended September 30,       2024     2023   Expected volatility     217.65%       172.63%   Expected dividend yield     –       –   Risk-free interest rate     3.98%       3.85%   Expected term (in years)     2.88       5.00
Schedule of warrants activity	Schedule of warrants activity                                     Shares     Weighted Average Exercise Price     Weighted Average Remaining Contractual Term (Years)     Aggregate Intrinsic Value   Outstanding, January 1, 2024     653,357     $ 58.54       4.20     $ 28,000   Granted     250,000     $ 0.60       4.10     $ 472,500   Cancelled or expired     –     $ –       –     $ –   Outstanding, September 30, 2024     903,357     $ 42.51       3.64     $ 903,500   Warrants exercisable, September 30, 2024     903,357     $ 42.51       3.64     $ 903,500

v3.24.3

EARNINGS (LOSS) PER SHARE (Tables)	9 Months Ended
	Sep. 30, 2024
Earnings Per Share [Abstract]
Schedule of potentially dilutive equity securities outstanding	Schedule of potentially dilutive equity securities outstanding                 September 30, 2024     December 31, 2023   Stock options     1,873,014       1,876,275   Warrants     903,357       653,358   Series AAA preferred stock     209,525       209,525   Series E preferred stock     10,281       10,281   Series H preferred stock     –       7,684,730   Total common stock equivalents     2,996,177       10,434,169

v3.24.3

ORGANIZATION AND NATURE OF OPERATIONS (Details - Subsidiaries)	9 Months Ended
	Sep. 30, 2024
Mobiquity Networks Inc [Member]
Name of subsidiary	Mobiquity Networks, Inc.
State of incorporation	New York
Advangelists LLC [Member]
Name of subsidiary	Advangelists, LLC
State of incorporation	Delaware

v3.24.3

ORGANIZATION AND NATURE OF OPERATIONS (Details Narrative) - USD ($)		3 Months Ended						9 Months Ended
	Aug. 07, 2023	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Reverse stock split	one-for-15 reverse stock split
Net loss		$ 1,131,316	$ 897,790	$ 1,042,260	$ 1,394,271	$ 2,108,939	$ 1,716,804	$ 3,071,366	$ 5,220,014
Net cash used in operations								1,798,860	3,732,469
Accumulated deficit		220,111,705						220,111,705		$ 217,040,339
Stockholders' equity		2,124,518	$ 1,900,066	$ 1,585,188	$ 1,551,487	$ 2,945,524	$ 2,200,634	2,124,518	$ 1,551,487	$ 2,208,328	$ (10,830)
Working capital deficit		2,598,410						2,598,410
Cash on hand		$ 189,810						$ 189,810

v3.24.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details - Allowance for credit losses) - USD ($)	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Accounting Policies [Abstract]
Allowance for credit losses, beginning	$ 1,157,910
Provision for credit losses	92,779	$ 46,458
Write off of previously-reserved account balances	(1,106,025)
Allowance for credit losses, ending	$ 144,664

v3.24.3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	Jan. 02, 2023
Product Information [Line Items]
Cash equivalents	$ 0		$ 0		$ 0
Net accounts receivable	144,664		144,664		34,628	$ 340,935
Asset impairment			0	$ 0
Impairment of goodwill			0		0
Amortization of debt discounts	118,262	$ 0	265,556	$ 738,142
Unamortized debt discounts	229,000		229,000
Contract liabilities	$ 77,110		$ 77,110		$ 195,135	$ 193,598
Customer Relationships [Member]
Product Information [Line Items]
Identifiable definite-lived intangible assets estimated period	5 years		5 years
Four Customers [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk percentage	86.00%
Three Customers [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk percentage		96.00%		76.00%
Five Customers [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk percentage			86.00%
Two Customers [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Product Information [Line Items]
Concentration risk percentage			70.00%

v3.24.3

INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS (Details - Intangible assets) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Customer Relationships [Member]
Finite-Lived Intangible Assets [Line Items]
Useful life	5 years
Intangible asset, gross	$ 3,003,676	$ 3,003,676
Less accumulated amortization	(3,003,676)	(2,927,188)
Intangible assets, net	$ 0	76,488
Software and Software Development Costs [Member]
Finite-Lived Intangible Assets [Line Items]
Useful life	5 years
Intangible asset, gross	$ 3,602,328	2,157,932
Less accumulated amortization	(237,649)	(108,024)
Intangible assets, net	$ 3,364,679	$ 2,049,908

v3.24.3

INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS (Details - Accumulated amortization) - Software Development [Member]	Sep. 30, 2024 USD ($)
Property, Plant and Equipment [Line Items]
Remainder of 2024	$ 180,116
2025	720,466
2026	720,466
2027	720,466
2028	612,443
2029	410,722
Total	$ 3,364,679

v3.24.3

INTANGIBLE ASSETS AND SOFTWARE DEVELOPMENT COSTS (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Amortization expense	$ 0	$ 150,184	$ 76,488	$ 450,551
Amortization on software development costs	43,209	$ 43,209	129,625	$ 64,813
ATOS4P Software Development [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Capitalized computer software development costs	3,600,000		3,600,000		$ 2,200,000
Unamortized software development costs	3,400,000		3,400,000
Ad Here [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Capitalized computer software development costs	$ 3,600,000		3,600,000		$ 2,200,000
Capitalized costs			$ 1,440,000

v3.24.3

DEBT (Details - Debt outstanding) - USD ($)	Sep. 30, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total Debt	$ 1,331,430	$ 216,089
Less: Unamortized debt discounts	(229,357)	(47,372)
Current portion of debt	1,102,073	168,717
Merchant Agreements [Member]
Debt Instrument [Line Items]
Total Debt	561,290	216,089
Related Party Salkind Loans [Member]
Debt Instrument [Line Items]
Total Debt	261,500	0
Related Party Other Loans [Member]
Debt Instrument [Line Items]
Total Debt	177,000	0
Promissory Note [Member]
Debt Instrument [Line Items]
Total Debt	$ 331,640	$ 0

v3.24.3

DEBT (Details Narrative) - USD ($)							1 Months Ended							3 Months Ended				6 Months Ended	9 Months Ended
	Jul. 23, 2024	Jul. 05, 2024	Oct. 10, 2023	Jun. 30, 2023	Jan. 05, 2023	Dec. 30, 2022	Aug. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Mar. 31, 2024	Feb. 29, 2024	Nov. 30, 2023	Jun. 30, 2020	Sep. 30, 2024	Jun. 30, 2024	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2024	Sep. 30, 2024	Sep. 30, 2023	Oct. 08, 2024	Jun. 27, 2024	Dec. 31, 2022
Short-Term Debt [Line Items]
Repayment of note payable																			$ 574,746	$ 1,587,500
Conversion rate														$ 0.50					$ 0.50
Debt discount														$ 229,000					$ 229,000
March 2024 Promissory Note [Member]
Short-Term Debt [Line Items]
Total interest payable										$ 17,710
Debt face amount										126,500
Original issue discount										$ 16,500
Amortization of debt discount														1,126					7,957
Debt maturity date										Jan. 15, 2025
Debt stated interest rate										14.00%
Debt discount										$ 24,650
Payment of debt issuance costs										$ 8,150
Principal and OID remain outstanding														69,000					69,000
April 2024 Promissory Note [Member]
Short-Term Debt [Line Items]
Total interest payable									$ 14,400
Debt face amount									96,000
Original issue discount									$ 16,000
Amortization of debt discount																			4,149
Debt maturity date									Mar. 31, 2025
Debt stated interest rate									15.00%
Principal and OID remain outstanding														51,000					51,000
Individual payments									$ 11,040
September 2024 Promissory Note [Member]
Short-Term Debt [Line Items]
Total interest payable														13,846					13,846
Debt face amount														98,900					98,900
Original issue discount														$ 20,300					20,300
Amortization of debt discount																			$ 362
Debt maturity date																			Jul. 15, 2025
Debt stated interest rate														14.00%					14.00%
Principal payment due, description																			principal as follows: $56,373 due March 15, 2025, $14,093 due on each of April 15, 2025 and May15, 2025 and $14,874 due on June 15, 2025
November 2023 Merchant Agreement [Member]
Short-Term Debt [Line Items]
Amortization of debt discount																		$ 33,578
Debt discount												$ 72,000
Proceeds for future receivables												200,000
Total amount to be paid from receivables funding												$ 272,000
Shares issued												16,765
Additional debt discount												$ 10,500
Cash settlement									127,000
February 2024 Merchant Agreement [Member]
Short-Term Debt [Line Items]
Amortization of debt discount																			$ 62,850
Debt discount											$ 62,850
Proceeds for future receivables											150,000
Total amount to be paid from receivables funding											$ 205,350
Shares issued											20,135
Additional debt discount											$ 7,500
Debt instrument fee amount											7,500
April 2024 Merchant Agreement [Member]
Short-Term Debt [Line Items]
Amortization of debt discount																			103,000
Proceeds for future receivables									250,000
Total amount to be paid from receivables funding									$ 342,250
Shares issued									12,854
Additional debt discount									$ 12,500
August 2024 Merchant Agreement [Member]
Short-Term Debt [Line Items]
Proceeds for future receivables							$ 200,000
Total amount to be paid from receivables funding							$ 273,800
Shares issued							2,779
Additional debt discount							$ 6,057
Cash proceeds from outstanding obligations							121,147
September 2024 Merchant Agreement [Member]
Short-Term Debt [Line Items]
Proceeds for future receivables																			250,000
Total amount to be paid from receivables funding																			$ 342,250
Shares issued														1,993					1,993
Additional debt discount														$ 5,560					$ 5,560
Cash proceeds from outstanding obligations																			98,699
February April August And September 2024 Merchant Agreements [Member]
Short-Term Debt [Line Items]
Amortization of debt discount														107,000					240,000
Debt discount														162,000					162,000
Financing Arrangement [Member]
Short-Term Debt [Line Items]
Total amount financed							$ 112,500
Interest rate							8.14%
Payments of principal and interest							$ 12,928
Dr Salkind [Member]
Short-Term Debt [Line Items]
Proceeds from loan	$ 50,000	$ 50,000
Principal outstanding														100,000					100,000
Debt discount														$ 643					$ 643
Salkind February 2024 Loan [Member]
Short-Term Debt [Line Items]
Short-term debt											$ 150,000
Debt stated interest rate											10.00%
Salkind October 2023 Loan [Member]
Short-Term Debt [Line Items]
Loan payable			$ 300,000
Debt maturity date			Nov. 30, 2023
Interest rate			15.00%
Conversion rate														$ 0.70					$ 0.70
Debt converted, amount converted												$ 300,000
Salkind June 2024 Loan [Member]
Short-Term Debt [Line Items]
Original issue discount																						$ 10,000
Loan payable																						$ 160,000
Conversion rate																						$ 0.50
Convertible debt																						$ 160,000
Principal outstanding															$ 150,000			150,000
Debt discount															5,080			5,080
Loan 1 [Member]
Short-Term Debt [Line Items]
Debt discount									4,000
Exchange issued									70,000
Principal amount paid															74,000
Interest expense																			$ 4,000
Loan 2 [Member]
Short-Term Debt [Line Items]
Exchange issued									$ 40,000
Loan 3 [Member]
Short-Term Debt [Line Items]
Original issue discount														$ 5,000	$ 5,000			$ 5,000	5,000
Conversion rate															$ 0.50			$ 0.50
Principal outstanding														20,000					20,000
Debt discount														2,734					2,734
Principal amount paid															$ 25,000
Exchange for cancellation															20,000			$ 20,000
Loan 4 [Member]
Short-Term Debt [Line Items]
Original issue discount														15,000	$ 15,000			$ 15,000	15,000
Conversion rate															$ 0.50			$ 0.50
Principal outstanding														37,000					37,000
Debt discount														$ 8,100					8,100
Exchange issued															$ 37,000
Principal amount paid															$ 52,000
Loans 5 And 6 [Member]
Short-Term Debt [Line Items]
Non interest bearing loans								$ 78,000
Debt principal amount payable								$ 78,000
Debt instrument payables																			27,000
Loan 7 [Member]
Short-Term Debt [Line Items]
Non interest bearing loans																			75,000
Debt principal amount payable																			75,000
Debt instrument payables																			$ 60,000
Loans 5, 6 And 7 [Member] | Subsequent Event [Member]
Short-Term Debt [Line Items]
Original issue discount																					$ 13,000
Conversion rate																					$ 1.00
Outstanding principal																					$ 87,000
Walleye Opportunities Master Fund [Member]
Short-Term Debt [Line Items]
Repayment of note payable				$ 1,437,500		$ 163,000
Debt face amount						1,437,500
Original issue discount						287,500
Subscription amount						$ 1,150,000
Warrants issued, shares						174,242
Issuance fees						$ 138,500
Proceeds from loan						1,011,500
Fair value of warrants						586,040
Debt issuance costs						$ 1,134,466
Amortization of debt discount																$ 377,149	$ 360,993
Walleye Opportunities Master Fund [Member] | Incentive Shares [Member]
Short-Term Debt [Line Items]
Stock issued new, shares						34,849
Fair value of warrants						$ 122,426
Economic Injury Disaster Loan [Member]
Short-Term Debt [Line Items]
Proceeds from loans													$ 150,000
Principal interest													$ 731
Total interest payable																							$ 13,594
Repayment of note payable					$ 163,885

v3.24.3

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)									1 Months Ended							3 Months Ended						5 Months Ended	7 Months Ended	9 Months Ended		12 Months Ended
	Aug. 15, 2024	Dec. 18, 2023	Nov. 07, 2023	Oct. 06, 2023	Aug. 07, 2023	Jun. 30, 2023	Feb. 13, 2023	Dec. 30, 2022	Aug. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Jan. 31, 2024	Dec. 31, 2023	Jul. 31, 2023	Apr. 30, 2023	Sep. 30, 2024	Jun. 30, 2024	Mar. 31, 2024	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2023	Aug. 06, 2024	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023
Class of Stock [Line Items]
Reverse stock split					one-for-15 reverse stock split
Common stock, shares authorized													100,000,000			100,000,000								100,000,000		100,000,000
Common stock par value													$ 0.0001			$ 0.0001								$ 0.0001		$ 0.0001
Accrued cash dividends																							$ 122,954
Stock issued for services, value																$ 42,117	$ 24,035	$ 65,000		$ 80,411
General and administrative expense																1,270,386			$ 1,262,988					$ 3,312,699	$ 3,900,693
Expense recognized																$ 4,000
Repayment of note payable																								574,746	1,587,500
Loss on extinguishment of debt																								$ (0)	(396,322)
Common stock outstanding													3,992,426	2,588,333		16,606,839								16,606,839		3,992,426
Stock issued new, value																$ 675,000	$ 1,062,000	$ 400,000
Accrued liabilities																$ 18,000								$ 18,000
Conversion price																$ 0.50								$ 0.50
Proceeds from issuance of common stock																								$ 2,237,000	$ 0
Subscription receivable																$ 675,000								$ 675,000
Subscription receivable shares																1,100,000								1,100,000
Upfront payment																$ 94,000								$ 110,000
Stock repurchased, shares																0		17								0
Minimum [Member]
Class of Stock [Line Items]
Conversion price																$ 0.50								$ 0.50
Maximum [Member]
Class of Stock [Line Items]
Conversion price																$ 1.00								$ 1.00
Stock Subscription Agreements [Member]
Class of Stock [Line Items]
Stock issued new, shares																								4,347,334
Proceeds from issuance of common stock																								$ 2,237,000
Gene Salkind [Member]
Class of Stock [Line Items]
Restricted stock granted, shares															6,667
CEO And Member Of Board Of Directors [Member]
Class of Stock [Line Items]
Restricted stock granted, shares															3,333
Legal Counsel [Member]
Class of Stock [Line Items]
Restricted stock granted, shares															4,791
Restricted stock granted, value															$ 12,000
Share price															$ 2.505
Various Vendors [Member]
Class of Stock [Line Items]
Restricted stock granted, shares															31,891
Restricted stock granted, value															$ 80,411
February 2023 Offering [Member]
Class of Stock [Line Items]
Warrants issued, shares							285,792
Stock issued new, shares							251,842
Proceeds from sale of equity							$ 3,207,500
February 2023 Offering [Member] | Underwriter [Member]
Class of Stock [Line Items]
Payment of stock issuance costs							$ 242,500
June 2023 Offering [Member]
Class of Stock [Line Items]
Warrants issued, shares						1,625,000
Payment of stock issuance costs						$ 472,001
Stock issued new, shares						375,000
Proceeds from sale of equity						$ 2,528,000
Gross proceeds from sale of equity						3,000,000
SBA Loan [Member]
Class of Stock [Line Items]
Repayment of note payable								$ 163,000
Walleye Opportunities Master Fund [Member]
Class of Stock [Line Items]
Debt face amount								1,437,500
Original issue discount								287,500
Subscription amount								$ 1,150,000
Warrants issued, shares								174,242
Payment of stock issuance costs								$ 138,500
Net proceeds notes payable								1,011,500
Repayment of note payable						$ 1,437,500		163,000
Fair value of warrants								$ 586,040
Amortization of debt discount																				377,149	$ 360,993
Loss on extinguishment of debt																				$ 396,322
Business Development Agreement [Member]
Class of Stock [Line Items]
Stock issued for services, shares	25,000
Amortization of prepaid asset	$ 12,500
Stock issued new, value	$ 12,500
Stock issued new, shares	25,000
Payment For Accrued And Unpaid Interest [Member] | Gene Salkind [Member]
Class of Stock [Line Items]
Stock issued new, value															$ 5,000
Stock issued new, shares															2,000
Settlement Of Vendor Liabilities [Member]
Class of Stock [Line Items]
Stock issued new, shares											18,000	100,000
Stock issued new, value											$ 12,000	$ 53,000
Business Consulting Services [Member]
Class of Stock [Line Items]
Warrants issued, shares										100,000
Amortization of prepaid asset																								$ 446,200
Upfront payment										$ 25,000
Monthly fee										5,000
Warrants issuance										$ 171,800
Issuance common stock warrant services, description																								In September 2024, the Company amended the consulting agreement to increase the monthly cash compensation to $10,000 and to issue additional warrants to purchase a total of 150,000 shares of common stock exercisable over a three-year period. The 150,000 warrant shares consist of 100,000 exercisable at $0.50 per share and 50,000 exercisable at $1.00 per share through September 10, 2027.
Mr Salkind [Member] | One Year Consulting Contract [Member]
Class of Stock [Line Items]
Stock issued for services, shares				150,000
Stock issued for services, value				$ 103,500
General and administrative expense																$ 25,875								$ 77,625
Unrelated Party [Member] | One Year Consulting Contract [Member]
Class of Stock [Line Items]
Stock issued for services, shares													100,000
Stock issued for services, value													$ 14,000
Signing bonus													$ 25,000
Warrants issued, shares													200,000
Warrant exercise price													$ 0.20													$ 0.20
Warrants issued, value													$ 25,000
Prepaid asset													$ 64,000			12,000								12,000		$ 64,000
Amortization of prepaid asset																$ 16,000								$ 48,000
Common Stock [Member]
Class of Stock [Line Items]
Reverse stock split					1-for-15 reverse stock split
Stock converted, shares issued																						285,792
Common Stock [Member] | June 2023 Offering [Member]
Class of Stock [Line Items]
Stock converted, shares issued														478,334
Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																5,000,000								5,000,000
Preferred stock, par value																$ 0.0001								$ 0.0001
Series AA Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																1,500,000								1,500,000
Preferred stock outstanding																0								0
Conversion rights of Preferred Stock																								Series AA – one share convertible into 3.33 shares of common stock
Series AAA Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																1,250,000								1,250,000
Preferred stock outstanding																31,413								31,413
Conversion rights of Preferred Stock																								Series AAA – one share convertible into 6.67 shares of common stock
Series AAAA Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																1,250								1,250
Preferred stock outstanding																0								0
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																1,500								1,500
Preferred stock outstanding																0								0
Conversion rights of Preferred Stock																								Series C – one share convertible into 6,667 shares of common stock
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																2								2
Preferred stock outstanding																0								0
Series E Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized													70,000			70,000								70,000		70,000
Preferred stock, par value													$ 0.0001			$ 0.0001								$ 0.0001		$ 0.0001
Preferred stock outstanding													61,688			61,688								61,688		61,688
Conversion rights of Preferred Stock																								Series E – one share at a rate of its Stated Value, as defined, divided by $0.08, convertible commencing January 31, 2020
Series F Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																1								1
Preferred stock outstanding																0								0
Series G Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized																300,789								300,789
Preferred stock outstanding																0								0
Conversion rights of Preferred Stock																								Series G – one share convertible into shares of common stock at a rate of its Stated Value divided by $0.50 (Series G Conversion Ratio)
Stock converted, shares converted		300,789
Stock issued new, shares			300,789
Proceeds from sale of equity			$ 1,503,495
Series H Preferred Stock [Member]
Class of Stock [Line Items]
Preferred shares authorized													770,000			770,000								770,000		770,000
Preferred stock, par value													$ 0.0001			$ 0.0001								$ 0.0001		$ 0.0001
Preferred stock outstanding									768,473				768,473			0								0		768,473
Conversion rights of Preferred Stock																								Series H – one share was convertible into shares of common stock at a rate of its Stated Value ($2.00 at August 7, 2024, date of mandatory conversion discussed below) divided by $0.20 (Series H Conversion Ratio)
Stock converted, shares converted									7,684,730
Accrued cash dividends									$ 122,954
Stock converted, shares issued		751,730							158,840														158,840
Series H Preferred Stock [Member] | Law Firm [Member]
Class of Stock [Line Items]
Conversion of accounts payable		$ 33,000
Conversion of accounts payable, shares issued		16,500
Incentive Shares [Member] | Walleye Opportunities Master Fund [Member]
Class of Stock [Line Items]
Stock issued new, shares								34,849
Fair value of warrants								$ 122,426
Prefunded Warrants [Member] | February 2023 Offering [Member] | Underwriter [Member]
Class of Stock [Line Items]
Warrants issued, shares							80,645
Prefunded Warrants [Member] | June 2023 Offering [Member]
Class of Stock [Line Items]
Stock converted, shares converted														$ 478,334
Series 2023 Warrants [Member] | February 2023 Offering [Member] | Underwriter [Member]
Class of Stock [Line Items]
Warrants issued, shares							120,968
Series 2023 Warrants [Member] | Cashless Basis [Member] | February 2023 Offering [Member]
Class of Stock [Line Items]
Warrants issued, shares							403,226

v3.24.3

STOCK OPTION PLANS AND WARRANTS (Details - Options assumptions) - Equity Option [Member]	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility	199.68%	166.87%
Expected dividend yield	0.00%	0.00%
Risk-free interest rate	3.42%	3.54%
Expected term (in years)	7 years 6 months	6 years 8 months 1 day

v3.24.3

STOCK OPTION PLANS AND WARRANTS (Details - Options outstanding) - Equity Option [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding, beginning balance	1,876,275
Weighted average exercise price outstanding, beginning balance	$ 9.11
Weighted average remaining contractual term (Years)	4 years 3 months 21 days	5 years 18 days
Aggregate intrinsic value outstanding, beginning balance	$ 252,000
Shares, granted	833
Weighted average exercise price, granted	$ 0.50
Weighted average contractual term, granted	8 years 6 months 3 days
Aggregate intrinsic value, granted	$ 1,658
Shares, cancelled or expired	(4,094)
Weighted average exercise price, cancelled or expired	$ 0
Aggregate intrinsic value, cancelled or expired	$ 0
Shares outstanding, ending balance	1,873,014	1,876,275
Weighted average exercise price outstanding, ending balance	$ 7.56	$ 9.11
Aggregate intrinsic value outstanding, ending balance	$ 4,123,658	$ 252,000
Shares, options exercisable	1,873,013
Weighted average exercise price, options exercisable	$ 7.56
Weighted average remaining contractual term (Years), options exercisable	4 years 3 months 21 days
Aggregate intrinsic value, options exercisable	$ 4,123,658

v3.24.3

STOCK OPTION PLANS AND WARRANTS (Details - Warrants assumptions) - Warrant [Member]	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Expected volatility	217.65%	172.63%
Expected dividend yield	0.00%	0.00%
Risk-free interest rate	3.98%	3.85%
Expected term (in years)	2 years 10 months 17 days	5 years

v3.24.3

STOCK OPTION PLANS AND WARRANTS (Details - Warrants outstanding) - Warrant [Member] - USD ($)	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares outstanding, beginning balance	653,357
Weighted average exercise price outstanding, beginning balance	$ 58.54
Weighted average remaining contractual term (years)	3 years 7 months 20 days	4 years 2 months 12 days
Aggregate intrinsic value outstanding, beginning balance	$ 28,000
Shares, granted	250,000
Weighted average exercise price, granted	$ 0.60
Weighted average remaining contractual term granted (years)	4 years 1 month 6 days
Aggregate intrinsic value, granted	$ 472,500
Shares, cancelled or expired	0
Weighted average exercise price, cancelled or expired	$ 0
Aggregate intrinsic value, expired	$ 0
Shares outstanding, ending balance	903,357	653,357
Weighted average exercise price outstanding, ending balance	$ 42.51	$ 58.54
Aggregate intrinsic value outstanding, ending balance	$ 903,500	$ 28,000
Shares, warrants exercisable	903,357
Weighted average exercise price, warrants exercisable	$ 42.51
Weighted average remaining contractual term (years), warrants exercisable	3 years 7 months 20 days
Warrants exercisable, aggregate intrinsic value	$ 903,500

v3.24.3

STOCK OPTION PLANS AND WARRANTS (Details Narrative) - USD ($)				1 Months Ended						9 Months Ended		12 Months Ended
	Jun. 03, 2024	Dec. 19, 2023	Jun. 30, 2023	Apr. 30, 2024	Jul. 31, 2023	Apr. 30, 2023	Mar. 31, 2023	Feb. 28, 2023	Apr. 30, 2022	Sep. 30, 2024	Sep. 30, 2023	Dec. 31, 2023	May 15, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Unamortized compensation cost										$ 464
Cash compensation										$ 1,410	$ 22,295
Warrants exercisable description										In September of 2024 the consultant received an additional 100,000 warrants exercisable at $0.50 and 50,000 warrants exercisable at $1.00 per share. Warrants contain the same terms as exist in the warrants issued in June of 2024. See Note 5 for further discussion
One Year Consulting Contract [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Cash compensation	$ 85,000
Signing bonus in cash	$ 25,000
Number of warrants purchased	100,000
Excercise price, per share	$ 0.50
Options [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Stock-based compensation expense										$ 1,410	$ 22,295
Common Stock Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants issued, shares												2,849,551
Common Stock Warrants [Member] | OID Promissory Note [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants issued, shares					174,242
Common Stock Warrants [Member] | February 2023 Offering [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants issued, shares								850,308
Common Stock Warrants [Member] | February 2023 Offering [Member] | Prefunded Warrants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants issued, shares								285,792
Prefunded Warrants [Member] | June 2023 Offering [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants issued, shares			1,625,000
Warrants exercised, shares					478,333
Consultant [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Warrants issued												200,000
Plan EP 2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares authorized													166,667
Plan 2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Number of shares authorized		2,000,000
Plan 2023 [Member] | Various Officers, Directors, Employees And Consultants [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares granted		1,800,000
Options granted, exercise price		$ 0.20
Plan 2021 [Member] | Dean Julia [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares granted				833		833			833
Options granted, exercise price				$ 0.50		$ 3.30			$ 23.25
Plan 2021 [Member] | Nate Knight [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares granted							1,667
Options granted, exercise price							$ 3.30
Plan 2021 [Member] | Byron Booker [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Shares granted						1,667
Options granted, exercise price						$ 3.30

v3.24.3

EARNINGS (LOSS) PER SHARE (Details - Potentially dilutive equity securities) - shares	9 Months Ended	12 Months Ended
	Sep. 30, 2024	Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	2,996,177	10,434,169
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	1,873,014	1,876,275
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	903,357	653,358
Series AAA Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	209,525	209,525
Series E Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	10,281	10,281
Series H Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total common stock equivalents	0	7,684,730

---